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This thesis describes a series of experiments using the
technique of microelectrophoresis. The aim of the experiments was
to investigate the pharmacological actions of noradrenaline on
single cerebral cortical neurones, and to study the interaction
between noradrenaline and tricyclic antidepressant drugs.
1. A series of experiments was conducted on the release
of "^C-labelled noradrenaline from micropipettes in vitro. It was
found that (a) in the absence of an electrophoretic current a constant
rate of release was established; (b) all retaining currents tested
gradually reduced spontaneous release to zero; (c) electrophcretic
release was linearly related to the intensity of the ejecting
current; (d) retaining currents reduced the amount of noradrenaline
released during a subsequent ejection period. These findings are
interpreted in terms of a theoretical model of ion movements in
micropipettes.
2. The effects of ejecting and retaining currents on the
time-course of neuronal responses were investigated. It was found
that the kinetics of neuronal responses to microelectrophoretically
applied drugs were closely related to the kinetics of drug release.
3. Three kinds of response could be evoked by noradrenaline
on cortical neurones: excitatory, depressant and biphasic responses.
It was found that the proportions of cells excited and depressed
by noradrenaline were related to the baseline firing rates of the
neurones studied, a high firing rate increasing the probability of
observing depressant responses, and a low firing rate favouring the
occurrence of excitatory responses. No correlation could be found
between the direction of the response to noradrenaline and the pH
of the noradrenaline solution within the micropipette.
4. The <J~~adrenoceptor stimulating agents phenylephrine
and methoxamine evoked only excitatory responses, whereas the
adrenoceptor agonist salbutamol had only depressant effects.
Isoprenaline, similarly to noradrenaline, could evoke both depressant
and excitatory responses: while lower doses evoked depressant
responses, higher doses were usually excitatory on the same cells.
Excitatory responses could be selectively antagonised by the e>£—
adrenoceptor blocking agents phentolamine and phenoxybenzamine, whereas
the depressant responses could be selectively antagonised by the
adrenoceptor blocking agent sotalol. These findings suggest that
both <4— and ^-adrenoceptors occur on cortical neurones, and that
these receptors mediate opposite effects, the <4-receptors being
excitatory, and the ^-receptors being inhibitory.
5* Dopamine, similarly to noradrenaline, could evoke both
excitatory and depressant responses on cortical neurones^ there was
a high correlation between the direction of responses to dopamine
and noradrenaline. Dopamine tended to evoke smaller responses than
noradrenaline, although the transport number of dopamine was somewhat
higher than that of noradrenaline. Both the cJL—adrenoceptor blocking
agent phenoxybenzamine, and the neuroleptics haloperidol and <4-
flupenthixol could discriminate between excitatory responses to
dopamine and noradrenaline: while responses to dopamine were more
sensitive to the antagonistic effects of neuroleptics, responses to
noradrenaline were more susceptible to the blocking effect of
phenoxybenzarnine. These observations suggest the existence of two
separate excitatory catecholamine receptors: an '/.-adrenoceptor and a
dopamine receptor.
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6. The noradrenaline pre cursor L-dihydroxyphe nylalanine
(DOPA) mimicked the effects of noradrenaline: each cell excited
by DOPA, was also excited by noradrenaline, and each cell depressed
by DOPA was also depressed by noradrenaline. DOPA appeared to be
less potent than noradrenaline, and evoked responses of a slower
time-course than noradrenaline. Responses to DOPA coiild be antagonised
by the adrenoceptor blocking agents phentolamine a.nd propranolol.
These results are consistent with the hypothesis that the responses
to DOPA are mediated via adrenoceptors.
7. The tricyclic antidepressant drugs imipramine and
desipramine had a dual effect on both excitatory and depressant
responses to noradrenaline: while smaller doses potentiated, bigger
doses antagonised the responses. It is suggested that potentiation
may reflect the blockade of uptake of noradrenaline into presynaptic
noradrenergic terminals, whereas antagonism may reflect the direct
post—synaptic adrenoceptor blocking properties of tricyclic
antidepressants.
8. Responses to noradrenaline could also be potentiated by
iprindole, a tricyclic antidepress.ant with no uptake blocking activity.
This observation would suggest the existence of a postsynaptic mechanism
for potentiation.
9. Responses to mescaline could also be potentiated by
desipramine, although this antidepressant does not block the uptake
of mescaline into brain tissue. This finding would suggest the
existence of a postsynaptic mechanism for potentiation.
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10. The indirectly acting sympathomimetic amine tyramine
could evoke "both, excitatory and depressant responses on cortical
neurones. There was a high correlation between the direction of
responses to tyramine and noradrenaline. Tyramine appeared to be
less potent than noradrenaline, although there was no significant
difference between the transport numbers of the two amines, Tyramine
evoked 'slower* responses than noradrenaline. Besipramine could
discriminate between responses to tyramine and noradrenaline: while
responses to tyramine were antagonised, responses to noradrenaline
were either potentiated or unaffected. These results are consistent
with the hypothesis that tyramine acts by releaseing noradrenaline
from presynaptic stores, and that desipramine blocks the uptake of
both tyramine and noradrenaline.
11. A theoretical model of 'antagonistic agonism* is
developed to describe the action of an agonist at two functionally
antagonistic receptor populations within the same pharmacological
test system. The model is applied to the case of functionally
antagonistic eL— and p—adrenoceptors on cortical neurones. The
possible functional significance of 'opposite receptors' is discussed.
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CHAPTER I
GENERAL INTRODUCTION
This thesis examines the pharmacology of neuronal adrenoceptors
in the cerebral cortex, and also investigates how tricyclic anti¬
depressant drugs interact with these receptors. The thesis consists
of eleven chapters which can be divided into three groups: Chapters II
and III deal with some methodological aspects of the microelectro-
phoretic technique; Chapters IV - VII examine the pharmacology of
neuronal adrenoceptors; Chapters VIII — XI are devoted to the neuronal
pharmacology of tricylic antidepressant drugs. Since the experimental
evidence presented in Chapters IV - VII suggests that noradrenaline
may activate functionally antagonistic receptors on the same neurone,
'an Appendix is included which examines the quantitative pharmacology
of such a test system.
The aim of this General Introduction is to briefly summarize
our state of knowledge in the fields most relevant to this thesis.
Since each Chapter has its own introduction, no attempt is made here
to give a comprehensive review of the literature.
1.1. ADRENOCEPTORS
Noradrenaline (NA) is the natural transmitter substance of
peripheral sumpathetic neurones, and adrenaline is the hormone released
by gland cells in the adrenal medulla. Both noradrenaline and
adrenaline evoke distinct pharmacological changes in peripheral
tissues (smooth muscle cells, gland cells). The pharmacological
receptors mediating these responses are referred to as adrenoceptors
(or adrenergic receptors) (see Furchgott, 1972; Burnstock & Costa, 1975j
Triggle & Triggle, 1976) .
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It is usual to distinguish, between two major classes of
adrenoceptors: cL—receptors and ^-receptors (Ahlquist, 1948)* The
distinction "between these two classes of adrenoceptor is based on
the relative potencies of various adrenergic agonists and on the
susceptibility to blockade by specific adrenergic antagonists.
oA-adrenoceptors are characterised by the following relative molar
potency series of agonists: adrenaline noradrenaline >phenylephrine
isoprenaline; these receptors can be specifically blocked by
phentolamine, dibenamine, or phenoxybenzamine. ^ —adrenoceptors are
characterized by the foilowing relative potency series of agonists:
isoprenaline "p? adrenal ir.e noradrenaline p> phenylephrine, or:
isoprenaline > noradrenaline > adrenaline 7> phenylephrine; these
receptors can be blocked by relatively low concentrations of
propranolol or pronethalol. Recently subtypes of (J-receptors
and (i ) have been differentiated (see Furchgott, 1972).
1.2. THB NORASREIIBRGIC SYSTEM 0? TH3 BRAIN
With the use of the Falck-Hillarp fluorescent histochemical
technique, Dahlstrom & Fuxe (1965) and Fuxe (1965) demonstrated a
noradrenergic neuronal system in the brain. The NA—containing cell
bodies are localized in distinct nuclei of the lower brain stem, and
project diffusely to most parts of the neuraxis. The terminals of the
NA—containing neurones arborize similarly to peripheral vegetative
neurones creating characteristic 'varicosities' (cf. the sympathetic
ground plexus or terminal network; see Burnstock & Costa, 1975)-
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There are three groups of HA—containing cell bodies in the
brain stem (Fig. l/l): 1. caudal group (in the lateral reticular
formation of the medulla oblongata); 2. oral group (in the
reticular formation of the medulla and the pons); 3. locus coeruleus
(Dahlstrom & Fuxe, 1965; Ungerstedt, 1971). The caudal group gives
rise to a descending system of fibres which innervate neurones in the
ventral and lateral horns of the spinal cord. The oral cell group
gives rise to two fibre tracts: 1. short axons to cells in the mid¬
brain reticular formation; 2. the ventral ascending noradrenaline-
bundle to the hypothalamus and the limbic system. The locus coeruleus
(a small cell group on the floor of the fourth ventricle) is the most
important of the HA—containing cell groups. Three important tracts
originate from this nucleus: 1. descending pathway to nuclei in the
lower brain stem; 2. lateral pathway to the cerebellum; 3. ascending
pathway ('dorsal ascending noradrenaline bundle') to the hypothalamus,
limbic system (especially hippocampus), and neocortex. There is
evidence suggesting that one single NA-containing neurone in the locus
coeruleus can send axon collaterals to three different structures (to
the neocortex, hippocampus, and cerebellum) (Ungerstedt, 1971)»
Recently it has been demonstrated that the majority of the
noradrenergic varicosities do not form synaptic contacts: they are
located in gaps between glia cells and nerve cells, and the released
noradrenaline probably affects a larger number of neurones situated
in the vicinity of the site of release (Descarries et al.t 1977).




FIGURE l/l. Schematic diagram of the noradrenaline-containing
neuronal system.
1; caudal cell group and the descending noradrenaline "bundle;
2: oral cell group and the ventral ascending noradrenaline "bundle;
3: locus coeruleus and its projections to the brain stem, to the
cerebellum, and to the limbic lobe and neocortex (dorsal ascending
noradrenaline bundle).
1.3. THE TECHNIQUE 0? MICR05LECTR0PH0EB5IS
The technique of microelectrophoresis enables the investigator
to apply drugs into the immediate vicinity of central neurones, whilst
recording the electrical activity of the neurone under study. This
technique was first developed by Nastuk (1953) an<^ Castillo & Katz
(1955; 1957) f°r study of muscle end—plate pharmacology; later
the technique was adopted by Curtis and his colleagues (see Curtis,
1964) for the study of the pharmacology of single central neurones.
For the study of central neurones, multibarrelled micro-
pipettes are usually used: one barrel is filled with a concentrated
sodium chloride solution for the recording of action potentials,
whe re as the remaining barrels contain ionized drug solutions. A
schematic diagram of the experimental 'set-up' is shown in Fig. 2/l;
for details see II.2. and III.2. Drug molecules are ejected from the
micropipette, or retained within the pipette by the passage of current
of appropriate polarity. Action potentials can be displayed on the
screen of an oscilloscope (which can be filmed for permanent records),
can be stored on tape, or can be converted into a ratemeter write-out
(see Fig. 3/l; for details see III.2.).
There are detailed reviews describing several aspects of the
microelectrophoretic technique (Curtis, 1964; Kelly, Simmonds &
Straughan, 1975? Kelly, 1975)* Chapters II and III of this thesis
deal with some quantitative aspects of the technique: Chapter II




FIGURE 2/l. Schematic diagram showing the experimental 'set-Tip' used
in microelectrophoresis experiments.
Only two "barrels of a mult i—barrel lad micropipette are
shown. The tip ox the micropipette is in the proximity of a central
neurone. On the left, the recording "barrel, which is filled with a
saline solution, is connected to an oscilloscope and to a ratemeter.
On the right, the 'drug "barrel1 is connected to an electrophoretic
current source.
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PIGUIS 3/1. The excitatory response of a single neurone in the
cerebral cortex of the cat to noradrenaline applied by microelectrophoresis.
The top of the figure shows excerpts from the oscilloscope
photographs of the firing of the neurone. Vertical deflections
correspond to individual action potentials. On the left: before
noradrenaline was applied; in the middle: during the application of
noradrenaline; on the right: after the application of noradrenaline.
The bottom of the figure shows the whole excitatory response
in the form of a ratemeter write-out. Ordinate: firing rate (spikes/
sec); abscissa: running time (min). The horizontal bar indicates the
microelectrophoretic application of noradrenaline; the number refers
to the intensity of the ejecting current in nanoamperes (nk).
~ 9 -
(e.g. noradrenaline) from micropipettes; Chapter III examines the
relationship "between the kinetics of the release of drugs from
micropipettes and the time—course of neuronal responses.
1.4. NEURONAL RESPONSES TO NORADRENALINE
The use of the microelectrophoretic technique has revealed
that most parts of the mammalian central nervous system contair-
neurones which are sensitive to NA (for reviews see Curtis &
Crawford, 1969; Krnjevic; 1974> Tebecis, 1974).
1,4.1. SPINAL COED
a, Intemeurones and Renshaw cells
Curtis et al. (l96l) found that NA was without an effect on
neurones in the spinal cords of cats anaesthetised with "barbiturates.
Later, however, both depressant and excitatory actions of NA were
described on spinal interneurones.
Bngberg & Eyall (1966) and Curtis et al. (1971) described
a depressant action of NA on spinal interneurones and Renshaw cells;
these responses could be blocked by strychnine while responses to
T—aminobutyric acid were not affected (Curtis et al., 1971). Weight
& Salmoiraghi (1966) observed both excitatory and depressant responses
of spinal interneurones to NA applied by microelectrophoresis.
Biphasic responses (consisting of an initial depressant phase followed
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by an excitation) also occurred in their material. Similarly, in
a recent paper, Headley & Lodge (1976) described two kinds of
responses to NA on spinal interneurones and Kershaw cells: monophasic
depressant responses and biphasic responses consisting of a depressant
phase followed by an excitatory phase. These authors suggested that
NA might activate both inhibitory and excitatory receptors on spinal
neurones.
b. Motoneurones
Sngberg & Marshall (1971) examined the effects of micro-
electrophoretically applied NA on the membrane potential of motoneurones,
using intracellular recording. These authors found that NA hyper-
polarized the motoneurone membrane; this hyperpolarisation was
accompanied by a decrease in membrane conductance. More recently,
Engberg et al. (1976) concluded that the membrane hyperpolarization
of motoneurones evoked by NA probably was not mediated via specific
adrenoceptors, since a wide range of different agents (adrenergic
agonists, antagonists, and neuroleptics) evoked very similar effects.
In contrast to the reports of Engberg and his collegues, Barasi &
Roberts (1977) found an excitatory action of NA on motoneurones: NA
increased the amplitude of field potentials originating from
antidromically activated motoneurones. These authors condluded that




Straschill & Perwein (1971) reported, a depressant action of
NA on neurones in the mesencephalic reticular formation. However,
most investigators described both excitatory and depressant responses
of neurones to HA in the "brain stem reticular formation (Boakes et al.,
1970; Boakes et al., 19717 HGsli et al., 1971; Anderson et al., 1973).
Biphasic responses were also observed.
The excitatory and depressant responses of brain stem neurones
were not affected by conventional and ^-adrenoceptor blocking
agents (Boakes et al., 1971). On the other hand, the excitatory
responses could be blocked by chlorpromasine (Bradley et al., 1966)
and tJL—methyl-no radrenaline (Boakes et al., 1971) ; where as the depressant
responses could be antagonised by mescaline (Gonzalez-Vegas, 19?l)>
3,4-limethoxyphenylethy1amine (Gonzalez-Vegas & Wolstencroft, 1971a),
and bulbocapnine (Gonzalez-Vegas & Wolstencroft, 1971b)«
b. Superior colliculus
Straschill & Perwein (1971) described a depressant action of
NA on collicular neurones.
c. Substantia nigra
■ . - . . . .1 ■w . 1 .
Kemp et al. (1977) described both excitatory and depressant




In the lateral vestibular nucleus, Yamamoto (1967) described
an excitatory action of KA on single neurones. This observation
has been recently confirmed by Kirsten & Sharma (1976)* Yamamoto
(1967) found that the excitatory responses were not antagonised by
phentolamine, but could be blocked by dichloroisoprenaline (fCl).
On the other hand, Kirsten & Sharma (1976) found that the excitatory
responses could be abolished by phentolamine, while sotalol or
propranolol were without effect.
In contrast to the lateral vestibular nucleus, a depressant
action of KA was described on neurones in the medial vestibular nucleus;
these depressant responses could not be modified by either the —
adrenoceptor blocking agent phentolamine, or the —adre nocept or
blocking agents sotalol and propranolol (Kirsten & Sharma, 1976).
e. Raphe nuclei
Both excitatory and depressant responses to KA were described
on neurones of the raphe nuclei (Couch, 1970).
f. Locus coeruleus
Only depressant responses to KA were reported on neurones
of the locus coeruleus (Svenson et al. 1975; Cederbaum & Aghajanian,
1976). These cells were depressed by three other adrenoceptor
stimulants (adrenaline, isoprenaline and clonidine); the depressant
responses could be antagonised by the ^-adrenoceptor blocking agent
piperoxane, but were not affected by the ^—adrenoceptor blocking
agent sotalol (Cederbaum & Aghajanian, 1976).
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1.4,3. CEREBELLUM
Yamamoto (1967) observed both excitatory and depressant
neuronal responses to HA in the cerebellar flocculus; approximately
two—thirds of the NA-sensitive cells responded with excitation, and
one-third with depression. On the other hand, HA had an almost
exclusively depressant effect on neurones in the neocerebellar
cortex.
Detailed studies have been made of the pharmacology of
cerebellar Purkinje cells in the past few years. These cells can
be identified by their characteristic firing, and, due to their
large size, are eminently suitable for intracellular recording.
Only a depressant action of HA has been described on cerebellar
Purkinje cells (Hoffer et al., 1971b; Siggins et al.t 1971a;
Curtis et al., 1971!? Godfraind & Pumain, 1972; Lake & Jordan,
1974; Woodward et al., 1974; Freedman & Hoffer, 1975; Kostopoulos
& Yarbrough, 1975? Preedman et al., 1975; Hoffer et al., 1976;
Yarbrough, 1976; Freedman et al., 1976). Experiments involving
intracellular recording (Siggins et al., 1971h) showed that HA
hyperpolarized the membrane of Purkinje cells; this hyperpolarization
was accompanied by a decrease in membrane conductance.
The depressant responses of Purkinje cells to HA could be
antagonised by the ^-adrenoceptor blocking agent sotalol (Hoffer
et al., 1971b; Woodward et al., 1974) and by the neuroleptics
fluphenazine (Preedman & Hoffer, 1975; Hoffer et al., 1976) and
flupenthixol (preedman & Hoffer, 1975). THe responses to HA
could be potentiated by the tricyclic antidepressant drug desipramine
(Hoffer et al., 1971b).
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Siggins et al. (1971a; 1971h) suggested that the depressant
responses of cerebellar Purkinje cells to NA were mediated by cyclic-
AKP: the depressant effects of NA were mimicked by cyclic-AKP, and
the effects of both NA and cyclic-AKP were potentiated by theophylline
and aminophylline, drugs which inhibit the enzyme phosphodiesterase
and thus increase the concentration of cyclic-AMP in the tissue.
However, Godfraind & Pumain (1972) and Lake & Jordan (1974) could
not replicate the observations of Siggins et al. (1971a.) • These dis¬
crepant results have been attributed to technical differences between
the laboratories concerned (Bloom, 1975)•
1.4.4* HYPOTHALAMUS
a. Supraoptic nucleus
_ Barker et al. (1971) studied the effects of NA, dopamine and
acetylcholine on neurones in the supraoptic nucleus. Only depressant
responses to NA occurred on supraoptic neurones; there was no
difference between neurosecretory (i.e. cells responsible for the
secretion of the antidiuretic hormone, ASH) and non—neurosecretory
cells, in this respect. The depressant responses to NA could be
antagonised by the ^-adrenoceptor blocking agent sotalol, and
could be potentiated by the tricyclic antidepressant drug desipramine.
Sakai et al. (1974) also observed a depressant action of NA on
supraoptic neurones in an in vitro organ culture preparation.
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b. 3upra.chiasmatic nucleus
Neurones in the suprachiasmatic nucleus are thought to be
involved with the regulation of the circadian rhythm of pineal
enzyme content (Moore & Klein, 1974); these neurones are also
functionally linked to the visual system (llishino et al., 1976).
Nishino & Koizumi (1977) examined the effects of NA°suprachiasmatic
neurones. The cells could be divided into three groups: cells
responding with an increase, a decrease, or no change in their
firing frequency to optic nerve stimulation. NA could evoke both
excitatory and depressant responses on neurones belonging to either
of the three neuronal groups.
c. Preoptic nuclei
i. Cells activated by the stimulation of the basal hypothalamus.
It is believed that these cells are involved in the control of ovulation
(Dyer, 1973). Only depressant responses to NA have been described on
these neurones (Dyball & Dyer, 1974 ; Dyball et al., 1974; Whitehead
& Huf, 1974).
ii. Thermosensitive cells. Both excitatory and depressant
responses to NA have been described on thermosensitive neurones in
the preoptic and .anterior hypothalamic area (Beckman & Eisenman, 1970;
Hori & Nakayama,1973; Jell, 1973; Murakami, 1973). No significant
difference could be found between thermosensitive and thermo—insensitive
cells on the basis of their responsiveness to NA (jell, 1973)* When
the responsiveness to NA of warm-sensitive and cold-sensitive cells
were compared, the waim—sensitive cells appeared to be usually depressed
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and the cold-sensitive cells usually excited by NA (Beckman &
Eisenman, 1970; Murakami, 1973). On the other hand, 5_Aydroxy—
tryptamine tended to excite the warm sensitive cells, and depress
the cold-sensitive ones (Murakami, 1973).
d. Paraventricular nucleus
Neurosecretory cells in this area are thought to be
responsible for the secretion of the hormone oxytocin (see Moss
et al., 1972). The neurosecretory cells can be identified in this
nucleus by the antidromic stimulation of ihe axons in the neural
hypophysis (Sunasten et al., 1970). NA could evoke responses on
both neurosecretory and non-neurcsecretory cells: while almost all
the NA-sensitive neurosecretory cells responded with depression
(Gross et al., 19715 Moss et al., 1972), the predominant action
of NA was excitation on the non—neurosecretory cells (Moss et al.,
1972).
e, Tuberal nuclei
This area of the hypothalamus (arcuate nucleus and median
eminence) is thought to be responsible for the production of
releaseing and inhibitory factors which control the secretion of
gonadotrophic hormones (McCann & Porter, 1969). Geller (1976)
studied the sensitivity of neurones to potential neurotransmitters
in these nuclei in vitro using explant tissue cultures, NA applied
by microelectrophoresis could evoke both excitatory and depressant
responses; the majority of the neurones, however, were depressed by
NA in this preparation.
- 17 -
1.4.5* THALAMUS
a. Yentrobasal nuclear complex
These thalamic nuclei contain the thalamo-cortical relay
neurones which can he identified by their antidromic responses to
stimulation of the somatosensory cortex. Both excitatory and
depressant responses to NA could be observed on neurones in the
ventrobasal thalamus; while more superficially situated neurones
were usually depressed, deeper neurones responded with excitation
or depression in approximately equal proportions (Phillis & Tebecis,
1967a; 1967b).
b< Medial geniculate nucleus
Tebecis (1967; 1970) observed excitatory, depressant and
biphasic responses to NA on unidentified medial geniculate neurones;
the majority of the NA-sensitive cells responded with depression.
Repeated applications of NA lead to desensitisation of excitatory,
but not of depressant responses. Strychnine blocked the depressant
effects of NA, but only when applied with much higher ejecting
currents than were required to antagonise depressant responses to
glycine.
c. Lateral geniculate nucleus
Curtis & Davis (1962) and Phillis et al., (1967) found that
NA depressed the orthodromic field potential and spontaneous firing
of lateral geniculate neurones. On the other hand, Satinsky (1967)





Host reports describe only a depressant action of NA on
hippocampal neurones (Stefanis, 1964? Herz & Nacimiento, 19&5i
Salmoiraghi & Stefanis, 1965? Biscoe & Straughan, 1966; Segal, 1974»
Segal & Bloom, 1974? Ssga.1, 1976). The depressant responses to NA
could be antagonised by the ^-adrenoceptor blocking agent sotalol,
and potentiated by the tricyclic antidepressant drug desipramine
(Segal & Bloom, 1974)» The depressant responses could also be
modified by drugs interfering with the cyclic-AMP system: the
phosphodiesterase inhibitor papaverine potentiated the responses,
whereas prostaglandins of the E series antagonised them, suggesting
the involvement of cyclic-AMP in the mediation of the responses
to NA (Segal & Bloom, 1974). There are some indications, however,
that NA may also have an excitatory action on hippocampal neurones:
Segal & Bloom (1974) reported that the depressant responses to
NA were often followed by a 'rebound* excitation,
b. Septal nuclei
Only a depressant effect of NA has been reported on neurones
in this brain area (Herz & Gogolak, 1965j Segal, 19746).
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c. Olfactory "bulb
Only a depressant action of NA has been described on
mitral cells in this structure (Baumgarten et al., 1963; Bloom et al»,
1964; Salmoiraghi et_jal., 1964; McLennan, 19?l)» The depressant
responses to NA could be blocked by the cL—adrenoceptor blocking
agent dibenamine, but not by the ^-adrenoceptor blocking agent
dichloroisoprenaline (BCl) (Salmoiraghi et al., 1964)•
In contrast to the mitral cells, granule cells in the
olfactory bulb were excited by NA, and this excitation was usually
accompanied by a depression of the firing of the mitral cell
recorded simultaneously (McLennan, 1971)• McLennan (1971) suggested
that the depression of mitral cells by NA might be mediated by the
excitation of granule cells which have inhibitory synaptic contacts
with the mitral cells.
1.4.7. CORPUS STRIATUM
Herz & Zieglgansberger (1968) described only depressant
responses to NA on single neurones in the caudate nucleus; most
other authors, however, reported both excitatory and depressant
responses (Bloom et al., 1965; Salmoiraghi & Stefanis, 1965; York,
1970; Spencer & Havlicek, 1974; Bevan et al., 1975c)« The excitatory
responses to NA could be antagonised by the ^-adrenoceptor blocking
agent phentolamine, whereas the depressant responses could be
antagonised by the ^-adrenoceptor blocking agents sotalol and INFEA
(York, 1970)• Both the excitatory and the depressant responses
could be potentiated by the tricyclic antidepressant drug desipramine
(Bevan et al., 1975c).
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1.4.8, CBHEBRAL CORTEX
For review of the literature see IV,1,
1.4.9. CONCLUSIONS
The review of the literature shows that, in most structures
of the "brain (spinal cord, brain stem, hypothalamus, thalamus, limbic
system, corpus striatum, cerebral cortex), NA has a dual effect:
both excitatory and depressant responses have been described. These
observations suggest that NA can activate both excitatory and
inhibitory receptors on central neurones, A study of the distribution
of these receptors suggests that while some neurones may contain only
one kind of receptor, other neurones may possess both excitatory
and inhibitory receptors for NA. Thus neurones in the lateral
vestibular nucleus (Yamaraoto, 1967), or cold—sensitive cells in
the anterior hypothalamus (Murakami, 1973) appear to possess only
excitatory receptors, whereas cerebellar Purkinje cells (Hoffer et al.t
1971b), or warm-sensitive cells in the anterior hypothalamus (Murakami,
1973) seem to have only inhibitory receptors. The occurrence of
biphasic responses to NA in several structures (e.g. spinal cord,
brain stem reticular formation, medial geniculate nucleus) suggests
that both excitatory and inhibitory receptors may be present on
the same cells (see Headley & Lodge, 197o> Hosli et al., 1971;
Tebecis, 1970).
There are also reports concerning the effects of both el¬
and ^-adrenoceptor blocking agents on neuronal responses to NA.
Although no general conclusions can be drawn from these experiments,
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some of the observations are consistent with the hypothesis that
the excitatory responses may be mediated by "sC—, and the depressant
responses by ^-adrenoceptors, Thus the excitatory responses to NA
could be antagonised by cA-adrenoceptor blocking agents in the
lateral vestibular nucleus (Kirsten & Sharma, 1976) and in the
striatum (York, 1970), whereas the depressant responses could be
abolished by (2> —adrenoceptor blocking agents in the cerebellum
(Hoffer et al., 1971b), supraoptic nucleus (Barker et al., 1971)>
hippocampus (Segal & Bloom, 1974) and striatum (York, 1970), On
the other hand, there are also observations which suggest that
depressant responses to NA may be mediated by *L-adrenoceptors
in some structures of the brain: depressant responses to NA of neurones
in the locus coeruleus (Cedarbaum & Aghajanian, 1976), and of mitral
cells in the olfactory bulb (Salmoiraghi et al., 1964) could be
antagonised by e£—adrenoceptor blocking agents, but not by (J —
adrenoceptor blocking drugs. It should be noted, however, that
the observations of McLennan (l97l) in the olfactory bulb suggest
that the depressant responses of mitral cells to NA may be mediated
by excitatory NA-receptors situated on inhibitory intemeurones,
1.5. TRICYCLIC ANTIDEPRESSANT DRUGS AND THE ADHENERGIC SYSTEM
The term •tricyclic antidepressant' refers to a group
of compounds with a structure and pharmacological action profile
which is similar to that of imipramine, Imipramine is a dibenzo—
zapine derivative with a structural formula very similar to that
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of chlorpromazine. The clinical antidepressant properties of
imipramine were discovered "by Kuhn in 1957; since then a large
number of similar compounds (e.g. desipramine, amitriptyline,
nortriptyline, protriptyline) have been synthesized. The
pharmacological actions of these drugs have been studied extensively
(for reviews see Domenjoz & Theobald, 1959; Klerman & Cole, 19^5;
Gyermek, 1966; Bickel, 1968; Bopp & Biel, 1974)• Similarly to
chlorpromazine, these drugs possess anticholinergic, antihistamine,
antiserotonin, adrenolytic and local anaesthetic properties. In
contrast to chlorpromazine, however, these drugs reverse the
reserpine-induced sedation in rodents, and potentiate the behavioural
and motor responses produced by amphetamine and L—DOPA. These effects
have been used in the pharmacological screening for compounds with
potential antidepressive properties. The most characteristic and
most widely studied effect of these drugs, however, is their inter¬
action with the adrenergic system.
1.5.1. UPTAKE BLOCKADE
NA applied to sympathetically innervated tissues is
accumulated into sympathetic nerve terminals by an active, temperature-
dependent, energy-requiring process. It is believed that the re-uptake
of the released NA by this active 'membrane pump' is the most
important way of eliminating the transmitter from the synaptic gap.
A similar active uptake process for NA has been described in brain
tissue. The active uptake of NA into nerve terminals can be
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inhibited by a variety of compounds, such as cocaine, sympathomimetic
amines, phenothiazines, and tricyclic antidepressants. In fact the
tricyclic antidepressants are among the most potent inhibitors of
NA uptake both in the periphery and in the CNS. (For reviews see
Iversen, 1967; Iversen, 1974; Iversen, 1975; see also VIII.1. and
IX.1.).
1.5.2, POTEKTIATION OF ADRENERGIC RESPONSES
The tricyclic antidepressants have been shown to be able
to potentiate the responses of smooth muscle preparations to
exogenously applied NA. Thus potentiation of the effects of NA
has been described in the nictitating membrane (Sigg, 1959; Goffer
& Gyermek, 1961; Sturman, 1971); in the vascular bed (Osborne &
Sigg, I960; Osborne , 1962) ; in isolated arteries (Tiirker &
Khairallah, 1967} Bassett et al., 1969; Hrdina & Ling, 1970;
Torda, 1971; McCulloch & Story, 1972); in the vas deferens (Westfall,
1973); in the anococcygeus muscle (Doggrell & Woodruff, 1977). The
tricyclic antidepressants can also potentiate tissue responses to
sympathetic nerve stimulation, especially when low frequencies of
stimulation are used (Sigg et_al., 1963; Haefely et al., 1964;
Sturman, 1971; Torda, 1971).
It is generally believed that there is a close relation¬
ship between the blockade of the neuronal uptake of NA and the
potentiation of adrenergic responses: uptake blockade results
in a higher concentration of NA at the postsynaptic receptors, and
this results in an increased response (see Iversen, 1974). This
hypothesis is supported "by the results of denervation experiments:
no potentiation of the effects of HA "by tricyclic antidepressants
could "be observed in sympathetically denervated smooth muscle
preparations (Gyermek & Possemato, I960; Callingham, 1967; Sturman,
1971J McCulloch & Story, 1972; Westfall, 1973).
There are reports, however, which suggest that uptake
"blockade and potentiation do not necessarily co-exist in the same
preparation. Thus in the Auerbach's plexus - longitudinal smooth
muscle preparation of the guinea pig, tricyclic antidepressants
fail to potentiate tissue responses to HA, although they effectively
"block the uptake of HA (Govier et al., 1969). On the other hand,
the tricyclic antidepressant iprindole potentiates tissue responses
to HA, although it does not "block the uptalee of HA (Gluckman &
Baum, 1969? Lahti & Maickel, 1971).
1.5.3. ADRENOLYTIC EFFECTS
The tricyclic antidepressants, similarly to chlorpromazine,
are able to antagonise the effects of HA in smooth muscle preparations.
This antagonistic effect of the antidepressants usually appears at
higher concentrations than are required for the potentiation of
the responses to HA. An 06-adrenoceptor blocking effect of these
drugs has been described by Callingham (1967); Tiirker & Khairallah,
(1967); Bassett et al. (1969); Scriabine (1969); Hrdina & Ling (1970)»
Torda (1971); McCulloch & Story (1972); Westfall (1973). There is less
evidence, however, concerning a possible ^—adrenoceptor blocking effect
of the tricyclic antidepressants (Govier et al., 19^7» Scriabine, 1969;
Tamayo et al., 1973).
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chapter ii
the release of noradrenaline from micropipettes
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II.1, INTRODUCTION
The time sequence of events occurring during the application of
a drug "by microelectrophoresis can he summarized in the following way:
ejecting current pulse —> electrophoretic release of the drug from the
micropipette —* concentration changes at the receptor sites —> neuronal
response. The relationship between ejecting current and response cannot
he interpreted unless the intervening processes are fully understood.
In this chapter I shall describe experiments which examine the relation¬
ship between ejecting current pul3e and the rate of release of noradrenaline
from micropipettes. As a framework for discussion I shall use a theoretical
model of ion movements in micropipettes.
II. 1.1. A MODEL OF ION MOVEMENTS IK MICROPIPBTTES
It is proposed that the orifice at the tip of the micropipette
can he regarded as a hypothetical boundary separating two fluid compart¬
ments: the drug solution in the micropipette and the external medium.
Thus, drug release can be defined as the passage of drug molecules across
this boundary into the external medium.
Drug release consists of spontaneous release (resulting from
diffusion and hydrodynamic outflow of the solution), and electrophoretic
release (resulting from iontophoresis and electro—osmosis) (Curtis, 1964).
The model deals only with diffusions! and iontophoretic drug release.
Hydrodynamic outflow has been neglected since its contribution to
spontaneous release is likely to be very small under normal experimental
conditions (Curtis, 1964), especially when dilute drug solutions are used
as was the case in most of our experiments. The contribution of electro—
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osmosis to total electrophorstic release is reckoned to "be small
(Krnjevi6, Mitchell & Szerb, 1963b; Curtis, 1964)* although it may be
important in the case of poorly ionised or less soluble compounds (Curtis,
1964). In the experiments described in this chapter electrophoretic
release resulting from electro-osmosis could not be differentiated from
that resulting from iontophoresis, and thu3, for the sake of simplicity,
electrophoretic release was regarded as resulting entirely from iontophoresis.
a. Ion transport in the absence of an electrophoretic current
Let tis assume that the drug solution in the micropipette is an
infinitely large diffusional source, and the external medium is an infinitely
large diffusional sink. Thus, after the tip of a micropipette has been
immersed in the external medium at time t = 0 (see Pig. l/ll), there will
be a period of gradually declining rate of diffusional release followed by
the establishment of a steady-state rate of release, at t = t^» The initial
period of decreasing rate of release reflects the development of an 'inter¬
phase layer' between the bulk of the drug solution in the micropipette and
the external medium. The establishment of a steady-state rate of release
implies the existence of an interphase layer of unchanging thickness.
Pick's first law of diffusion is applicable to this condition:
^ - D -g- jTr2 (1)
where is the rate of diffusional release, D is the diffusion coefficient,
cic
— is the concentration gradient across the tip boundary, and r is the
radius of the tip. For the sake of simplicity, the concentration gradient

































FIGURE l/ll. Hypothetical changes in the rate of diffusional release
from a micropipette freshly immersed in an external medium.
The development of an interphase layer within the tip of
the raicropipette is shown above the graph. £ : thickness of the
interphase layer.
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This assumption of linearity is also made in the derivation of the
Planck—Henderson equation for the diffusional potential across an
interphase region. The assumption is necessary, since without it any
mathematical treatment of ion transport in the interphase layer beomes
unmanageable (Bockris & Reddy, 1970; PP« 417-420). On the basis of the
approximation, R can be expressed as
D
RD = D-^l^-JTr2 (2)
where c is the concentration of the drug ions in the bulk of the solution,
£
ness of the interphase layer. Since cq <^c, equation (2) can be simplified:
cq is the concentration of drug just outside the tip, and O is the thick-
Bp- . (3)
b« Ion transport during the passage of an electrophoretic current
Ions can be transported in a solution either under the influence
of a concentration gradient (diffusion) or under the influence of an
electrostatic potential gradient (iontophoresis). When both forces are
acting, the net ion flux (rate of ion transport) will reflect the algebraic
sum of the two forces (Bockris & Reddy, 1970). When a retaining potential
is applied to the drug solution 'within the micropipette, these forces act
in opposite directions; when an ejecting potential is applied, both forces
act in the same direction.
Retaining currents. When a retaining potential is applied, ion
transport in the bulk of the solution and in the interphase layer will be
affected differently. In the bulk of the solution ('where there is no
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concentration gradient) there will "be only one ion flux, the iontophoretic
flux (Rj,). In the interphase layer the net ion flux (R,p) will he the
algebraic sum of the inward iontophoretic flux (R^) and the outward
diffusional flux (R^): R^ = R^ - R^. The diffusional ion transport
across the tip boundary (diffusional release) in the presence of a
retaining current will reflect the relationship between the ion fluxes.
If R^<1 Rp» there will be some diffusional release, if R^)> R^, there
will be no outward ion transport across the tip boundary.
The relationship between time and rate of release in the presence
of a retaining current is shown in Figure 2/lI. If a relatively weak
retaining current is applied at t = O^it will not initially counteract
diffusional leakage, i.e. R^<( Rp« However, an unopposed ionic drift
(R^) will start in the bulk of the solution instantaneously. Thus, the
boundary of the bulk will drift inwards, away from the tip, and the
thickness of the interphase layer will increase. Since the rate of
diffusional flux in the interphase layer is inversely related to the
thickness of the interphase layer (see equation (3))» the rate of diffus¬
ional release will gradually decrease, until at t = R^ = R^. From
this time on, there will be no diffusional release. Thus, a retaining
current, which initially is not adequate, can, after some time ("minimal
effective retention time", ^m^n)» become effective. If the application
of a retaining current is continued for longer than t . , the ionic^ ° mm'
drift in the bulk of the solution will further increase the thickness
of the interphase layer, and this will further decrease the diffusional
flux in the interphase layer (R^")> Rp). Under these circumstances, the
lower boundary of the interphase layer will move away from the tip
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t = 0 t-tmin
FIGURE 2/lI. hypothetical decrease in the rate of diffusional
release froa a micropipette in the presence of a retaining current*
A: electrophoretic current; B: rate of diffusional
release. The positions of the concentration layers within the
micropipette are shown at the top of the figure. In the presence
of the retaining current the rate of diffusional release decreases
in time; for the sake of simplicity this is shown as a linear
function.
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boundary, and the terminal part of the micropipette will become devoid
of drug ions. Three "concentration layers" can be distinguished at
this stage: the bulk of the solution, the interphase layer, and the
terminal depleted layer. The thickness of these layers is determined
by both parameters (intensity and duration) of the retaining current
pulse. The distance travelled by the boundary of the bulk during the
retention period depends upon the velocity of the ionic drift in the
bulk (determined by the intensity of the retaining current) and on the
retention time.
The minimal effective retention time can be calculated. Let
us assume that the terminal part of the micropipette has a cylindrical
shape of radius r, and the thickness of the interphase layer is SQ at
time t = 0, when the application of the retaining current starts. After
this point in time the boundary of the hulk of the solution migrates
gradually away from the tip, until at t = when the thickness of the
interphase layer is <§ (critical thickness of the interphase layer),
R_ = R.» At t = t . the boundary between the bulk of the solution andD 1 mm J
-
the minimal effective retention time can be expressed as
the interphase layer will have moved through a distance 6 - 6. Hence,c o
6 - £
c o
t . = —h 2L , (4)mm v ' v '
where v is the drift velocity in the bulk of the solution. If, however,
the bulk of the solution starts migrating from the tip boundary (as can
.) <5
In this case, equation (4) simplifies to




It is possible to derive expressions for both 0~ and v. At t = t . ,c mm*
Ri = Rd, and = Be 3Tr2/c?0 (Pick's first law of diffusion, sea
equation (3)). Therefore
DcdTr2 f DclT: 2X BcTTr frS
3 "r (s)
The drift velocity (v) can be expressed in terms of the






Substituting Sc from equation (6), and v from equation (7) equation (5)
becomes:
t . . . (8)mm n2 v 'K.
1
The iontophoretic flux (R^) can be obtained on the basis of Faraday's
Law (see Curtis, 1964):
where i is the intensity of the iontophoretic current, n is the transport
number of the drug, z is the valency and P is Faraday's constant.
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Substituting from equation (9), equation (8) becomes:
„ 2 2 2 2 4
, f Z.... (io)mm . 2 2 '
l n
In the above derivation it was assumed that the transport
number of a given ionic species is the same in the interphase layer and
in the bulk of the solution. When a (negative) retaining current is
applied, positive ions fronrexternal medium (mainly sodium ions) will
migrate into the fluid compartment within the micropipette. In the
presence of these other ions, the transport number of the drug ion3
will depend upon the relative concentrations of all ionic species
present. Any reduction in the transport number of the drug ions due to
the presence of other ions will be greater in the interphase layer than
in the bulk of the solution, because of the lower concentration of
drug ions within the interphase layer. Thus a more precise version of
equation (10) i3
^2 2^2 2 4
+ Be z i1 TI r /17\
min . 2 *iA'
where is the transport number of the drug ions in the bulk of the
solution, and is the average transport number of the drug ions in
the interphase layer. Since ng^n^, equation (ll) yields a greater
value for t . than equation (10).
mm v
In deriving equation (10), it was assumed that r was constant
in the terminal part of the micropipette. In reality, however, the
terminal part usually has a conical shape, and thus r increases
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gradually with the distance from the tip boundary. This would prolong
tjniix* because the drift velocity of the boundary of the bulk will
gradually decrease as the boundary migrates away from the tip, and partly
because there will be a higher diffusional efflux from the bulk as the
surface area of this boundary gradually increases.
tmi is an expression of the efficacy of a retaining current
of given intensity, increases linearly with the square of the
equivalent concentration (c.z) of the drug solution. als° increases
linearly with the diffusion coefficient of the drug ions, but it decreases
with the transport number. As both the diffusion coefficient and the
transport number depend upon the absolute mobility of the ions, it is
apparent that a given retaining current will be more effective in
counteracting the diffusional efflux of more mobile ions. Since t^n
increases linearly with the fourth power of the radius, it is obvious
that a small increase in the size of the tip orifice will greatly reduce
the effectiveness of a given retaining current.
The above theoretical considerations concerned retaining currents
which were not adequate to counteract diffusional release at the beginning
of their application. As retaining currents of increasing intensities
are tested, will be gradually reduced until, in the presence of a
certain retaining current ("critical retaining current") tmin = 0. This
retaining current (and higher retaining currents) will completely counteract
spontaneous leakage at time t = 0.
As reflects the distance through which the boundary of the
bulk of the solution has to migrate before a particular retaining current
becomes effective, t ^ will be longer after an ejection period than after
a period of steady-state diffusional release.
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Ejecting currents. When an ejecting potential is applied, drug
ions in the hulk of the solution drift at a steady rate towards the tip.
The rate of iontophoretic transport across the tip boundary (i.e. rate
of iontophoretic release), however, will change in time until the boundary
of the bulk arrives at the tip boundary. The rate of release at any time
is the sura of the iontophoretic and diffusional fluxes across the tip
boundary: R^ = R^ + Hp.
II.1.2. THE RELEASE CURVE
The release curve describes how the rate of release changes in
time in response to an ejecting current pulse. The total release curve
is obtained by the summation of the iontophoretic and diffusional curves
(Fig. 3/II).
a. Iontophoretic release curve
The hypothetical shape of the iontophoretic release curve is
shown in Fig. 3/IIS). When an ejecting potential is applied after a
prior retaining current (a), the current flow starts immediately, but
drug release will not start until the interphase layer reaches the tip
boundary (b). There will be a further delay before the bulk of the
solution reaches the tip boundary and thus a steady—state rate of release
is established (c). The rate of drug release continues at this steady
level until the end of the ejection period. The height of the plateau
of the iontophoretic release curve is entirely determined by the intensity
of the ejecting current and the transport number of the drug ions
(Faraday's Lav/). When the application of the ejecting current is
terminated (d), iontophoretic drug release stops instantaneously.
♦ T i T ♦
a b c d e
RUNNING TIME
FIGURE 3/lI, Hypothetical relationship between ejecting current pulse (A);
iontophoretic release curve (B); diffusional release curve (C); and, total
release curve (D).
The positions of the concentration layers are indicated at the top
of the figure, a: onset of ejecting current pulse; b: onset of drug release
c: establishment of steady-state rate of release; d: termination of ejecting
pulse; e: offset of diffusional release. For the sake of simplicity^changes
in the rate of release are shown as linear functions of time.
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The gradual rise in the rate of release between (b) and (c)
reflects a gradual increase in the transport number of drug ions in
the interphase layer. (This gradual increase in transport number is
due to the gradual increase in concentration of drug molecules in the
interphase layer towards the bulk of the solution, since the transport
number of any ion depends upon the concentration if several ionic species
are present. This is inevitably the case in the tip of a micropipette,
which freely communicates with the external medium.)
Since the shape of the release curve reflects the position
and thickness of the "concentration layers" in the terminal part of the
micropipette, it can be predicted that a higher retaining current or a
longer retention time will increase the release latency (a-b) and prolong
the rising phase of the release curve (b-c).
b. Diffusional release curve
The hypothetical (simplified) shape of the diffusional release
cux*ve is shown in Pig. 3/lIC. Since the rate of diffusional release depends
on the concentration gradient across the tip boundary, the diffusional
release curve follows the iontophoretic release curve. After a release
latency the rate of diffusional release increases until a steady relation¬
ship is established between the two compartments during the steady—state
phase of iontophoretic release. When the application of the ejecting
current is terminated, diffusional release will not stop instantaneously,
but will continue at a gradually decreasing rate, until the post—ejection
retaining current becomes effective (Fig. 3/lIe).
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11,1.3, MEASUREMENT OF THB RELEASE OF NORADREKALIMS
We have examined the shape of the release curve (rate of release
plotted against time) by measuring the release of l14c] -noradrenaline (NA).
There have been previous reports concerning the release of M from
micropipettes, in which either a fluorimetric assay of NA (Krnjevid,
Laverty & Sharraan, 19o3a.) or, more recently the liquid scintillation
technique to assay £^h]—NAwere used (Bradley &. Candy, 1970? Hoffer, Neff
& Siggins, 1971)• The latter technique is more sensitive but less specific
than the fluorimetric method since it has been reported that as much as
50% of the radioactivity in samples of [^H}-NA may not be carried by NA
molecules (Offerman & Merrills, 1968). Therefore, r^cj —NA was used in
the present experiments.
11,2. METHODS
Five barrelled micropipettes were constructed from Pyrex glass
tubing of external diameter 1.5 mm and internal diameter 1,0 mm (Hers,
Wickelmaier & Nacimiento, 1965)? and were filled by boiling in distilled
water under reduced pressure. The water in the barrels was replaced by
the appropriate solutions by means of a thin Portex catheter. After
filling, the pipettes were stored in the dark at 4°C in an atmosphere
of nitrogen for at least 36 h before use. Immediately before use, the tip
of the micropipette was carefully broken in order to obtain an overall
tip diameter of 4*0—6.5 /ma.
Four barrels of each micropipette were filled with radioactive
noradrenaline (NA) solution (0.02 M, specific activity 5 mCi/mmole). In
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some preliminary experiments in which £^IIj -NA was used., it was found,
that more radioactivity was released during the passage of retaining
currents than when no current was passed. Subsequent chromatographic
analysis of the samples collected during the passage of retaining
currents showed that the radioactivity released was not associated with
NA (see also Offerraan & Merrills, 1968). Therefore, because of its
greater radiochemical stability, we decided to use l14d] —HA rather than
the labelled compound in our experiments. The lower specific
activity of the £^cj—NA, however, made it necessary to dilute the
radioactivity as little as possible with unlabelled NA when preparing
the final solution. Accordingly, we used a 0.02 JJ solution in most of
these experiments. In order to increase the resolution of the method
when very small outputs were measured, as in the presence of retaining
currents, four barrels of each micropipette 'were filled with the radio¬
active NA solution and the electrophoretic currents were applied to all
of them simultaneously. Errors were further reduced by the use of long
sampling periods (4-128 minutes).
Freeze—dried (—)-noradrenaline Jjcarbinol—"(—)—'bitartrate
(specific activity 22, 52 and 54 mCi/mmol) was obtained from the
/+ \Radiochemical Centre, Amersham, England. A solution of (—)—noradrenaline
'bitartrate was prepared by mixing the required amount of radioactive and
non—radioactive NA to give the final solution to be used in the micro-
pipettes (0.02_M, specific activity 5 mCi/mmol). The pH of this solution
was 3.0.
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An additional series of experiments (see II.3.4. and II.3.5.)
was conducted vising 0.2 M NA. In these experiments it was intended to
examine the effect of the addition of other ionic species to the drug
solution. Six—!barrelled pipettes were used. Three of the barrels con¬
tained D,L—noradrenaline £carbinol-^cj (-)-bitartrate (0.2 M, pH 3»5>
specific activity 0.5 raCi/mmole). The other three barrels contained a
similar solution whose pH had been adjusted to 5«0 by the addition of
1 N NaOH.
The microelectrophoretic circuit used in these experiments was
described by Roberts & Straughan (1967). The elctrophoretic current was
continuously monitored with a Pye Scalamp Galvanometer (see also III.2.4.)#
The micropipette was held vertically in a micromanipulator and
the tip was lowered into a small glass vial containing 1.0 ml 0.165 H
NaCl solution. A silver wire, immersed into the saline solution, served
as an earth electrode. Electrophoretic currents of identical intensities
were applied to each of the four NA-containing barrels. Since the NA
ion is a cation, positive currents were used to eject and negative currents
to retain the drug ions. (Values of current intensity will always refer
to the intensity of the electrophoretic current applied to each of the
NA-containing barrels). The outer surface of the micropipette was washed
with distilled water before the collection of each sample.
At the end of each period of collection, the contents of the
vial were transferred into a glass scintillation vial. The collecting
vial was washed repeatedly with the scintillator and the washings were
added to the contents of the scintillation vial. A total of 10 ml of
scintillator wa3 added to each sample. The scintillator contained 0.267%
PPO (2,5-diphenoxyl-oxazole), 0.0067% POPOP (l,2-bis-(5-phenyloxazol-2-yl)—
benzene) in toluene v/ith 33^ Triton X-100.
- 42 -
Disintegrations for each sample were counted for 10 min in a
Packard Tricarb liquid scintillation spectrometer. Disintegrations per
minute (d/min) values were determined for each sample (after subtraction
of the background), and these were converted into pmole values on the
basis of the specific activity of the NA solution contained in the micro-
pipette. Background counts per min were approximately eqiuvalent to
2.5-3.0 pmole NA.
II.3. RESULTS
II.3.1. RELEASE IN TH5 ABSENCE OP AN ELECTRQPHOHETIC CURRENT
In fourteen micropipettes (Nos. 1-14» see Table l/ll) the
spontaneous release of £~^cJ-NA was measured before any electrophoretic
current had been applied. Before the first sample was collected, the tip
of the micropipette was broken in order to obtain the desired tip diameter
(4.O—6.5 pm). Then, samples were collected during successively increasing
periods of time (8-128 minute). With most micropipettes, the rate of
spontaneous release fell from an initially high level, until a steady-
state rate of release was attained 8—64 min after the start of the
experiment (Fig. 4/ll).
The mean rate of spontaneous release from 14 micropipettes
measured under steady state conditions was 0.36 - 0.06 pmole/barrel/min
(see Table l/ll).
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FIGURE 4/II. Ths rate of spontaneous release of noradrenaline from two
micropipettes.
Ordinates: rate of release of noradrenaline (NA) (pmole/barrel/min).
Abscissae: running time (min). The times at which samples were collected are
indicated by arrows below the time base.
The rate of spontaneous release, measured before any currant had been
applied to the micropipette, declined from an initially high level until a
steady—state rate was attained* A: micropipette no. 9? 3: micropicette no. 4
(see Table l/ll).
II. 3.2. RELEASE IN THE PRESENCE 0? A RETAINING CURRENT
a. When, the passage of a retaining current is not preceded, "by an
ejecting pulse
The effectiveness of various retaining currents in counteracting
the spontaneous release of jj^Cj -NA was examined with two micropipettes
(nos. 10 and 14). The spontaneous output of NA during a 16 min period,
during, which no current was applied, was compared with the output measured
during a 16 min period when a retaining current was passed. The retaining
currents used were -5, -10, —15, -20 and —25 nA» Each passage of a
retaining current was preceded by two successive 16 min periods of
spontaneous release. Prom both micropipettes, a retaining current of —5 nA
reduced the output to about 2*y?° of the spontaneous release. A further
reduction in the spontaneous release was observed when higher retaining
currents were used; no spontaneous release could be detected when -25 rA
was applied. The results obtained from micropipetta No. 10 are displayed
in Fig. 5/lI.
b» When the passage of a retaining current is preceded by an ejecting pulse
A higher output was measured during the passage of a retaining
current if the retention period was preceded by an ejecting pulse. The
results obtained from micropipette No. 10 are shown in Pig. 5/lI« Similar
observations were made with micropipettes Nos. 8 and 9* with which retain¬
ing currents of up to -100 nA were tested. The output decreased with higher
currents hut could not be eliminated completely within the first collection
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FIGURE 5/lI* The relationship between the intensity of the retaining
current and the release of noradrenaline from one micropipette.
Micropipette no. 10 (see Table l/ll). Ordinate: amount of
noradrenaline (NA) released during each 16 min period (pmole/barrel).
Abscissa: intensity of retaining current applied to each of the four NA—
containing barrels (nA). Closed circles: release in the presence of a
retaining current following a period (32 min) when no current was applied.
Closed triangles:release in the presence of a retaining current following
an ejecting pulse (+100 nA , lo min).
The release of NA declined as higher retaining currents were passed.
A retaining current was less effective following an ejecting pulse.
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The time-course of the action of retaining currents was measured
by passing a retaining current of given intensity continuously and measuring
the output at regular intervals of 5 minutes. Every retaining current tested
(—5 to -100 nA) invariably became effective if it was passed for a long
enough time. This was true even of weak retaining currents (Fig. 8/lIC).
II.3«3. RELEASE IN THE PRESENCE OF AN EJECTING CURRENT
a. ifnen the passage of an ejecting current is not preceded by a retaining
pulse
The electrophoretic release of [14c] —NA was measured with a wide
range of ejecting current intensities (+25 to +200 nA) and a wide range of
collection times (4-128 minutes). Since the prior application of a retaining
current can influence subsequent drug release (see below), it was important
to ensure that measurements of the rate of electrophoretic release were not
subject to this distortion. Therefore retention periods or periods of
spontaneous release were not interspersed between ejection periods.
In all the micropipettes tested (Nos. 1—13) the rate of release
of NA was linearly related to the intensity of the ejecting current (see
Fig. 6/II). The transport number of NA was calculated individually for
each sample collected from each micropipette, by substitution in the





where n is the transport number, z is the valency (in the case of NA,
z = l), F (coulombs) is Faraday's constant, i (amps) is the total ejecting
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RATE OF RELEASE OF NA
A 8 :
FIGURE 6/lI. The relationship "between the intensity of the ejecting current
and the rate of release of noradrenaline from three micropipettes.
Ordinates: rate of release of noradrenaline (NA) (pmole/barrel/min).
Abscissae: intensity of ejecting currents applied to each of the four NA—
containing barrels (rul).
The rate of release was linearly related to current intensity over a
wide range of ejecting current intensities (+12.5 to +200 nA). A: micropipette
no. 10 (see Table l/ll); calculated regression line: y = 1.623 +'0.414*. B:
micropipette no. 7; calculated regression line: y = 3.690 + 0.308x. C:
micropipette no. 2; calculated regression line: y = O.832 + 0.331x.
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TABLE l/ll. Rata of steady-state spontaneous release and transport
number of KA obtained from each of the micropipettes (1-14)«
Transport numbers were calculated individually for each of the
samples collected from each micropipette. Four "barrels of each micropipette













1 5 0.09 0.11 - 0.04
2 5 0.34 0.14 - 0.02
3 5 0.35 0.03 - 0.00
4 4 0.12 0.19 - 0.01
5 5 0.16 0.11 - 0.03
6 5 0.22 0.14 - 0.04
7 5 0.75 0.13 1 0.02
8 5 0.32 0.29 i 0.06
9 5 0.04 0.19 - 0.02
10 6.5 0.82 0.17 - C.OO
11 5 0.20 0.22 - 0.02
12 6 0.48 0.33 - 0.05 ^
13 5.5 O.64 0.18 ~ 0.01
14 6 0.51 not measured
The mean value of the transport number obtained from 13 micropipettes
was 0.17 - 0.02.
current applied to all four "barrels and R^ (mole/s)is the rate of
electropi^oretic release of NA (total rate of release minus steady-
state rate of spontaneous release). Mean values of the transport
numbers obtained from each of the micropipettes are shown in Table l/ll;
the average value for the 13 micropipettes was 0.17 ~ 0.02. It can be
seen that the transport number of NA measured in most of the micro-
pipettes was between 0.1 and O.25. No correlation could be found
between the transport number measured with different micropipettes and
tip diameter, electrical resistance or steady—state rate of spontaneous
release (product moment correlation test).
b, When the passage of an ejecting current is preceded by a retaining pulse
In microelectrophoresis experiments, the passage of an ejecting
current is normally preceded by the passage of a retaining current. We,
therefore, examined the release of NA during ejecting periods following
retaining pulses of various intensities and durations using five micro¬
pipettes (8, 9, 12, 13 end 14).
When standard ejecting pulses were used, an increase in the
intensity of the retaining current reduced the amount of MA released
during the subsequent ejecting pulses. Restoration of the original
retaining current resulted in a progressive increase in the output of
NA over the course of the next few ejecting pulses (Fig. l/ll).
We examined whether the reduction in output brought about by
a prior retaining current was due to a change in the time—course of drug
release. In these experiments, the ejecting current was passed for a
prolonged period and samples were collected at regular intervals of 5 rain






























FIGURE 7/lI- The effect of various retaining currents upon the electrophoretic
release of noradrenaline from one raieropipette.
Micropipette no. 8 (see Table l/ll). Lower graph: elect rophoretic
current applied to each of the four noradrenaline (NA; containing barrels
(ordinate: current intensity, nA, positive upwards; abscissa: running time, rain
Stippled area: retaining current; hatched area: ejecting current. Upper graph:
release of NA during each of the 8 rain period of sample collection (ordinate:
release of NA, pmole/barrel/rain; abscissa: running time, the same scale as in
the lower graph).
Ejecting and retaining currents were applied alternately; the para¬
meters (intensity and duration) of the ejecting pulse were kept constant
throughout the study. Changes in the parameters of the applied currents are
indicated by capital letters under the time base.
After a prolonged application of a retaining current (A — B),
successive ejecting pulses (B - C) evoked progressively greater outputs.
Increases in the intensity of the retaining current reduced the amount of NA
released by the ejecting pulse (C — D, D — E). Restoration of the original
retaining pulse (E) was followed by progressively increasing outputs.
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RATE OF RELEASE OF NA
r—t—i—i 1—»—»—i—i—i—i—i .
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FIGURE 8/lI. The_ effects of retaining currents on the kinetics of the
electrophoretic release of noradrenaline.
Lower graph: electrophoretic currents applied (see Fig. l/ll). Upper
graph: release curves for noradrenaline (NA) (ordinate: rate of release of NA,
pmole/barrel/ 5 min; abscissa: running time; abscissa: running time, min).
A: micropipette no. 11 (see Table l/ll): increases in the retention
time prolonged the rising phase of the release curve. B: micropipette no. 13:
increases in the intensity of the retaining current prolonged the rising phase
of the release curve. C: micropipette no. 12: a weak retaining current (~5 nA)
did not abolish spontaneous release immediately, but prolonged the rising phase
of a subsequent release curve.
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passage of the ejecting current resulted in a rectangular release curve.
The effect of the prior passage of a retaining current was to prolong
the rising phase of the release curve without affecting the plateau rate
of release. Increases in either the intensity (Pig. 8/lI3) or the
duration (Fig. 8/II.A) of the retaining current magnified this distortion
of the release curve. It can he seen that, after a high retaining current
or a long retention time, the rate of release during the ejection period
gradually increased before a steady-state rate of release was achieved.
Even weak retaining currents, when passed for prolonged periods, distorted
the rising phase of the release curve. In the experiment shown in Pig. 8/lI.C
a retaining current of -5 nA was not effective for the initial 20 min of its
passage, hut, after it had been passed for a further 60 min, it caused a
marked distortion of the release curve during the next ejection period.
II.3.4. EFFECT OP CONCENTRATION
Since in our in vivo experiments more concentrated (0.05 M and
0.2 H) NA solutions were used, it was of interest to study the release
of NA from micropipettes containing a 0.2 M solution. Five six-barrelled
micropipettes were used in these experiments (nos. 15—19; see Table 2/ll).
Three barrels of the micropipettes contained -NA (0.2 M; pH 3.5;
specific activity 0.5 mCi/mmole). The remaining three barrels contained
14
a £ Cj —NA solution whose pH had been adjusted by the addition of NaOH.
(These latter three barrels were used to evaluate the effects of the
addition of other ions; see II.3.5.) When the release from barrels
containing one solution was being studied, spontaneous release from the
other three barrels was either taken into account as a constant factor
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to be subtracted from the total release measured, or was eliminated by
the passage of a high retaining current (-300 nil) which had proved
instantaneously effective. Ten minute sample collection periods were used.
a. Spontaneous release
There was a considerable variation between rnicropipettes with
respect to the rate of spontaneous release (see Table 2/ll). The mean rate
of release of NA from the solution at pH 3.5 (i.e. when no other ions had
been added) was 8.8 — 4.0 pmole/barrel/min. Micropipette no. 15, which had
a tip diameter of 8 showed a very high rate of release (24.1 pmole/barrel/
min). If this micropipette is excluded, the mean rate of spontaneous release
becomes 4»9 — 1.4 pmoles/barrel/min. This value is somewhat greater than
ten times the mean rate of spontaneous release from the 0.02 M solution
(0.36 i 0.06 pmole/barrel/min; see II.3.1.).
There was a significant correlation between the tip diameter and
the rate of spontaneous release (product moment correlation test: r = 0.995,
p <0.05).
b. Release in the presence of a retaining current
The efficacy of retaining currents was evaluated using two
micropipettes (15 and 19). First an ejecting current (+100 nA) was
passed and the output during a 10 min retention period was measured.
The release curve for +100 nA was then repeated, and the retaining
current of —25 nA was applied again, this time for 20 rain. The output
during the 10 min retention period was subtracted from the output during
the 20 min retention period in order to obtains an estimate during the
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final 10 miji of the 20 tain retention Denied. This procedure was repeated,
using successively increasing retention times up to 60 min.
It was found that the output of NA decreased in time during the
prolonged application of a retaining current. The results obtained from
micropipette no. 19 are illustrated in Pig. 9/lI. Similar results were
obtained with micropipette no. If.
During the first 30 min retention with -25 nA the amount of HA
released from the 0.2 M solution was (micropipette no. 17) and 44i*
(micropipette no, 19) of the amount released during an equivalent period
when no current was applied. Comparison of Pig. S/lI with Fig. 8/lI
shows that this retaining current was much less affective in counteracting
spontaneous release from the 0.2 M solution than were similar retaining
currents in the case of the 0.02 M solution. With the 0.2 M solution,
the minimal effective retention time for -25 nA was more than 50 min
(micropipette no. 19; see Pig. S/ll) 7 whereas a much weaker retaining
current (—5 nA) totally abolished spontaneous release from the 0.02 M
solution within 20 min of its application (micropipette no. 12, see
Fig. 8/lI.C.).
c. Release in the presence of an ejecting current
Electrophoretic release was measured using a range of ejecting
current intensities (+ 12.5 to + 200 nA). The rate of electrophoretic
release was linearly related to the intensity of the ejecting current
(see Pig. lo/ll; filled circles).
The transport numbers calculated for each micropipette are
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FIGURE $/lI. The effect of a retaining current on the rate of spontaneous
release.
Micropipet!e no. 17 (see Table 2/ll). Lower graph: electrophoretic
current applied to each of the three barrels containing noradrenaline (NA)
(0.2 M, pH 3.5) (ordinate: current intensity, nA, positive upwards; abscissa:
running time, min). Upper graph: output of NA during sequential 10 min periods
of sample collection (ordinate: output of NA, pmole/barrel/lO min); abscissa:
running time, the same scale as in the lower graph). Broken line indicates the
steady-state rate of spontaneous release.
The rate of release gradually declined during the application of the
retaining current.
five micropipettes was 0.29 ~ 0.05. This value is significantly higher
than the mean transport number of NA obtained using the 0.02 M solution
(0.17 i 0.02) (t test; p<0.05).
II.3.9. EFP3CT OF THE ADDITION OF OTHER IONS
The effect of the addition of other ions upon the release of NA from
an 0.2 M solution was investigated by comparing the output from a solution
prepared by disolving NA bitartrate in double glass—distilled water (the pH
of this solution was 3.5) with the output from a similar solution to which
NaOH had been added in order to raise the pH to 5.0. NaOH was used in these
experiments since it had been suggested that in in vivo experiments the
electrophoretic application of NA is accompanied by artefactual neuronal
4.
responses due to the release of H , and that in order to eliminate these
responses it is necessary to raise the pH of the NA solution by the addition
of NaOH (prederickson et_al.» 1971? see III.B.3).
Some of the characteristics of the five micropipettes used are
summarised in Table 2/lI. The electrical resistance was lower in the case
of barrels containing NA at pH 5-0 (Wilcoxon test: p <,0.005).
a. Spontaneous release
There was no significant difference between the rate of spontaneous
release of NA from the solution at pH 3.5 a-cL from the solution at pH 5-0
(t test , p > O.l).
b« Release in the presence of a retaining current
The efficacy of retaining currents was studied in detail using
only two micropipettes. The output of NA from the pH 5»0 solution was
2.6 times (raicropipette no.17) and 2.5 times (micropipette no. 19) greater
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than the output from the pH 3.5 solution during the application of —25 nA
for a standard period (40 or 60 min). Thus the retaining current was less
effective with the pH 5.0 solution.
c. Release in the presence of an ejecting current
Electrophoretic release was measured using a range of ejecting
currents (+ 12,5 to + 200 nA). With all the five micropipettes tested,
any given ejecting current was less effective in releaseing HA. from the
solution at pH 5*0 than from the solution at pH 3.5. The relationship
"between current intensity and rate of electrophoretic release for one
micropipette is shown in Pig. lo/ll. The transport number of HA was
calculated individually for each sample collected from each micropipette.
The mean values for the transport number obtained from each micropipette
are shown in Table 2/lI. In every case the transport number of NA was
lower when release was measured from the pH 5»0 solution. The overall
mean values from the five micropipettes were 0.29 ~ 0.05 (pH 3.5 solution)
and 0.11 i 0.03 (pH 5«0 solution); the difference between these two values
is statistically significant (t test: p<C.0.0l).
II.4. DISCUSSION
In the first part of the Discussion the present results are
interpreted in terms of the theoretical model of ion movements and in
terms of the theoretical 'release curve*. In the second part of the
discussion some practical implications of the results are considered.
RATE OF RELEASE OF MA
FIGURE lO/lI. Rate of release of noradrenaline at different pH values.
Micropipette no. 17 (see Table 2/II). Ordinate: rate of release of
noradrenaline (HA) (pmole/barrel/min); abscissa: intensity of ejecting current
applied to each of the three NA—containing barrels* Closed circles: release
from barrels containing NA at pH 3»5> open circles: release from barrels con¬
taining NA at pH Each point is the mean of four measurements (standard
error is indicated except when it was less than + 0.25 pmole/barrel/min. Both
lines were obtained by linear regression. The rate of spontaneous release is
indicated by the broken line.
The total rate of release of NA is greater from the solution at
pH 3.5 than from the solution at pH 5»0.
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II.4.1. INTERPRETATION OF TIE RESULTS ON THE BASIS 0? THE MODEL
a. Release in the absence of an electrophoretic current
In our experiments, the tip of the micropipette was "broken (i.e.
the surface area of the tip orifice was increased) immediately "before
spontaneous release was measured. The increase in the size of the tip
orifice would upset the steady-state diffusional relationship which presum¬
ably existed before the tip was broken. Thus it would take some time before
an interphase layer of unchanging thickness could be re-established at a
different level (Fig. l/ll). This could explain the finding that, after
the tip of the micropipette had been broken, the rate of release first
gradually decreased until a steady-state rate of release was established
(Fig. 4/II).
Diffusional leakage from micropipettes can be significant. Using
a 0.02 M NA solution, the average rate of spontaneous release was 0.36 pmole/
barrel/min, which is approximately lOJb of the total rate of release during
the passage of +25 nA. However, when a 0.2 M solution was used (as is often
the case in in vivo experiments), spontaneous release (8.8 pmole/barrel/min)
accounted for as much as 65/5 of the release in the presence of +25 nA.
b. Release in the presence of a retaining current
The model proposes that drug retention is a time-dependent process.
The results obtained in our experiments are in agreement with this proposition.
Fig. 8/lI.C shows that a weak retaining current gradually became completely
effective during the period of retention (see also Fig. 9/ll)» results
shown in Fig. 5/lI also support experimental predictions derived from the
model: as higher retaining currents were tested, the amount of drug
released during the first 16 min retention was progressively reduced.
Since there was no release at all in the presence of —25 is possible
to conclude that this current abolished release as soon as it was passed.
According to equation (lo) tm^n is directly proportional to the
square of the concentration of the drug solution contained in the micro-
pipette. Thus, any given retaining current should be less effective in
counteracting release from more concentrated solutions. Pig. 9/lI offers
qualitative confirmation of this expectation: in contrast to the micropipett
shown in Pig. 5/H (0.02 M), Pig. 9/lI shows that even after 5® tn^n a retain
ing current of —25 nA had not succeeded in completely abolishing spontaneous
release from a micropipette containing a 0.2 M solution (the two micropipett
had similar tip diameters).
Equation (10) also indicates that retaining currents should take
longer to become effective if the transport number of the drug ions is
reduced. This prediction is also confirmed by the present experiments
(see II.3.5.).
The fact that any given retaining current was less effective if
it followed an ejection period than if it followed a period of spontaneous
release (Pig. 5/lt) lends support to the concept of 'after-diffusion'
(Castillo & Katz, 1957)» and is readily explicable in terms of the model.
During steady-state electrophoretic release the bulk of the solution is
assumed to be at the tip boundary (Pig. 3/ll). When an ejecting pulse is
followed immediately by the passage of a retaining current, the boundary
of the bulk of the solution has to migrate through a relatively greater
distance ( S compared to £ - 6j before that particular retaining
c CO
current becomes effective. Thus it is suggested that the reduced efficacy
of a retaining current after an ejecting pulse is a reflection of the
prolongation of t . .43
mm
c. Release in the presence of an ejecting current
The transport number of noradrenaline. As a preceding retaining
pulse can interfere with the release during an ejection period (see below),
it was necessary to examine the electrophoretic release when no retaining
current had been applied previously. In these experiments, there was a
linear relationship between the intensity of the ejecting current and the
rate of drug release (Figs. 6/II and lO/ll). This shows that drug release,
under these circumstances, can be described by Faraday's Law. The data
obtained from these experiments were used to calculate the transport number
of NA. When transport numbers are calculated, it is necessary to know the
contribution of spontaneous release to total release. Our practical procedure
was to subtract the steady-state rate of spontaneous release from the total
rate of release during an ejection period, This was, however, a necessary
simplification since the application of the ejecting current may result in
local changes in the concentration of drug ions inside and outside the tip,
which in turn would alter the rate of diffusional release.
The mean transport number of NA (0.02 M NA bitartrate, pH 3.0), for
the 13 micropipettes tested, was 0.17. When a more concentrated solution
(0.2 M NA bitartrate, pH 3.5) was used, however, the transport number was
considerably greater. A possible reason for this difference is that there
were proportionately fewer 'foreign' ionic species in the stronger NA solution
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Other workers have determined the transport number of NA on the
basis of electrophoretic release experiments, using a NA hydrochloride
solution. Values of 0.34 and 0.37 were obtained from two micropipettes
(1.7 K, pH 3.O-4.O) using a fluorirnetric method for the assay of NA
(Krnjevic et al., 1963a), and values of 0.09 (0.03 M, pH 5*5)1 0.19 (0.3 M,
pH 5.5) (Bradley & Candy, 1970), and 0.05-0.30 (0.5 M) (Hoffer et al.t 1971a)
were obtained using a liquid scintillation method for the assay of -NA.
Our results are within the range of values obtained, by these T^orkers. More
precise comparisons, however, are not possible because of the use of differen
experimental parameters in these studies (e.g. different NA salt,
labelled NA, the application of retaining currents between ejecting pulses).
The effect of retaining currents. It has been suggested (Curtis,
1964) that 'the use of an excessively strong retaining current for prolonged
periods .... (may) .... prevent the substance under test from being ejected
from the micropipette during the application of short current pulses'. Our
results confirm this suggestion (Fig. j/ll).
In order to avoid this unfortunate effect of strong retaining curren
Curtis (1964) has recommended the use of a 'just-adequate* retaining current,
i.e. a retaining current which exactly counteracts spontaneous leakage withou
interfering with subsequent electrophoretic release. However, the concept
of such a 'just—adequate' retaining current is incompatible with the proposed
model, according to which every retaining current, however weak, will eventua
become completely effective in counteracting diffusional efflux. Furthermore
the model proposes that if a retaining current is passed beyond the point in
time at which it successfully counteracts diffusional efflux (minimal effecti
retention time, t ^ ) it will necessarily begin to deplete the tip of the
micropipette of drug ions, thus inevitably interfering with electrophoretic
release during the next ejection period.
The model is apparently vindicated hy the present results. Fig.
shows that 'when no retaining current had been applied previously, the relea
curve was rectangular in shape. The effect of a pre-ejection retaining
current was to prolong the rising phase of the release curve. Both the
intensity (Fig. 8/lI.B) and the duration of passage (Fig. 8/lI.A) were
important in determining the magnitude of this distortion, thus supporting
the proposal that drug retention is a time—dependent process. Fig. 8/lI.C.
shows that a weak retaining current (-5 nA) was not initially effective
in counteracting spontaneous release, but became effective before the end
of the fourth 5 win collection period. (Thus, t . for this retaining7 mm
current was between 15 and 20 min.) The continued application of this
current for a further 60 rain resulted in a significant distortion of the
release curve during the subsequent ejection period. (Clarke et al. (1973)»
measuring the release of radioactive sodium ions, also found a distorting
effect of retaining currents on subsequent electrophoretic release.)
II.4.2. SOME PRACTICAL IMPLICATIONS
a. Contribution of spontaneous release
The estimation of dose in microelectrophoresis experiments is
based on Faraday's Law. Faraday's Law, however, applies only to drug ions
released from the micropipette by iontophoresis. Even if we are prepared
to neglect the contribution of electro-osmosis, there still remains the
awkward problem of diffusional release which is necessarily an unknown
factor in the in vivo situation. One solution has been proposed by Curtis
et al. (l97l)• they suggest that the rate of spontaneous release may be
assessed in terms of the magnitude of the retaining current needed to curb
it. Thus, these workers have added the intensity of the 'just-adequate'
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retaining current to the intensity of the ejecting current in order to
calculate the 'true* dose of drug applied. Since, however, drug retention
is a time—dependent process (see above), this procedure seems to be
theoretically unjustified. There would seem to be no easy answer to this
problem. However, it may be possible to circumvent it by using very dilute
drug solutions, so that the contribution of diffusion to total release is
relatively very small. The rate of release would then be almost entirely
iontophoretic, and thus governed by Faraday's Law.
b. Use of retaining currents
The present results indicate that if it is intended to deliver
standard pulses of a drugjit is essential that not only the intensity and
the duration of the ejecting pulses, but also the intensity and duration
of the retaining pulses are kept scrupulously constant. Furthermore, the
results shown in Fig. 7/lI suggest that after a protracted retention period
it may be necessary to apply standard ejecting pulses several times before
they can be expected to result in standard pulses of drug release.
c. Introduction of 'foreign' ions
The results of these experiments show that the transport number
of noradrenaline was lower when noradrenaline was released from a pH 5-0
solution compared to the transport number obtained with a pH 3.5 solution
(see II.3.5)* The lower transport number of noradrenaline in the pH 5»0
solution is most likely to be due to the introduction of Na+ into the solution
when the pH was adjusted. By titrating with 1 N NaOH a 0.2 M noradrenaline
bitartrate solution, we have found that it behaves as a buffer within the
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pH range 2.0—5.0. This reflects the two pX values for tartaric acid
cl
(2.98 and 4.34; see Weast, 1972). Thus approximately 110 times more
NaOH had to be added to the pH 3.5 solution in order to raise the pH
to 5.0 than would have been predicted if only the H+ existing at pH 3.5
had been titrated. Indeed, the concentration of Xa+ in the final solution
at pH 5.0 was 0.1 M.
The reduction in the transport number brought about by the
addition of other ions is reflected in a diminished efficacy of both ejecting
and retaining currents. The addition of extranous ions should therefore be
avoided wherever possible. In the case of NA there would seem to be no
advantage to the practice of raising the pH by the addition of NaOH (see
111.33.3). However, the addition of NaCl may be necessary in order to assist
the passage of electrophoretic currents when poorly ionised compounds are
applied (e.g. see Curtis et al., 1971).
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CHAPTER III
THE TIME-COURSE OF NEURONAL RESPONSES
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III.I. INTRODUCTION
It has been known for a long time that the time—course of
the neuronal response to a microelectrophoretically applied drug is
characteristic of the drug applied (see Curtis & Crawford, 1969).
This has been taken as suggestive that the time-course of responses
could yield information about the nature of the drug-receptor inter¬
action, and possibly about the physiological role of the drug (e.g.
Yamamoto, 1967; Bradley, 1968; Stone, 1972b). Such conclusions
cannot be drawn, however, until it is known to what extent physico-
chemical processes (release, diffusion) contribute to the time—course
of the response.
In an in vitro study, using £"^cj -noradrenaline (see
Chapter II), we have shown that ejecting and retaining currents inter¬
act in determining the shape of the release curve (rate of release
plotted against time) during an ejection period. These experiments
have demonstrated that a prior retaining current delays the onset of
drug release, and prolongs the time necessity to establish a steady-
state rate of release. The experiments described below (ill.3.)
examine how the distortions in the release curve appear in the time-
course of the neuronal response.
As a framework for the discussion of the results I shall use
some theoretical considerations presented in this Introduction.
Ill,1.1. RELATIONSHIP BETWEEN DOSB AND RESPONSE
The relationship between dose and response in microelectro¬
phoresis experiments can be broken down into the following steps:
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I. ejecting current pulse ('dose') ^ drug release;
II. drug release ^ concentration changes at receptors;
III. concentration changes > neuronal response.
In the previous chapter I have discussed the relationship
"between ejecting current pulse and drug release (step I). In this
Introduction I shall discuss first the relationship "between release
and concentration changes (step II), and then the relationship
between concentration changes and neuronal respons (step III).
Ill.1,2. THE 'CONCENTRATION CURVE'
The 'concentration curve* (concentration plotted against
time) describes how the concentration changes in time at a given
point in the external medium during the passage of an ejecting
current pulse. If, for the sake of simplicity, we ignore the con¬
tribution of biological factors (e.g. active transport, diffusional
barriers, etc.), we can use a simple physico-chemical model in order
to define the relationship between drug release and concentration
attained in the tissue. The assumptions underlying this model were
put forward by Curtis, Perrin & Vlatkins (i960). The basic assumptions
are: 1. the tip of the micropipette is a point source; 2. the brain
tissue is a homogenous medium; and 3. drug ions are released by ionto¬
phoresis, but spread in the tissue by diffusion. These assumptions
enable us to use the equations derived for the conduction of heat
from a point source in solids (Carslaw & Jaeger, 1959)•
The equation proposed by Curtis et al. (i960) indicates that
there is a close relationship between steady—state rate of drug release
from the micropipette and the concentration (c) attained at any distance
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where R. is the rate of iontoDhorstic release, D is the diffusion
x
coefficient, and t_ is time measured from the onset of the ejecting
pulse. If the ejecting pulse is sufficiently long (i.e. t )oo),




(see Curtis, 1964). Equation (2) indicates that during the prolonged
passage of an ejecting current, a steady-state concentration should
eventually he attained at any given distance from the tip of the
micropipette. This steady-state concentration would reflect a bal¬
anced relationship between arrival of drug molecules at the fixed
point in the external medium and diffusion away from that point.
Since Faraday's Law is applicable to describe the release of a drug
from a micropipette during the passage of an ejecting current,
under steady-state conditions (see II.3.3•)» we now have a linear
relationship between intensity of ejecting current (i), rate of ionto-
phoretic drug release (R^)> an<i "the concentration achieved at a fixed
point in the external medium (c):
klRi = k2i O)























































FIGURE l/lll. Hypothetical relationship between ejecting current
pulse (a), total release curvemz concentration curve (C), and
response curve for an excitatory response (D).
Horizontal broken line in C indicates level of threshold
concentration; arrows indicate the direction of the shift of the
threshold in the presence of an antagonist (upward) or a protagonist
(downward). Small letters indicate response parameters: a: onset
of ejecting pulse; b: onset of response; c: establishment of plateau
firing rate; d: termination of ejecting pulse; e: offset of response;
f-^: baseline firing rate; f^: plateau firing rats.
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Equation (l) enables us to make some predictions about
shape of the concentration curve at distance d from the tip of the
micropipette (see Pig. l/lII.C.). During an ejection period, the
concentration first increases with time before an equilibrium
concentration is attained. The equilibrium concentration, which
is directly proportional to the rate of drug release, will be
maintained until the steady-state iontophoretic release continues.
When iontophoretic release is terminated, the concentration curve
will decline at a rate which depends on diffusion.
In Pig. l/lII.C. no assumptions are made about the actual
shape of the ascending and descending phases of the concentration
curve, and, for the sake of simplicity, both phases are indicated
as linear functions of time. There are, however, theoretical reasons
for believing that there would be an exponential relationship between
time and concentration during the rising and the declining phases of
the curve. During these phases, the concentration changes would be
described by Pick's second law of non-steady state diffusion, and
thus would follow first-order kinetics (see Bockris & Eeddy, 1970?
Goldstein, Aronow & Kalman, 1974). These theoretical predictions
have been confirmed by recent experiments using ion-specific micro-
electrodes. The use of these electrodes enables the experimenter
to record the entire concentration curve in the external medium during
the iontophoretic application of a substance. According to such
measurements, the concentration curve has an exponential rising phase,
a plateau, and an exponential declining phase. (Morris & Krnjevic,
1974? Heineman, Lux & Gutnick, 1977).
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It is predicted that changes in the kinetics of drug release
would also appear in the concentration curve (see Pig. l/lll):
1. Effect of retaining currents. If the rate of drug release
does not rise instantaneously to a plateau level, as is the case after
the passage of a prior retaining current (see II.3.3.), it will take
a longer time to establish the equilibrium concentration at a point
in the external medium. The declining phase of the concentration
curve will be influenced by the efficacy of a post-ejection retaining
current in counteracting diffusional release after the termination
of the ejecting pulse.
2. Effect of ejecting currents. When the same drug is applied
with ejecting currents of successively increasing intensities, the
concentration curve is likely to be altered in the following way: the
latency should become shorter (reflecting the shortening of the release
latency), the plateau higher, and the decay time longer (as it would
take a longer time for diffusion to reduce the concentration from a
higher level to zero).
3. Effect of the mobility of the drug ions. The shape of
the concentration curve will reflect the absolute mobility of the drug
ions. Let us compare the hypothetical concentration curves for a more
mobile drug (A) and a less mobile drug (B), released under identical
conditions (the same molarity of the drug solution, the same ejecting,
current, the same condition of the 'concentration layers' within the
micropipette before the start of the ejecting pulse). The release
curve of drug A will have a shorter latency, a steeper rise, and a
higher plateau, due to the higher transport number of A. All these
features will "be reflected in the concentration curve of drug A,
which in addition will have a faster declining phase, due to the
higher diffusion coefficient of A. Thus the 'fast' time course
(short latency, steep rise, high plateau, fast decline) of the
concentration curve of drug A contrasts with the 'slow' time course
of the concentration curve of drug B (longer latency, less steep
rise, lower plateau, long decline).
It must be emphasised at this point that this discussion
of the concentration curve has been concerned only with the contribu¬
tion of physical factors. In vivo, the concentration curve may be
modified by biological factors such as diffusional barriers and path¬
ways, active transport mechanisms, enzymic degradation, etc.
III. 1.3. THE 'RESP0I-IS5 CURVE'
A neurone can 'respond' to the presence of drug molecules
by a change in its electrical excitability. If intracellular recording
is used, it is possible to observe the graded membrane response. In the
case of extracellular recording (as in the experiments described in
this thesis), one can only observe the unitary action potentials, and
use the frequency of action potential generation as an index of
cellular excitability. Central neurones studied in vivo are often
spontaneously active due to their afferent synaptic inputs. Thus
the response of a single neurone to a microelectrophoretically applied
drug can be either an increase (excitation) or a decrease (depression)
in its firing rate. The time-course of this change is described by
the response curve (firing rate plotted against time; see Pig. l/lII.D.).
The response curve (for an excitatory response) consists of three main
parts: 1. rising phase (including the response latency); 2. plateau;
3. declining phase. (The 'depressant' response curve is a mirror image
of the 'excitatory' curve).
It is possible to make some predictions about the relationship
between concentration curve and response curve if we make the following
simplifying assumptions: 1. there is only one ' homogeneous receptor
population; 2. the receptors are localized at one point in the tissue;
3. the receptors respond instantaneously to a given drug concentration
(see Cuthbert & Dunnant, 1970)j 4» there is a fixed relationship between
concentration change and change in firing rate. It follows from these
assumptions that the response curve should closely follow the concent¬
ration curve, and any change brought about in the concentration curve
(e.g. by manipulating drug release) should also appear in the response
curve.
The hypothetical relationship between current pulse (a),
release curve (B), concentration curve (c), and the response curve
(B) is illustrated in Fig. l/lll. A rectangular ejecting current
pulse (A) may result in the release curve shown in line B: the rising
phase of the curve may be distorted by a pre-ejection retaining
current, and the declining phase may be distorted by diffusional
release (see Chapter II). These changes are reflected in the concentra¬
tion curve (c). The onset of the response (D,b) indicates the presence
of a threshold concentration of drug molecules which elicits a detectable
change in firing rate. As the concentration rises, the firing rate
gradually increases (in the case of an excitatory response) (b — c),
and the establishment of a steady concentration will be reflected in
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the attainement of the plateau firing rate (c). The declining
phase of the concentration curve is reflected in the declining
phase of the response curve (d — e), and when the concentration
falls to the threshold level, the baseline firing rate recovers
(e).
It is possible to derive some experimental predictions
from the hypothesis about the close relationship between concent¬
ration curve and response curve:
1. Physical factors (release, diffusion) which influence
the concentration curve should also influence the time course of
the neuronal response.
2. Drugs may modify the response curve in two ways:
a. by altering the concentration curve (e.g. uptake
inhibitors);
b. by altering the threshold concentration, without
changing the concentration curve (see Pig. l/lll.). It is expected
that drugs which raise the threshold concentration (antagonists)
would increase the response latency, and reduce the recovery time
of the response, as well as reducing the height of the plateau. On
the other hand, drugs which lower the threshold (protagonists) should
shorten the latency, and prolong the recovery time of the response, as
well as increasing the height of the plateau.
The experiments described in Section III.3. examine the first
group of predictions. Some of the experimental evidence obtained from
drug-interact ion studies (see later Chapters) will be interpreted by
using the second group of predictions.
III.2. METHODS
III.2,1. PREPARATION OF THE ANIMALS
Cats of either sex weighing between 2.0 and 3.5 kg were
used in these experiments. Two different techniques were used to
prepare the animals.
(a) In earlier experiments the cats were prepared according to
the methods of Roberts & Straughan (1967). Anaesthesia was induced
using halothane (approximately 2.5%) delivered via a face mask,
and was maintained throughout the experiment with halothane (about 1%)
delivered via a tracheostomy cannula with an Ayer's T-piece—like
arrangement. Catheters were inserted into the cephalic vein and
femoral artery for the injection of drugs and recording of blood
pressure. ECG was continuously monitored. Two silver ball electrodes
were inserted through burr holes in the skull contralateral to the site
of single unit recording for monitoring epidural EEC. Rectal temperature
was maintained between 37°and 38°C with a heating pad controlled by a
thermosensitive rectal probe.
The cat's head was held rigidly in a stereotaxic frame, and
the muscles of the back of the neck were cauterised transversely to
expose the atlanto-occipital membrane. The membrane was then incised,
allowing CSF to run out. A hole about 1 cm in diameter was cut in the
skull overlying the anterior sigmoid gyrus, the dura was removed, and
1% agar (at 38°C )was poured into the hole in order to reduce pulsation
of the brain during recording.
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(b) During the course of the project, several modifications were
made to the above techniques.
Under local anaesthesia, a Portex cannula was inserted into
the cephalic vein for the injection of thiopentone, which was used to
induce general anaesthesia. It was found that this method of induction
was less stressful for the animals and obviated the need for high
concentrations of halothane during the surgery. High concentrations of
halothane were associated with hypotension,cardiac dysrhythmia and raised
intra—cranial pressure. After the surgical preparation of the animal had
been completed, the administration of thiopentone was discontinued (total
amount injected 40-140 mg), and anaesthesia was maintained with halothane,
administered via a tracheostomy cannula, for the rest of the experiment.
Halothane was delivered from a termperature and flow-rate compensated
vapouriser (Pluotek Mk III, Cyprane Ltd.), enabling us to administer
a constant concentration of halothane (0.6-1,2%) throughout the experiment.
No cell recordings were made until at least 3 hours after the discontinuation
of thiopentone.
As well as the continuous monitoring of SCG, EEG, blood pressure
and rectal temperature, CO^ (*) levels at the bifurcation of the trachea
were also continuously monitored using a Beckman gas analyser (L3-l).
The animals respired spontaneously, inspiring the oxygen—halothane
mixture from a reservoir bag via a low resistance non—return valve, and
expiring into the atmosphere via another non-return valve. Constant
inflation of the. inspiratory reservoir bag was maintained by adjusting
the flow rate of the oxgen supply. The flow rate thus yielded a
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continuous monitor of the respiratory minute volume. Artificial
ventilation was used if the spontaneous repiration "became irregular,
if the respiration minute volume was markedly reduced, or if the
end-tidal CO^ exceeded jfo. During the course of the experiment a
continuous infusion of a dextrose-saline solution (5% dextrose, 0.9/£
NaCl) was administered at a rate of 4 ml hour, and the bladder was
continuously drained using an indwelling catheter.
Modifications were also made to the method of exposing the
area of cerebral cortex for recording. A small hole was made in
the skull overlying the anterior sigmoid gyrus using a dental burr.
An incision was made in the dura (0.5-1 mm in length) under microscopic
control, and the arachnoid ruptured using a glass probe, allowing C3P
to leak out. The micropipette could then be introduced under micro¬
scopic control. This technique has the advantage that it is not
necessary to remove CSF and thus the skull behaves as a practically
closed box; in this way problems associated with pulsation are minimised.
III.2.2. PREPARATION OF THE MICROPIFETTE5
The five-barrelled raicropipettes used in these experiments
were similar to those used in the in vitro experiments (see II.2). One
of the five barrels was always filled with 3 M or 4 | NaCl for recording
action potentials. In most of the experiments a second barrel was also
filled with NaCl for use in 'current balancing* (Roberts & Straughan,
1967). The drug solutions used in the micropipettes were as follows:
(-)noradrenaline bitarfcrate (0.2 M, pH 3.0-3.5); 5--h-y<iro2ytryptamine
himaleate (0.2 M, pH 3.0-3.5); mescaline hydrochloride (0.2 M, pH 3.5-4.5);
acetylcholine chloride (0.2 M, pH 4.0-4.5); carbachol chloride (0.2 M,
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pll 4.0-4.5)i sodium glutamate (0.2 M, pH 8.5). With the exception
of the sodium glutamate solution, all the solutions were prepared "by-
dissolving the drug salt in double—glass distilled water. The pH of
the sodium glutamate solution was adjusted to 8.5 by the addition of
NaOH.
111,2.3. RECORDING OF ACTION POTENTIALS
The recording techniques used in these experiments have been
described by Roberts & Straughan (1967). Extracellular action potentials
were recorded via a 3 or 4 M NaCl solution contained in one barrel of the
micropipette (resistance: 3—10 megohm). The action potentials were
amplified using a Bioelectric Electrometer and a Tektronix pre—amplifier,
and were fed into an oscilloscope (Tektronix 5^5) f°r visual observation.
Spikes of equal amplitude were isolated from the noise using a pulse
height selector. The pulse height selector generated two sets of standard
pulses. One set of pulses was fed back into the oscilloscope to provide
a visual monitor of the isolation of spikes from the noise. The other
set of pulses was fed into a ratemeter (Ekco, N522C) with a time- constant
of 1 sec, and a cumulative recorder (Grass Unit Integrater UI—l). The
outputs of the ratemeter were displayed on a pen-writing oscillograph
with curvilinear write-out (Grass, model 7).
III.2.4- MICR0BLECTR0PHQR3TIC APPLICATION OF DRUGS
Ejecting and retaining currents were provided by the circuit
described by Roberts & Straughan (1967). A 300V DC supply was reduced
stepwise to obtain voltages, and thus currents, of an appropriate
magnitude. The final output resistance of the circuit was 1000 megohm
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which minimised, any changes in the current flow resulting from
eventual changes in the electrical resistance of the drug barrels.
The electrophoretic current passed through each drug barrel of the
micropipette was continuously monitored using a Pye Scalamp galvanometer.
Artefacts, produced by switching from positive to negative
current, were minimised by the use of mercury-wetted reed switches.
These were controlled by an independent 12V circuit. The reed switches
could be operated either manually or automatically using a sequential
timing device (Sevan & Bradshaw, 1973)* The current source provided
for up to five independent electrophoresis channels.
To control for possible current effects on the cell under
study, 'current balancing* was routinely used. This was achieved by
passing currents of appropriate polarity and intensity through a
barrel of the micropipette containing a 4 | NaCl solution in such a
way that a) either the total positive and negative currents passed
through all the barrels remained constant during both ejection and
retention periods (Roberts & Straughan, 1967), b) or the net current
flow through the tip of the micropipette remained zero throughout the
experiment (Salmoiraghi & Weight, 1968).
III.2.5. RESPONSE MEASURES
In these experiments,act ion potentials generated by a single
unit were defined as spikes of equal amplitude which were clearly
separated from the noise level and from spikes of lower amplitude.
Pharmacological responses were evaluated on the basis of the ratemeter
and cumulative spike counter records. The following parameters were
used (see Pig. 2/lIl):
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FIGURE 2/lII. Parameters of an excitatory response to acetylcholine.
A. Sleetrophoretic current passed through the solution
of acetylcholine chloride (0.2 M) contained in one barrel of the
micropipette (ordinate: current intensity, nA, positive upwards;
abscissa: running time, min).
B. Ratemeter recording of the firing rate of a single
cortical neurone (ordinate: firing rate, spikes/sec; abscissa:
running time, min).
C. Cumulative record of the total number of action potentials
generated by the neurone (ordinate: total spikes; abscissa: running
tirae, min).
Response parameters are indicated by letters above and to
the right of the traces. See text for explanation.
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a) The spontaneous (baseline) firing rate (P-^).
b) The latency of onset of excitation, measured from the
onset of the ejecting pulse (response latency) (Tq - T^).
c) The maximum (equilibrium) firing rate obtained by the
cell during the ejection period (P^). The maximum firing rate was
measured under equilibrium conditions, i.e. when prolongation of
the ejection period led to no further change in the firing rate.
The baseline firing rate was subtracted from the maximum (equilibrium)
firing rate in order to obtain the maximum change in firing rate (Pg —
d) The time taken to achieve the maximum firing rate (Tq - T^).
e) The time taken for the recovery of the spontaneous firing
rate after the termination of the ejecting pulse (recovery time) (T^ — T^).
f) The t ot al number of action potentials generated in response
to the ejecting pulse (total spike number). This measure was used as
an index of the magnitude of the excitatory response.
The response latency, the time taken to achieve the maximum
firing rate, and the recovery time were estimated by determining the
point in time at which the angle of slope of the write-out of the
cumulative spike counter stopped changing. This method was found to
yield more reliable values than could be obtained by direct measurement
of the ratemeter tracing.
The total spike number was either measured directly, using
the cumulative spike counter, or was estimated by measurement of the




All the neurones studied in these experiments were spontaneously
actives and in no case was the firing rate controlled by the'background'
application of excitant amino acids. Only excitatory responses were
used. In these experiments, we followed the usual practice of passing
a retaining current through the drug-containing barrel continuously
when ejecting currents were not being passed.
I11.3a, THE ROLE OF EJECTING CURRENTS
In these experiments, the parameters of the retaining pulse
(intensity, and retention time) were kept constant, and the intensity
of the ejecting pulse was increased with successive applications.
The following changes in the excitatory responses were observed:
a. The response latency became progressively shorter.
b. The latency to plateau became progressively shorter,
e. The maximum firing rate attained by the cell increased,
d» The recovery time was prolonged (in the presence of a
post-ejection retaining current of standard intensity).
e. The total spike number increased (when a standard
ejection time was used).
Eatemeter recordings of the responses of a single cortical
neurone to 5~-HT, released from a micropipette with a range of different
current intnesities, are displayed in Fig. 3/lH. Response latencies
and latencies to plateau of responses to ACh, carbachol (CCh), 5-HT and
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FIGURE 4/lH. The relationship "between the intensity of the
ejecting current and the latencies of neuronal responses.
Each graph shows the latencies to onset and latencies to
plateau of responses of one individual neurone. Ordinates: latency
(sec); abscissae: intensity of ejecting current (nA, log scale).
Closed circles: latency to onset of the response; closed triangles:
latency to plateau.
In the case of all four agonists (ACh: acetylcholine; CCh:
carbachol; 5HT: 5-hydroxytryptamine; NA: noradrenaline) the latencies
were reduced when higher ejecting currents were passed.
but it was not possible to measure the recovery time of these responses,
due to their fast time-course.
III.3.2, THB ROLE OF RETAINING CURRENTS
a. Pre-e.lection retaining currents
When the intensity of the retaining current applied between
ejecting pulses was increased, the response to the standard ejecting
pulse was markedly reduced, and, in some cases, completely abolished.
This observation is illustrated in Pig. 5/ill.
These observations were extended further, using excitatory
responses to glutamate. Because of their fast time-course, these
responses are particularly suitable for such studies. It was found
that a reduction in the size of the response to a standard ejecting
pulse could be achieved by increasing the retention time, as well
as by increasing the intensity of the retaining current. This
observation is illustrated in Pig. 6/lII. When the intensity, or
duration of application of the retaining current was increased, the
reduction in the total spike number was accompanied by an increase
in the response latency.
In the studies shown in Pig. 5/ill and 6/III, ejecting
pulses of standard duration were used. Thus, as the response latency
increased following a higher retaining current or a longer retention
time, it was not always possible to achieve the plateau firing rate.
In order to obtain information about the effect of retaining currents
upon other response parameters (plateau firing rate, latency to plateau
and recovery time), it was necessary to vary the ejection time according
12721701 2387-831 561285
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to the response. Therefore, following each retention period, an
ejecting current of standard intensity was applied continuously for
a sufficient length of time to enable the firing rate of the cell
to reach an equilibrium value. Such an experiment is illustrated
in Pig. 7/lII. When either parameter of the retaining current was
increased^ the response latency and the latency to plateau increased
(Pigs. 7/lH and 8/lIl), but there was no change in the height of
the plateau or in the recovery time in the presence of a retaining
current of standard intensity (Pig. 7/lIl). In the study shown in
these figures the retention time was increased: similar observations
were made when the intensity of the retaining current was increased.
b. Post-ejection retaining currents
After any given ejecting current, the recovery time of the
response was constant in the presence of a standard post-ejection
retaining current (see previous section). However, when the intensity
of the post-ejection retaining current was increased, a reduction in
the recovery time was observed, although it was not possible to reduce
the recovery time to zero, even when very high retaining currents we. e
applied. An example of this observation is displayed in Pig. 9/1II,
which shows the recovery times of responses of a cell to ACh.
III. 4. DISCUSSION
The results presented in Section III.3 support the suggestion
that the response curve closely follows the concentration cuive. The
FIGURE7/lII•Theeff ctofchangesitdurationofapplicationfthpre-ejectionr ai ingurre t uponneuro alr sp sestacetylcholine. Lowertrac s:electrophoreticur entpa sedth oughthsolutionfacetylcholineh or de(0.2M)containedi nbarr lfthmicropipette(ordi at s:urr ntint n ity,Apositive upwards;abscissae:runningtim ,i ).Stippl da a:retainingcurre t;h tch dea:ej ctingcurrent. Uppertrac s:exc rptsfromtherecordingftfirinatefsi gleticalneurone(ordinates:f ringate,spikes/seo;abscissae:runningt m ,thamec llow rr c s).Arrowsabovether cesindi atethon tft r ponse,thattainmentfmaximumfiringate,a dtherecoveryofthb s linef ri gat .Thinte sityft r ainingnd ejectingcurrentswak pconstantthr ughoutthes udy,bt re entiontimewasvari d.A.Pre-ejectionretentiontime:5. B.Pre-ejectionretentiontime:10i ;thresp sela cya dheimt k nattainthemaximumfir ngatewereincreased. C.Pre-ejectionretentiontime:40i ;thr sponsela cya dthmt k nattainthemaximumfir ngatewerefurth rincr ased,withnochangei emaximumf ngratendthrecoverytime.
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FIGUHS 8/lII. The effect of retention time on response latency and
latency to plateau of the response of a single cortical neurone to
acetylcholine.
Closed circles: response latency; closed triangles: latency
to plateau. The intensity of the retaining current was -100 riA,
and the intensity of the ejecting current was +2p nA.
An increase in the retention time resulted in an increase
in the response latency and the latency to plateau.
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FIGURE 9/lH. The effect of the intensity of the post—ejection
retaining current upon the recovery time of responses of a
single cortical neurone to acetylcholine.
Recovery times were measured in the presence of retaining
currents of various intensities following plateau responses to
acetylcholine (ejecting current, +100 nA.).
The recovery time was reduced when higher post-ejection
retaining currents were used.
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changes in the response curve observed, when increasingly higher
ejecting currents were -used are consistent with the predictions
presented in III.1.2. for the concentration curve: the latency is
reduced, the plateau is raised, and the recovery time is prolonged.
Since it is proposed that the concentration curve reflects
in part the shape of the release curve, it is to he expected that
all the distortions imposed on the release curve by the passage of
retaining currents would be manifested in the response curve. This
prediction is confirmed by the present experiments:
a. Pre-e,jection retaining currents
An increase in either the intensity or the duration of the
pre-ejection retaining current results in an increase in the response
latency and latency to plateau, but doe3 not alter the plateau firing
rate itself. These findings are complementary to the observations
of the release curve measured in vitro (e.g. compare Pigs. 8 /ii
and 7/lIl). When standard ejecting pulses are used, the distortions
in the response curve are reflected in a decrease in the total spike
number; this presumably results from a decrease in the total drug
output during the ejection period (compare Pigs. 7/II and 6/lIl).
It is apparent from Pig. 6/lII that an increase in the
interval between consecutive ejecting pulses can result in the complete
abolition of neuronal responses to giutamate. It is obvious, therefore,
that if quantitatively reliable responses are to be achieved in a
microelectrophoresis experiment, it is essential that each drug being
tested is applied at regular intervals throughout the study.
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b. Post~e,lection retaining currents
The post-ejection retaining current can modify the recovery
time of the response (Fig. S/lIl). The finding that even in the
presence of —5 nA. the original baseline firing rate completely recovered
is supported by the finding that very weak retaining currents which
are not capable of abolishing diffusional release instantaneously
eventually became completely effective (cf. Fig. 8/lI.C.). The
progressive shortening of the recovery time in the presence of
retaining currants of higher intensities is presumably a reflection
of progressive shortening of the minimal effective retention time
(t . ). The fact that —25 nA. was practically as effective as —100 nA\ min' J
suggests that —25 nA almost instantaneously abolished spontaneous
release (i.e. t . = 0), and that the recovery time observed in thex
rnxn '1 J
presence of these currents reflects the reduction in concentration
of the drug at receptor sites when there was no diffusional leakage
from the micropipette.
The in vivo observations reported in Section III.3. confirm
the practical relevance of the in vitro studies for the use of the
microelectrophoretic technique under 'normal' experimental conditions.
It is important to note that despite the fact that more dilute drug
solutions were used in most of the in vitro experiments, the effects
of retaining currents on the release curve are parallelled in every
way by their effects on the response curve. Retaining currents are
universally used in microelectrophoresis experiments. There is little,
if anything, to be gained from the use of weak retaining currents,
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for if a retaining current is to "be effective in counteracting
spontaneous release it must necessarily distort the rising phase of
the subsequent release curve (and hence also the response curve).
The use of a relatively high retaining current has the advantage
that it may abolish release promptly and thus allow time for the
neurone to recover before the next ejecting pulse. Sustained
diffusional release may give rise to subthreshold concentrations
of drugs whose presence becomes apparent only in the presence of a
protagonist (Curtis et al.t 1970)» it may also be source of desens-
itisation (Roberts & Straughan, 1967).
It was mentioned in III.l. that many workers have attributed
some biological significance to the different time-courses observed
with different drugs. The alternative position considered here is
that differences between time-courses of responses to different drugs
are to a great extent due to differences between the mobilities of the
drug molecules. It was suggested earlier, on theoretical grounds, that
the concentration curve of a more mobile drug will have a 'faster'
time-course than that of a less mobile drug released under identical
conditions (III.1.2.). These hypothetical differences between the
concentration curves correlate well with actual differences between
the response curves; more mobile drugs tend to evoke 'faster' responses
than less mobile drugs (see Table l/lll). It is also relevant that
the same drug applied microelectrophoretically in different tissues
tends to evoke responses of similar time-courses (Stone, 1971? 1972a).
Of course, on the basis of the presently available evidence, one cannot
conclude with certainty that physical factors alone are responsible for
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the shape of the response curves. However, any conclusion about
the involvement of biological factors (e.g. kinetics of drug-receptor
interaction) should be based on an understanding of the contribution




RESPONSES 0? CORTICAL NEURONES TO NORADRENALINE
- 100 -
IV.1. INTRODUCTION
The term 'cerebral cortex' refers to the neocortex;
archicortical structures (e.g. hippocampus) are described, under a
separate heading (for review see 1.4.)• The term 'cortical neurone*
usually designates an anatomically unidentified neurone recorded
in the frontal (somato-motor) or parietal (somato—sensory) region
of the neocortex. When the pharmacology of neurones in the temporal
(auditory) or occipital (visual) cortex is studied, these neurones
are usually specified by the cortical region studied.
Most of the experimental information available in the
literature derives from two species: the cat and the rat. All the
earlier experiments were performed with cats, the traditional
experimental animal of neurophysiology. More recently, however,
mainly due to financial pressures, many laboratories have started
using rats for microelectrophoresis experiments. This applies also
to the work presented in this thesis: the earlier work has been done
with cats, more recent data, however, have been obtained with rats.
It will always be specified which species was used for a particular
series of experiments.
IV.1.1. DIRECTION OF RESPONSES
Similarly to neurones in most other structures of the brain
(see I.3.), cerebral cortical neurones can respond with both excitation
and depression to NA applied by microelectrophoresis.
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a. Cat
In an early study, Krnjevic & Phillis (1963c) described a
predominantly depressant action of HA in barbiturate anaesthetised
cats. Although excitatory responses were occasionally observed
when higher ejecting currents were used, these authors suggested
that these were probably of a non-specific nature.
Johnson et al. (1969a.) described both excitatory and
depressant responses in the cerebral cortex of the halothane-
anaesthetized cat. These authors found excitations more frequently
than depressions, and suggested that probably the excitations
represented the genuine pharmacological effects of HA. This suggestion
was based on txvo different experimental observations: 1. the
proportion of cells excited was higher in halothane-anaesthetized
or unanaesthetized encephale isole preparations than in barbiturate-
anaesthetized preparations in which depressions predominated (Johnson
et al., 1969b); 2. excitatory responses to noradrenaline could be
reversibly antagonized by and ^—adrenoceptor blocking agents,
whereas the depressant responses were relatively insensitive to the
adrenoceptor blocking agents (see below).
In 7 cats, anaesthetized with a mixture of methoxyflurane
and nitrous oxide, Lake, Jordan & Phillis (1972) described only
depressant responses to microelectrophoretically applied HA. In
another paper, the same authors (Jordan, Lake & Phillis, 1972c)




In a series of experiments, using unanaesthetized cats
(cerveau isole or conscious animals, Frederickson et al. (1971» 1972)
described both, excitatory and depressant responses? however, v/hen the
pH of the 1JA solution was 4«0 or higher (see 17.1.3.), the proportion
of cells excited was relatively small (about 10^ of all responses).
b. Rat
Apart from our laboratory (see Results: 17.3.1.), two other
laboratories have investigated the effects of HA on single neurones
in the cerebral cortex of the rat: Phillis and his colleagues in
Winnipeg and later in Saskatoon, and Stone in Aberdeen. Unfortunately,
the results from the three laboratories are not directly comparable
due to the use of different anaesthetics: Phillis and his colleagues
used a mixture of methoxyflurane and nitrous oxide, Stone used
urethane, and we used halothane.
The reports from Phillis1 laboratory describe only a
depressant action of NA on neurones in the cerebral cortex of the
rat anaesthetized with a methoxyflurane-nitrous oxide mixture (Jordan,
Lake & Phillis, 1972c; Phillis, Lake & Yarbrough, 1973; Yarbrough,
Lake & Phillis, 1974; Phillis, 1974). Stone in his earlier papers
described both excitatory and depressant responses to M on cortical
neurones in the urethane-anaesthetized rat (stone, 1973a; Stone, 1973b;
Anderson & Stone, 1974)? most of the responses were depressions, and
only a small proportion (5 - 1C$) of the responses were excitations.
In some more recent papers (Stone, 1974; Stone, Taylor & Bloom, 1975)
only depressant responses to NA were reported by the same author.
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c. Guinea pig
Jordan et al. (1972c) reported only depressant responses
to NA in the cerebral cortices of 11 guinea pigs anaesthetized with
methoxyflurane-nitrous oxide.
d» Rabbit
Giardina et al. (1973) described both excitatory and depressant
neuronal responses to NA in the cerebral cortex of the unanaesthetized
rabbit: 5&f° of the responses x<rere excitations, and 5were depressions.
e. Monkey
Nelson et al. (1973) described both depressant and excitatory
responses to NA in the cerebral cortex of the squirrel monkey
anaesthetized with chloralose or halothane. There was a predominance
of depressions: only about 5% the responses were excitatory.
Foote et al. (1975) examined the effect of microelectro—
phoretically applied NA on acoustically evoked neuronal responses
in the auditory cortex of the unanaesthetized squirrel monkey: NA had
a depressant effect on these evoked responses.
IV.1.2. THE ROLE OF ANAESTHESIA
In microelectrophoresis experiments, as in most neurophys¬
iologies! experiments, anaesthetized animals are used. The presence
of a chemical anaesthetic is an experimental variable which may well
influence the physiological and pharmacological observations made
on single neurones. There are three possible ways of avoiding the
interpretative dangers arising from the use of anaesthetics:
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1. to use unanaesthetized animals paralysed with a muscle relaxant;
2. to use unanaesthetiaed, unrestrained, awake animals; 3. to use
an anaesthetic which interferes least with the physiological and
pharmacological observations,
The first alternative has to be rejected on ethical
grounds. A compromise seems to be to use •encephale isole'
preparations in combination with the muscle relaxant (Johnson
et al., 1969b); but in this case the preparation might well be
affected by the major surgery, and also by the muscle relaxant
(e.g. gallamine). Although microslectrophoretic drug application
and recording of single neuronal activity have been tried in
unanaasthetized, unrestrained, conscious animals (Prederickson,
Jordan & Phillis, 1972; 1973)» these preparations are too unstable
for the lengthy studies required when the interaction between
drugs is investigated. Therefore, at present, the last alternative
is the most practicable: i.e. it is necessary to find the 'ideal'
anaesthetic 'which has the minimum detrimental effect on the
pharmacological observation. The search for the 'ideal'
anaesthetic is based on exclusion: anaesthetics with marked effects
on neuronal responsiveness have to be avoided.
There is now ample evidence showing that the barbiturates
can alter markedly the pharmacological responses of neurones
in the CNS. Bloom et al. (1965) reported that ACh had an
excitatory effect on caudate neurones in the unanaesthetized cat
which was abolished or converted into a depressant effect in
barbiturate anaesthesia. Johnson et al. (1969b) observed that
the proportions of cortical neurones excited by NA and p—HT were
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reduced, in thippentona anaesthesia, and that excitatory responses
to the monoamines co-aid be abolished by the systemic injection of
thiopentone. Microelectrophoretically applied barbiturates were
found to abolish responses to homocysteate and to ACh in the cerebral
cortex (Crawford, 1970)• Barbiturates administered intravenously
or microelectrophoretically were found to block selectively excit¬
atory responses of brain stem neurones to ACh (Bradley & Dray, 1973)•
In an olfactory slice preparation barbiturates were described to
depress the sensitivity of neurones to glutaraate (Richards & Smaje,
1976); excitatory responses to ACh, however, were less affected
(Smaje, 1976).
There are some recent reports suggesting a possible direct
postsynaptic inhibitory action for barbiturates. Nicoll et al.
(1975) found that barbiturates hyperpolarize hippocampal neurones,
and markedly prolong synaptically evoked post-synaptic inhibitory
potentials. Barker (l975a? 19756) reported a similar post-synaptic
depressant effect of barbiturates on the crustacean neuromuscular
junction and on invertebrate neurones.
There is less detailed information concerning the effects
of other anaesthetics on the chemical sensitivity of central neurones.
Johnson et al. (1969b) found that halothane, in contrast to barb¬
iturates and chloralose, did not alter the sensitivity and the
pattern of responsiveness of cortical neurones to NA and 5*~HT.
Crawford (1970) reported that chloralose markedly reduced the
sensitivity of cortical neurones to ACh and excitant amino acids;
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whereas urethane, nitrous oxide, trichloroethylene, methoxyf1urane,
and halothane had little effect. Bradley & Dray (1970) found
that t ribrornost hanol and ure thane did not change the proportions
of cells excited or depressed "by ACh, 5_HT and NA in the brain
stem. In an in vitro preparation of the guinea pig olfactory
cortex, Richard & Smaje (1976) observed that ether, methoxyflurane,
trichloroethylene, and alphaxolone, similarly to the barbiturates,
depressed the sensitivity of neurones to gluts-mate, whereas halothane
did not affect neuronal sensitivity.
Halothane would seem to be a reasonable choice of anaesthetic
for the following reasons: 1. halothane has little effect on the
chemical sensitivity of central neurones (Crawford, 1970; Richard &
Smaje, 1976); 2. halothane does not prevent the occurrence of excit¬
atory responses to M and 5~HT, which are frequently observed in
unanaesthetized 'enc^phale isol4' preparations (Johnson et al», 1969b);
3. it is easy to administer halothane in a reliable way to maintain
a steady level of anaesthesia for periods of many hours; 4« halothane
can be administered in pure oxygen, and thus the danger of hypoxia
can be avoided.
Therefore, halothane was used routinely in all our in vivo
experiments. We are aware, however, of the possibility that even
this inear-ideal' anaesthetic might have interfered with the neuronal
pharmacology observed by us. A further series of experiments is in
progress which will repeat some of the pharmacological studies described
in this thesis using in vitro recording from brain slice preparations
in the absence of any anaesthetic.
IV,1.3. THE ROLF OF pH
Krnjevi6 & Fhillis (1963a) reported that hydrogen ions,
when released from acidic solutions with high ejecting currents
for prolonged periods, could, rather unpredictably, excite some
cortical neurones. After a systematic study with NaCl solutions
at different pH values, these authors concluded that this effect
was very unlikely to occur unless the pH of the drug solution
contained within the micropipette was lower than 2,5» Nevertheless,
this raises the possibility that H+ released from an acidic drug
solution may modify the neuronal response to the drug.
Johnson et al. (1969a) conducted careful controls for
the possible effects of H released during the electrophoretic
ejection of NA. Since NA released from solutions at pH 3.0 had
identical effects to NA released from solutions at pH 5»0» these
authors concluded that H+ was unlikely to play a role in the
responses to NA. Their findings have been confirmed by Stone (1972c)
Frederickson, Jordan & Phillis (1971) obtained results
which were in direct conflict with those of Johnson et al. (1969a),
They reported that NA released from solutions at pH 4*0 or pH 5.0
was depressant. However, if solutions at pH 3.0 or less were used,
excitatory responses were frequently encountered. Similar results
were obtained with 5~HT (Jordan, Frederickson, Phillis & Lake, 1972a)
In subsequent papers, the same authors (Jordan, Lake & Phillis,
1972b; Hewes & Frederickson, 1974) reported that H+ released
electrophoretically from HC1 solutions could also excite cortical
neurones. These authors concluded that their results 'clearly
show that hydrogen ions applied iontophoretically from drug solutions
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or from solutions of HC1 can cause excitation of neurones, and
that such hydrogen ion effects are responsible for a major portion
of the excitation observed in the cerebral cortex when NA is applied
from acidic solutions' (Jordan et al., 1972b). They further argued
that 'the true action of 5_KT (and NA) on cortical neurones
is inhibitory'.
In view of the controversy about the nature of excitatory
responses to NA, it was decided during the present project to
conduct a further investigation of the involvement of H in these
responses. The results of these experiments are described below
(IV.3.3.).
IV.1.4. THE ROLE OF INDIRECT EFFECTS
When a drug is applied by microelectrophoresis, it may
have a direct effect on the cell whose activity is being recorded;
the drug, however, may affect the electrical activity of the nerve
cell in an indirect way by exerting an action on neighbouring
structures (e.g. other neurones that are in synaptic contact with
the neurone studied, axon terminals of more distant neurones,
glia cells, blood vessels). It is often difficult to differentiate
between direct and indirect effects, and the evidence supporting
an argument either way is often circumstantial.
Stone (1971) suggested that the excitatory responses to
microelectrophoretically applied NA might be due to an indirect effect
of the drug on neighbouring small blood vessels: NA would cause
constriction in the vessel, which in turn would result in hypoxia;
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and hypoxia would cause depolarisation of the neurone. This suggestion
was hased on Stone's observation (Stone, 1971? 1972a) that mesenteric
arterioles of the rat are constricted "by microelectrophoretically
applied NA, and this vasoconstriction has a 'slow* time-course
reminiscent of the time-course of the 'slow' excitatory responses
to NA.
Stone's argument has "been criticised on several grounds.
Krnjevic (1973) pointed out that cerebral blood vessels were
insensitive to NA. Boakes et al. (1972) drew attention to the
fact that not only excitatory, but also depressant responses to
NA often had a 'slow' time-course. Brawley &, Johnson (1973)
emphasized that it was a crude simplification to talk about 'the
latency' of the response to NA; response latency varied considerably
from cell to cell, and was related to the baseline firing rate of
the neurone. Szabadi & Bradshaw (1972; 1973) pointed out that not
only NA evoked 'slow' excitatory responses; similar responses
were evoked by 5~HT, isoprenaline, and mescaline, and these drugs
did not have an unequivocal vasoconstrictor effect on cerebral
blood vessels. These authors also argued that the 'slow' time-
course of these responses might reflect the physical properties
of the drug molecules rather than some biological feature of
drug action (see also III.4. and Table l/lll).
We can conclude, therefore, that, although it is not
possible to rule out completely indirect vascular effects in
in vivo microelectrophoresis experiments, there are no good
reasons for believing that the excitatory responses to NA, in
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particular, are due to such effects. A possible vascular contribution
to a neuronal response could be eliminated, however, by repeating the
experiments in vitro using a tissue slice preparation,
IV.1=Q. MODIFICATION OF RESPONSES TO NORADRENALINE BY DRUGS
a. Adrenoceptor blocking agents
The most comprehensive study involving these drugs was
conducted by Johnson st al. (1969a) in the cerebral cortex of
the cat. These authors found that the "^.-adrenoceptor blocking
agents dibenamina, phentolarr.ine, and thymoxamine selectively
antagonised excitatory responses to MA (responses to A.Ch, glutamate
or 5-HT were not affected). The effects of phentolamine and
thymoxamine were reversible. Depressant responses were usually
unaffected by these antagonists; only on one occasion did thymoxamine
antagonise the response. The ^-adrenoceptor blocking agents
propranolol, isopropylaminoitrophenylethanol (iNFEA), and sotalol
were also effective in antagonising excitatory responses to NA»
Propranolol occasionally (on 2 out of 8 cells) antagonised the
depressant response to NA; INFEA and sotalol did not seem to be
effective in antagonising depressant responses. The authors
concluded that the excitatory responses might be mediated by
adrenoceptors which are different from peripheral adrenoceptors,
and that the depressant responses might be of a 'non-specific*
nature.
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In agreement with. Johnson et al,, (1969a), Sevan et al. „
(1974a) found that the ^-adrenoceptor "blocking agent, sotalol,
was an effective antagonist of excitatory responses to NA in
the cerebral cortex of the cat. Sotalol, however, was found to
be less specific than was suggested earlier by Johnson et al.,
(1969a): when the response to NA was antagonised, the response
to 5-ET was also abolished; responses to ACh were not affected.
Sotalol was also an effective antagonist of excitatory responses
to mescaline. When sotalol was applied with a low ejecting current
continuously, it often first potentiated the responses to the
monoamines, and antagonism occurred only when the 'dose' of sotalol
was increased (Bevan et al., 1974a; Bevan et al., 1974h).
Frederickson et al. (1972) reported that, in the cerebral
cortex of the cat, the ot -adrenergic blocking agents dibenamine,
phentolamine, and phenoxybenzamins were effective in antagonising
both excitatory and depressant responses to NA, without affecting
depressant responses to GAM; however, responses to 5~HT and ACh
were also affected by these antagonists. The (1-receptor blocking
agent INPEA was also effective in antagonising both kinds of responses
to NA.
Stone (1973a) reported that, in the cerebral cortex of
the rat, the di-adrenoceptor blocking agent, phentolamine, was
usually unable to antagonise depressant responses to NA; on a
few cells, however, phentolamine proved to be effective. The
effect of phentolamine v/as not studied on excitatory responses.
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The (^-adrenoceptor "blocking agents, propranolol and soialol, were
effective in antagonising "both depressant and excitatory responses
to NA. The author concluded that the depressant responses to NA
might "be mediated via ^-adrenoceptors.
Freedman et al., (1975) observed that the ^-adrenoceptor
blocking agent, dichloroisoprenaline (DCl) could antagonise depressant
responses to NA in the cerebral cortex of the rat; however, DCI also
had a powerful direct depressant effect on the firing rate of the
neurones.
In conclusion, the review of the literature suggests that
the -adrenoceptor blocking agents are effective in antagonising
excitatory responses to NA (Johnson et al., 1969a). Both Johnson,
et al. (1969a) and Stone (1973a) emphasised the relative inability
of these drugs to modify depressant responses to NA. In contrast
to these authors, Frederickson et al., (1972) described the
antagonism of depressant responses to NA by c(-adrenoceptor blocking
agents; this effect, however, probably was not specific, since
responses to ACh were also affected. On the other hand, the
-adrenoceptor blocking agents appear to be effective in antagonising
both depressant (Johnson et al., 1969a; Stone, 1973a; Freedman et al.,
1975) and excitatory (Johnson et al., 1969a; Stone, 1973; Sevan
et al., 1974a) responses.
b. Drugs interfering with the cyclic-AMP system
Lake et al. (1972) found that the phosphodiesterase
inhibitors aminophylline and papaverine could potentiate depressant
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responses to NA. These authors emphasized, however, that this
does not necessarily imply that the effects of NA are mediated
via cyclic—AMP, since the potentiation might have been due to
the direct depressant effect of aminophylline and papaverine,
c. Drugs interfering with the transport and binding of calcium
In a series of papers, Phillis and his colleagues examined
the hypothesis that calcium may play an important role in the
mediation of the depressant responses to NA and to other mono¬
amines, These authors found that drugs which interfere with the
transport and binding of calcium (e.g. lanthanum, verapamil,
manganese, nickel, cobalt, neomycin, ruthenium) effectively
antagonised the depressant responses to the monoamines (NA, 5~HT,
dopamine, histamine) and also the depressant responses to ACh,
without affecting depressant responses to GABA and excitatory
responses to ACh (Phillis et al., 1973? Yarbrough et al., 1974?
Phillis, 1974).
d» Other drugs
Phillis & York (1967) reported that strychnine antagonised
the depressant effect of NA on cortical neurones. This observation,
however, could not be repeated by Stone (1973a? 1973c).
Anderson & Stone (1974) found that depressant responses
to NA could occasionally be antagonised by bulbocapnine.
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IV.2. METHODS




Male albino Wistar rats, weighing between 250g and 300g,
were used.
Anaesthesia was induced with halothane (3.O/0), delivered
from a temperature and flow—rate compensated vapouriaer (Fluotec,
Mk 3, Cyprane Ltd.). Tracheostomy was then performed and a tracheal
cannula connected to a Y-piece inserted for the administration of
the anaesthetic gas mixture. Animals respired spontaneously
throughout the experiment. Luring the course of the preparation
of the animal, the halothane concentration was gradually reduced,
so that by the time the animal was ready for recording the halothane
concentration was 0.5%— 1.0/&, and was maintained at this level
throughout the experiment. The flow-rate of oxygen used was
500 ml/min.
The animal's head was held rigidly in a stereotaxic frame
(David Kopf), and an area of the cerebral cortex was exposed for
recording (see III.2.1.). The dura was either incised with a
hypodermic needle under microscopic control (see III.2.1.), or
was penetrated directly with the micropipette. The recording
site was defined by the following stereotaxic coordinates:
- 115 -
A 4.8 - 6.5; L 0.9 - 2.4 (Konig & Xlippel, 1963); this area corresponds
to the somatosensory cortex.
ECG and rectal temperature were monitored continuously
throughout the experiment. Rectal temperature was maintained
between 37° and 38°C by a heating pad placed under the belly of
the animal.
IV.2.2. PREPARATION OF THE HICROPIFSTTBS
Five- and six-barrelled micropipettes were prepared as
described in II.2. and III.2.2.
The following drug solutions were used: noradrenaline
bitartrate (0.2 M or 0.05 M, pH 3.0 — 3«5; 5~kydre^yt ryptamine
bimaleate (0.2 M, pH 3.0 — 3.5); mescaline hydrochloride (0.2 M,
pH 3.5 — 4.5); acetylcholine chloride (0.2 M, pH 4.0 — 4»5)»
In one series of experiments in which the effects of
pH were examined (see IV.3.3.)* a different method was used
for the filling of the micropipettes. Five—barrelled micro¬
pipettes were pulled, and their tips broken to the desired
diameter (3.0 — 6.0 p.). Freshly prepared drug solutions were
then introduced into the barrels, and air was expelled from the
tips by centrifugation at 3000 r.p.m. for 30 min (see Curtis,
1964). The solutions used in these experiments were noradrenaline
bitartrate (0.2 M, pH 3.1); noradrenaline bitartrate (0.2 M, pH 5»0)»
and hydrochloric acid (0.01 M, pH 2.0). The solution of noradrenaline
bitartrate at pH 3.1 (— O.l) was obtained by dissolving (-)noradrenaline
bitartrate in glass-distilled water, whereas the solution at pH 5.0
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(~ 0.1) was obtained, by adjustment with 1.0 N NaOH solution.
The pH values of these solutions were measured using a Pye
Universal pH meter (model EJ 660). Hydrochloric acid solutions
of 0.01 M were used because this was the lowest concentration
which adequately carried electrophoretic currents.
IV.2.3. RECORDING OF ACTION POTENTIALS, MICROELECTROPHOHETIC
APPLICATION OF DRUGS
See III.2.3. and III.2.4.
IV.3. RESULTS
IV.3.1. RESPONSE TYPES
Three kinds of responses to microelectrophoretically
applied NA could be observed: 1. excitatory responses; 2. depressant
responses; 3. biphasic responses. The excitatory and depressant
responses are monophasic responses which have a latency, .an
initial rising (or declining) phase, a plateau, and a terminal
declining (or rising) phase (see III.1.3.). The biphasic responses
invariably consist of an initial depressant phase, followed by
an excitatory phase. On no occasion could we observe the two
phases in the reverse order, i.e. an excitation was never followed
by a depression. The same three types of responses could be observed
not only with NA, but also with other monoamines (e.g. 5—HT and
mescaline; see Fig. l/lV). The same response types could be observed































FIGURE l/lV. Examples of the types of neuronal responses to
monoamines and, acetylcholine observed in the cerebral cortex
of t he cat♦
Each excerpt is taken from ratemeter recordings of the
firing rate of an individual cortical neurone. Ordinates:
firing rate (spikes/sec); abscissae: time (min). Horizontal
bars indicate drug applications (numbers refer to intensity of
ejecting current (nA).
Acetylcholine (ACh) was excitatory, whereas noradrenaline
(NA), 5-hydroxytlyptamine (5—HT), and mescaline (MESC) could
evoke excitatory, depressant and biphasic responses.
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TABLE l/lV. Responses to noradrenaline
Number of cells responding
Excitation Depression Biphasic Total
Cat 388 108 12 508
(76.4#) (21.3#) (2.3#) (100#)
Rat 338 139 4 481
(70.3#) (28.9#) (0.8#) (100#)
The proportions of cells responding in each of the three
possible ways are shown in Table l/lV. It is apparent from the
table, that there was a predominance of excitatory responses in
both species: about three quarters (76.4# in the cat, and 70.3#
in the rat) of all the responses were excitations, and only about
one quarter (21.3# in the cat, and 28.9# in the rat) of the responses
were depressions. The proportions of cells responding in a biphasic
fashion were small in both species (2.3# and 0.8#). The predom¬
inance of excitatory responses was highly significant in both
species (binomial test; p<^0.000l). There was a small, but
statistically significant difference between the frequencies of
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occurrence of excitations and depressions in the two species:
in the cat, excitations were slightly more common, and depressions
2
slightly less common than in the rat ( ^ test; p<^O.Ol).
IV.3.2. THE ROLE 0? THE BASELINE FIRING RATS
a. Cat
We have examined the relationship "between the "baseline
firing rates of the neurones and the direction of responses to NA.
For this analysis, cells were selected to which NA was
applied with an ejecting current of +50 nA. For the sake of
comparison, responses to 5-HT and mescaline were also analysed;
the current to apply 5-HT was +50 nA, and the current to apply
mescaline was +100 nA. Each drug was applied at least on two
occasions to each cell. Only cells showing consistent responsive¬
ness or lack of responsi\reness were included in the statistical
analysis.
The effects of NA were studied on 325 cells: 272 cells
(83.7/0 gave consistent responses, and 53 cells (l6.3^o) did not
respond. The total population of 325 cells was divided into seven
groups on the basis of the firing rate (spikes/sec): 0 — 5» 6 — 10;
11—15; 16-20; 21—25; 26-30; 31 — 50. As the proportion of
non—responsive cells did not depend on the firing rate (product
moment correlation: r = O.46, p^O.l), we included only the pop¬
ulation of cells which did respond to NA (272 neurones) in our
further analysis. The proportions of cells excited and depressed
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by NA were calculated separately for each firing rate category.
The results are shown in Pig. 2./IV: with increasing firing rates
the proportion of excitations decreased, and the proportion of
depressions increased (product moment correlation: r = 0.95?
p <0.001).
Similar results were obtained with 5-HT and mescaline.
Out of 252 cells, 199 cells (79/0 responded to 5"~HT, and out
of I89 cells, I64 (86/S) responded to mescaline. In the case
of both 5—HT and mescaline, the proportions of cells excited
decreased, and the proportions of cells depressed increased with
increasing firing rates (5™KT: r = 0.98? p< O.OOI5 mescaline:
r « O.94, p< 0.005) (Pig. 2/lV).
On a few cells, which were not included in the
statistical analysis described above, we observed, that a spontaneous
shift in the baseline firing rate was accompanied by a reversal
of the direction of the response to NA, 5~HT or mescaline. On
each occasion, a lower firing rate corresponded to an excitatory
response, and a higher firing rate to a depressant response.
Examples of these observations are shown in Pig. 3/lV.
After having established a close correlation between
firing rate and direction of response to the monoamines, we also
examined whether there was any relationship between the anatomical
position of a neurone in the cortex and the firing rate recorded.
To this end, vie selected randomly the results from 20 cats out
of the total experimental material collected from 257 animals.
All the cells recorded in these 20 cats were displayed in the
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graph shown in Pig. 4/lY« in this graph, each dot represents
a cell, and the position of any individual neurone is determined
hy the depth in the cortex and the spontaneous firing rate.
The figure shows that there was no statistically significant
correlation between the location of the cell within the cortex
and the firing rate recorded (product moment correlation;
r = 0.C07, p>0.2).
b. Rat
For this analysis, 332 cells were selected which gave
consistent excitatory or depressant responses to M applied with
an ejecting current of +25 nA. The same procedure was adopted
as with the data from the cat (see above); the proportions of
cells excited and depressed were calculated for each of the seven
firing rate categories. The results are shown in Pig. 5/iV: with
increasing firing rates the proportion of excitations decreased,
and the proportion of depressions increased (product moment
correlation: r = O.84, p^C.0.02).
On a few cells, which were not included in the statist¬
ical analysis, we observed that a shift in the baseline firing
rate was accompanied by a reversal of the direction of the response
to NA. On each occasion, a lower firing rate corresponded to an
excitatory response, and a higher firing rate to a depressant
response. An example of this observation is shown in Pig. 6/lV.
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20 CATS : 154 CORTICAL NEURONES
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r = 0-007 ; N.S.








































FIGURE 4/lV. Eelat ionship between the positions of neurones in the
somatosensory cortex of the cat and their spontanso~as firing rate.
Data were collected, from 154 neurones recorded in 20 cats*
Ordinate: spontaneous firing rate (spikes/sen); abscissa: depth from
the surface of the cortex (mm)* Each dot corresponds to a neurone.
There is no correlation between depth in the cortex and
spontaneous firing rate (r 0.007, P> 0.2 (N.S.)).
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FIGURE6/IV.Spontaneousrev rsalofthedir ctionfthsn uronalresponsetnoradrenalinefo lowingsh ftt e"baselinefiri gat . Excerptsfromtheratemeterr cordingofthfirinatefsi glecorticalneuronei therat.O dinate:firingr te(spikes/sec);abscissa:runningime(mi .Horizontal"barsindicatemicroelectrophoreticdrugap lications;numbersr f ri ten ityfj ctingurre t( A).Thecellwasdepressedbynoradr naline(NA)whenthb seli efir gratwasgh,dexcitedbynoradrenalinewhethf i gatwaslow.
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c. Comparison of the two species
Table l/lV shows that excitations to NA were slightly
more common, and depressions were slightly less common in the
cat than in the rat; this difference between the two species
was statistically significant (see IV.3.1.). Therefore, it was
of interest to examine whether this difference in the proportions
of cells excited or depressed could reflect a difference in the
baseline firing rates of the neurones recorded in the two species*
Pig. T/TV shows the distribution of the neurones,
included in Table l/lV, between eleven firing rate categories*
It is apparent from the figure that the frequency distribution of fir¬
ing rates was different in the two species; the distribution
obtained in the cat having a greater skew to the left than the
distribution obtained in the rat. This is reflected in a lower
median firing rate in the cat (10 spikes/sec) than in the rat
(20 spikes/sec). The difference between the two patterns of
distribution is statistically significant (median test; p^O.OOl).
IV.3° TEG ROLE OF THE pH OF THE NORADRENALINE SOLUTION
These experiments were conducted in cats. The responses
of 16 neurones to NA released from solutions at pH 3.1 and 5®0 snd
to H released from a HC1 solution were compared.
a. Comparison of FA (pH 3.1) and NA (pH 5.0)
Of the 16 cells studied, the 13 neurones which were
excited by NA (pH 3.1) were also excited by NA (5.0), and the
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3 neurones depressed "by NA (pH 3.1) were also depressed by NA
(pH 5»0)• No cell responded differently to the drug at different
pH values. An example of this finding is shown in Fig. 8/lV,
b. Effect of H+
Of the 16 NA—sensitive cells, 15 did not respond to
H+ even when currents of up to +200 nA were used (see Figs. 8/lV
and 10/lV)» One neurone, which was depressed by NA, was also
*4"
depressed by H . Changes in spike amplitude did not occur.
The application of H+ frequently reduced the size of
the response to a subsequent application of NA. Furthermore,
when NA (pH 5.0) and H+ were ejected simultaneously from adjacent
barrels of the micropipette, there was a reduction in the size
of the excitatory response (Fig. 9/lV).
c. Dose-response studies
It was observed on 9 cells that NA (pH 3.1) evoked
larger responses than NA (pH 5*0) (see Fig. 8/lV). As this
suggested a difference in potency between NA (pH 3.1) and NA
(pH 5.0), we conducted detailed comparative studies on three
cells. A range of current intensities was used to compare the
responses bf the same cell to NA (pH 3.1) and NA (pH 5«0). The
results obtained from one cell are displayed in Fig. 10/lV and
ll/lV. At the lower current intensities NA (pH 3.1) and NA (pH 5»0)
were approximately equipotent, whereas NA (pH 3.1) was considerably
more potent when currents of higher intensities were used.
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FIGURE 8/lV. Responses of a single cortical neurone to noradrenaline
(ITA) ejected, from solutions at different pH.
Continuous recording of the firing rate of a single cortical
neurone. Ordinate: firing rate (spikes/sec): abscissa: time (min).
Horizontal bars indicate drug applications (numbers refer to intensities
of ejecting currents (nA)).
The neurone was excited by NA (pH 3.1) and pH (5*0), but did
not respond to H .
05I0_152025 H+75nANA(pH5.0)75NA(pH5.0)75nANA(pH5.0)75n H+75nA
ijilfJU










FIGURE 10/lV. Excitat 017/- responses of a cortical neurone to
noradrenaline applied from solutions at different pH.
Continuous recording of the firing rate of a single cortical
neurone. Ordinate: firing rate (spikes/sec); abscissa: time (min).
Horizontal bars indicate drug applications (numbers refer to intensities
of ejecting current (nA)).
A - D: NA (pH 3.1) and NA (pH 5*0) applied with successively
higher currents evoked progressively larger responses. At higher current
intensities NA (pH 3.1) evoked larger responses than NA (pH 5»0)»


























FIGURE ll/lV. Magnitude of excitatory responses of a cortical neurone
to noradrenaline (NA) applied from solutions at different pH^
Ordinate: total spike number; abscissa: intensity of ejecting
current (nA), on a log scale. Open circles: NA (pH 3.1); closed circles:
NA (pH 5.0); open triangles: H • Data are derived from the study shown
in Fig. 7/lV.




IV.4.1. THS DUAL EFPSCT OF NORADRENALINE ON CORTICAL NEURONES
In agreement with previous findings (see IV.1.1.), we
could observe both excitatory and depressant neuronal responses
to microelectrophoretically applied NA in the neocortices of
both cats and rats. In our material there was a predominance
of excitatory responses: about three quarters of all responses
were excitatory in both species studied. Similar results were
reported by Johnson et al., (1969a; 1969b) in the halothane—
anaesthetised cat.
Although most authors have described both excitatory
and depressant responses to NA on cortical neurones (see IV.1.1.),
there has been some controversy concerning the true nature of
these responses. One group of authors suggested that the depres¬
sant responses represented the genuine pharmacological effect
of NA, whereas the excitatory responses were either artefacts
(Krnjevi^ & Phillis, 19o3c; Prederickson et_al., 1971) or indirect
effects (Stone, 1971)- Another group of investigators argued
that the excitatory responses were genuine, whereas the depressant
responses might be 'non-specific' in nature (Johnson et al., 1969a).
On the basis of our results, there is no a priori
reason for assuming that only one kind of neuronal response
represents a genuine pharmacological action of NA, whereas the
other kind of response is artefactual. Indeed, this thesis presents
experimental evidence which suggests that both the excitatory and
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depressant responses are genuine pharmacological effects, in
other words, that NA can activate both excitatory and inhibitory
receptors on cortical neurones.
This chapter already presents some evidence which
suggests that both excitatory and inhibitory receptors to NA
may occur on the same neurone. The existence of biphasic
responses could be regarded as one piece of such evidence.
Biphasic responses are not unique to the cortex: such responses
to NA have been described in the spinal cord (Weight &
Salinoiraghi, 1966), Deiters' nucleus (Yamamoto, 1967)* medial
geniculate nucleus (Tebeci3, 1970)* brain stem (Boakes
et al., 197l)♦ The time-course of the biphasic response suggests
that inhibitory receptors may be more sensitive to NA, since
the depressant phase appears first when the concentration of
the drug at receptor sites is probably still rising. The
excitatory phase may reflect the presence of a higher drug
concentration which is necessary for the activation of the
less sensitive excitatory receptors. Observations on invertebrate
ganglion cells (see Gerschenfeld, 1973) have shown that both
excitatory and inhibitory receptors to the same transmitter sub¬
stance can co-exist on the same neurone. Moreover, it has been
shown on invertebrate neurones that the activation of two
functionally opposing receptor populations can be the basis for
biphasic responses (Ascher, 1972).
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An alternative explanation for biphasic responses could,
be that there is only one type of receptor (e.g. excitatory) which
is located on a principal neurone and on an inhibitory inter-
neurone. The first, depressant phase of the response would reflect
the indirect, whereas the second excitatory phase the direct
activation of the principal neurone. However, if an action on
an interneurone were responsible for one of the phases, it might
be expected that the sequence of occurrence of the two phases
would occasionally be reversed, depending on the relative positive
positions of the tip of the micropipette, the interneurone, and
the recorded neurone. It has been observed, however, that the
depressant phase always precedes the excitatory one (Boakes et al.,
1971j see also present Results). Furthermore, if inhibitory intere
neurones were responsible for biphasic responses to the monoamines,
it is surprising that there is no direct evidence concerning the
existence of such a mechanism. It has been observed in the
olfactory bulb (McLennan, 197l) and in the dorsal horn of the
spinal cord (Zieglgansberger & Hers, 1971) that an 'excitant'
amino acid can cause paradoxical depression of the principal neurone
accompanied by the excitation of a smaller neurone recorded
simultaneously. On cortical neurones, however, we have never
observed excitation of a smaller neurone while recording the
depressant phase of a biphasic response to NA or to another
monoamine.
- 137 -
The phenomenon of response reversal (Fig. 3/lV and
6/IV) is further evidence in favour of the hypothesis that "both
excitatory and inhibitory receptors for NA can occur on the
same neurone. This observation would suggest that even in the
case of monophasic responses both excitatory and inhibitory
receptors may be activated, and the time-course of the response
reflects the relationship between the two receptor populations.
This has been demonstrated to occur on invertebrate ganglion cells
(Kehoe, 1972b). In this case, one type of receptor is dominant
(i.e. its activation determines the direction of the observed
response), whereas the opposite type of receptor is masked
for the whole time-course of the response. In the case of
response reversal a switch in receptor dominance may occur: when
the baseline i3 low, the excitatory receptors are dominant, and
when the baseline shifts to a higher position, the inhibitory
receptors become dominant.
Further evidence in favour of the co—existence of
functionally opposite NA receptors on the same neurones will be
presented in Chapter V.
In conclusion, the results presented in IV.3. are
consistent with the hypothesis that NA can activate both
excitatory and inhibitory receptors on cortical neurones. This
effect of NA is not surprising, since a similar dual action is
one of the most striking properties of this drug in peripheral
tissues (see e.g. Furchgott, 1972). Moreover, there is evidence
indicating that in most other structures of the brain (e.g.
spinal cord, brain stem, hypothalamus) NA has a similar dual effect
(see I.4.).
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IV.4.2. FACTORS MODIFYING THE DIRECTION OF THE RESPONSE TO
NORADRENALIKS
a. Baseline firing rate
The data presented in IV.3.2. show that the probability
of observing an excitatory response to NA (and to the other
monoamines) depends on the firing rate of the neurone: a
greater proportion of cortical neurones is excited when the
firing rate is low. The same correlation was found both in
the cat and the rat. Our results are consistent with the hypo¬
thesis that most cortical neurones contain both excitatory and
inhibitory receptors for the monoamines, and that neuronal
responses to the monoamines reflect a 'functional balance'
between the two kinds of receptor (see IV.4«1»)» The data
presented here suggest that the relationship between excitatory
and inhibitory receptors may be influenced by the baseline
firing rate of the neurone: a low firing rate would favour the
functional dominance of the excitatory receptors, whereas a
high firing rate would shift the balance in favour of the
inhibitory receptors.
An alternative possibility is that the slowly and
fast firing cells represent two anatomically distinct populations
of cortical neurones: the slow cells contain mainly excitatory
receptors, whereas the fast cells possess mostly inhibitory
receptors. This hypothesis, however, is not supported by the
survey shown in Fig. 4/lV: no correlation could be found between
location of a neurone in the cortex and its firing rate. Moreover,
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the phenomenon of response reversal would favour the hypothesis
of the co—existence of the two kinds of receptors on the same
cells.
The finding that a spontaneous shift in the "baseline
firing rate is sometimes accompanied "by a reversal of the
direction of the response to NA, 5-HT or mescaline (see Fig.
3/lV and 7/lV) seems to be in agreement with observations in
the periphery. There is evidence that in smooth muscle prep¬
arations containing both excitatory &/- and inhibitory ^—adreno¬
ceptors, the direction of the response to NA and adrenaline
depends on the baseline activity of the test system. When the
baseline tone is low, these drugs evoke contractile responses,
whereas the same drugs have a relaxing effect when the baseline
tone of the preparation has been raised (Guimaraes, 19£>9j
Haffner, 1971).
The relationship between baseline firing rate and
direction of the response may explain a difference between the
two species: in the cat, uhave the median firing rate of cortical
neurones was lower (10 spikes/sec), excitatory responses to NA
occurred significantly more frequently than in the rat, where the
median firing rate of cortical neurones was higher (20 spikes/sec)
(see Table l/lV and Fig. 7/lV).
Our observations may also help to explain the discrepancies
between reports from different laboratories concerning the
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proportions of excitations and depressions to NA (see IV.1.1.).
For example, in our material collected from cats (see Table 1/IV),
of the p08 cells responding to NA, 76.4% were excited, and 21,y/o
were depressed. The relatively high proportion of excitatory
responses observed by us may reflect the large number of slowly
firing cells in our material: about 50?° of the neurones had
a lower firing rate than 10 spilces/sec, and 73% fired more
slowly than 20 spikes/sec. Moreover, it is not surprising that
a higher proportion of cells is depressed by NA when the baseline
firing rates of the neurones aire artificially raised with
excitant amino acids (see e.g. Frederickson et al., 1972).
b. Role of the pH of the noradrenaline solution
The present results (IV.3.3.) confirm the observations
of Johnson et al., (1969a) and Stone (1972) that M ejected
from solutions at high and low pH values has qualitatively the
same effect. Thus it is unlikely that the occurrence of
excitatory responses to NA is due to its use in solutions at
low pH values. This conclusion is further supported "by the
frequent observation of excitatory responses of brain stem
neurones to NA applied from solutions at pH 5.0 - 6.0 (Boakes,
et al., 1971). Furthermore, phenylephrine appeared to he
exclusively excitatory on cortical neurones (see Chapter V) ,
and this drug was released from a solution at pH 5»0 - 5»5«
We were unable to confirm the findings of Jordan
et al. (1972b) and Hewes & Frederickson (1974) that cortical
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neurones can "be excited "by H ejected from HC1 solutions. Indeed,
+ 4*
H reduced the size of excitatory responses to NA when H and NA
were ejected simultaneously from adjacent "barrels of the micropipette.
Although NA released from solutions at different pH
values evoked qualitatively similar responses, the size of the
depressant or excitatory responses of any neurone to NA ejected
from a solution at pH 3.1 "was usually greater than that of the
response to NA ejected from a solution at pH 5»0. The current-
response studies show that when ejected from solutions at pH 3.1»
NA appeared to be more potent than when ejected from solutions at
pH 5,0, especially when electrophoretic currents of higher
intensities were used. The difference between the action of
NA released from solutions at different pH values was interpreted
by Frederickson et al. (1971) in terms of an excitatory action
*4"
of H released from solutions at lower pH values. Such an
explanation is no longer tenable in the light of the present
results. However, the apparent difference in potency may result
from a lower rate of NA release from the solution at pH 5.0. This
would be due to the large number of Na+ introduced into the
solution when the pH was adjusted to 5«0 (0.1 N in the final
solution). This would tend to reduce the transport number of NA,
The in vitro experiments described in II.3.5- show that this is
indeed the case.
It is apparent, therefore, that there are no good reasons
for avoiding the use of NA solutions at pH 3.0 - 3.5 i*1 microelectro¬
phoresis experiments. However, there are disadvantages associated
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with the adjustment of the pH to a higher level "by the addition
of NaOH: firstly, do3e-response relations are distorted, and
secondly, there is a greater risk of obtaining misleading








Ths evidence presented in the previous Chapter, together with
the literature reviewed (lV.1.1.), indicates that single cortical neurones
are sensitive to NA applied "by microelectrophoresis: both excitatory
and depressant responses can be observed. So far, however, these
responses have not been characterized in terms of the classical cL
and ^ categories (Ahlquist, 1948).
There are basically three methods available for receptor
categorization: comparison of agonists; comparison of antagonists;
and desensitization (Schild, 1973). Previous attempts to classify
neuronal responses concentrated mainly on the use of antagonists
(see IV.1.5.). It has been reported that both and |3-receptor
blocking agents can antagonise excitatory responses to MA, whereas
depressant responses to MA seem to be much more resistant to these
antagonists (Johnson et al.. 1969a). Johnson et al. (1969a) concluded
that the excitatory responses might be mediated by receptors which
are different from the classical peripheral o£- and (i-adrenoceptors,
and that the depressant responses might be 'non-specific' in nature.
Stone (1973a) confirmed the relative ineffectiveness of <*£-adrenoceptor
blocking agents in antagonising depressant responses to MA; he reported,
however, that (J-adrenoceptor blocking agents could antagonise these
responses. Stone (1973a) concluded that the depressant responses
might be mediated via ^-adrenoceptors.
There are fewer data concerning the effects of different
adrenergic agonists. Although it has been reported that isoprenaline
(iPMA) can evoke both excitatory and depressant responses on cortical
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neurones (Johnson et al., 1969a; Stone, 1973a), the effects of more
selective (i-adrenoceptor stimulants (e.g. salhutamol), or the effects
of more selective <4-receptor stimulants (e.g. phenylephrine, methoxamine)
have never "been tested.
In the experiments presented in this Chapter, we have compared
the effects of a range of at - and (J-receptor stimulating agents on
cortical neurones. We have also re-examined the selectivity of adren¬
ergic antagonists.
V.2. METHODS
All the experiments presented in this Chapter were conducted
in rats; for the preparation of the animals see IV.2.1. Our methods
for the manufacture of six-harrelled micropipettes, for the extra¬
cellular recording of action potentials and the microelectrophoretic
application of drugs have "been described in III.2.
The following drug solutions were used in the micropipettes:
(—)noradrenaline bitartrate (0.05 M, pH 3.0 - 3*5)5 (-)phenylephrine
hydrochloride (0.05 M, pH 5.0 - 5*5)» (-)methoxamine hydrochloride
(0.05 M, pH 4.5); salbutamol sulphate (0.05 M, pH 5»5)j (-)isoprenaline
hydrochloride (0.05 M, pH 5*5)j acetylcholine chloride (0.05 M, pH 3.5 ~
4.0);phentolamine mesylate (0.01 M, pH 4.5 - 5*5)j phenoxybenzamine
hydrochloride (0.01 M, pH 3.0); propranolol hydrochloride (0.01 M,
pH 4.5 - 5.5); sotalol hydrochloride (0.01 M, pH 4*0 - 5«0).
Only spontaneously active neurones were studied in these
experiments. All the drugs were applied by microelectrophoresis.
When a suitable unit was encountered, the agonists were applied in
a regular cycle. Between successive drug applications retaining
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currents of -10 nA were passed. Retaining currents of -25 nA were
used for the antagonists. Intervals between successive applications
of the same agonist were kept constant in order to standardize the
effects of the retaining current upon drug release during the ejection
period (see II.3.3. and III.3.2.). The sizes of the neuronal responses
to the agonists were expressed as the total number of action potentials
produced in response to each drug application ('total spike number';
see III.2.5.).
The effects of antagonists were evaluated in the following
way. When suitable responses to the agonist had been obtained, the
antagonist was applied continuously, either by removal of the retaining
current (thus allowing the drug to diffuse out from the micropipette),
or by the passage of a weak ejecting current (5 — 10 n.4.), and the time-
course of the developing antagonism was followed. If necessary, the
intensity of the ejecting current to apply the antagonist was increased
until antagonism was observed. After antagonism of the response to
the agonist had been established, application of the antagonist was
continued until a further response to the control agonist(s) could be
observed. Then the application of the antagonist was terminated, and
the time-course of recovery was followed. The response to an agonist
was regarded as antagonised if there was at least 50% reduction in
the total spike number (Sevan et ad., 1974a)•
V.3. RESULTS
V.3.1. COMPARISON OF ADRENERGIC AGONISTS
The proportions of cells responding with excitation or
depression to each adrenergic agonist studied are shown in Table l/v.
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It is apparent from the table that phenylephrine and methox.amine
were exclusively excitatory, whereas salbutamol was entirely depressant.
On the other hand, NA and IPNA could evoke both excitatory and
depressant responses. Examples of cells responding both with excit¬
ation and depression to different agonists are shown in Fig. l/V.
Table l/v. Percentage of cortical neurones responding either with
excitation or depression to adrenergic agonists
Percentage of cells responding
Excitation Depression n
Phenylephrine 100 0 78
Methoxamine 100 0 11
Noradrenaline 66 34 194
Isoprenaline 23 77 138
Salbutamol 0 100 16
IPNA could evoke both depressant and excitatory responses
in a dose~dependent fashion on the same cell: on 14 cells a lower
current of IPNA evoked a depression whereas a higher current evoked
an excitation. Examples of this observation are shown in Fig. 2/v.
On the basis of this observation, we could predictably evoke depressant
responses to IPNA by applying the drug with relatively low ejecting
currents ( < 25 nA) ( see antagonism studies in V.3.2.).
a75r
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FIGURE2/V.Responsesfac rticalneuronetisop en line(IPNA)app i dw thi c easingi t nsitiesfI
ejctingcurrent.
Ratemeterrecordingofthfirinatefsi glecort calneuronethat.Ordin te:
firingate(spikes/sec);bscissae:tim(min).Horizontalbarsndicatem croel ctrophoreticugapplications;numbersref rtointensi esfj ctingur ents( A). Notethreversalft responsef omd pr siontxcitationahintensityfh ejectingcurre twasin r sed.
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The relative potencies of methoxamine and phenylephrine
were compared on 10 cells: in order to obtain approximately equiv¬
alent responses to the two drugs, the current needed to apply
methoxamine was at least five times greater than that needed to
apply phenylephrine.
V.3.2, EFFECTS OF ADRENERGIC ANTAGONISTS
a. -Adrenoceptor blocking agents
The c^-adrenoceptor blocking agents phentolamine and
phenoxybenzamine were effective in reversibly antagonising excitatory
responses to adrenergic agonists, while excitatory responses to ACh
were not affected. Phentolamine reversibly and selectively antagonised
excitatory responses to NA on 10 cells.* Phenoxybenza-mine reversibly
and selectively antagonised excitatory responses to HA (5 cells),
phenylephrine (ll cells), and IFNA (5 cells) (e.g. Pig. 3/v)« On
one of the cells excited by IPNA, a depressant phase was revealed
after the abolition of the excitatory response by phenoxybenzamine.
On one cell, which did not respond to IPNA, a depressant response
to IPNA appeared in the presence of phenoxybenzamine; this response
dissappeared after the application of the antagonist had been
terminated.
We have also examined whether the cv-adrenoceptor blocking
agents can discriminate between excitatory and depressant responses
to adrenergic agonists on the same cell. In these experiments.











excitatory responses were evoked by phenylephrine, depressant responses
were evoked by either IPNA or salbutamol, and phenoxybenzamine was
used as the antagonist. Antagonism studies were successfully com¬
pleted on 7 cells; on all these cells the excitatory response was
antagonised, whereas the depressant response was not affected. A
example of this observation is shown in Pig. 4/V.
b. ^-Adrenoceptor blocking agents
The (5—adrenoceptor blocking agent sotalol was effective
in reversibly antagonising depressant responses to IPNA while responses
to ACh were not affected (19 cells) (see Pig. 5/^a). 0n two cells
depressed by IPNA, an excitation was revealed after the abolition
of the depressant responses by sotalol. On one cell which did not
respond to IPN A, an excitatory response appeared in the presence of
sotalol; this response disappeared after the application of sotalol
had been terminated. The (^-receptor blocking agents, propranolol
and sotalol could also reversibly antagonise excitatory responses
to adrenoceptor agonists, without affecting responses to ACh: excit¬
atory responses were antagonised by propranolol on 4 cells, and
excitatory responses to IPNA were antagonised by sotalol on 2 cells
(see Pig. 5/Vb).
We have also examined whether these antagonists can dis¬
criminate between depressant and excitatory responses to adrenergic
agonists on the same cell. In these experiments, depressant responses
were evoked by IPNA, excitatory responses were evoked by phenylephrine",
and sotalol was used as the antagonist. Antagonism studies were
















FIGURE 4/v,, Effects of phenoxybenzamine on excitatory g,nd
depressant responses to adrenergic agonists.
Ratemeter recording of the firing rate of a single cortical
neurone in the rat. Ordinates: firing rate (spikes/sec); abscissae:
running time/min. Horizontal bars indicate microelectrophoretic
drug applications; numbers refer to intensities of ejecting currents
(nA)o Figures above the traces indicate total spike numbers (%),
taking the sizes of the control responses to each agonist as lOO^t.
a. Control responses to phenylephrine (Phe) and isoprenaline (iPKA).
b. Responses to the agonists during the continuous application
of phenoxybenzamine. At the start of trace (b) ph.eno.xy-
benzamine (0 nA) had been applied continuously for 15 min.
The excitatory response to phenylephrine, but not the depressant
response to IPNA was antagonised.
c» Recovery of the response to phenylephrine 20 min after the





















response was antagonised, whereas the excitatory response was not
affected (see Fig. 6/v).
V.4. DISCUSSION
The action of adrenergic agonists (see Table l/v) strongly
suggests that the excitatory responses to these drugs are mediated
by <4-, whereas the depressant responses are mediated by —
receptors. Phenylephrine (Furchgott, 1972; Basse & Furchgott, 1976)
and methoxamine (Furchgott, 1970; Innes & Nickerson, 1975) are highly
selective aL-adrenoceptor agonists, whereas salbutamol is a selective
^-receptor stimulant with no affinity for q6—adrenoceptors (Brittain
et al., 1970; Spedding & Weetman, 1972). On the other hand, IPNA and
NA can act at both <4 — and ^"-receptors (see Furchgott, 1972). It
is well documented in the periphery that the dose-response curve to
IPNA is a biphasic ones lower doses of the drug relax smooth muscle
preparation due to the stimulation of (3--receptors, whereas higher
concentrations have a contractile effect due to the activation of
excitatory ^-receptors (Spedding & Weetrnan, 1972; Trendelenburg, 1974)»
A very similar observation was made in our experiments; lower doses
of IPNA depressed, whereas somewhat higher doses excited the same
cortical neurone (see Fig. 2/v).
Methoxamine appeared to be less potent than phenylephrine
in our experiments. This is in agreement with observations in the
periphery where methoxamine has a considerably lower potency than
phenylephrine (Furchgott, 1970; Schumann & Endoh, 1976). However,
an apparent difference in potency in our experiments might also
reflect physical factors, such as difference between the transport














The results with the adrenergic antagonists support our
suggestion, "based on the action of the agonists, that excitatory
responses are mediated by &C-, and depressant responses are mediated
by ^-receptors. In agreement with previous findings (Johnson et al.t
19o9a), we have found that the ^-adrenoceptor blocking agent3 could
reversibly antagonise excitatory responses to adrenergic agonists,
while excitatory responses to ACh were not affected. On the other
hand, depressant responses to adrenergic agonists seemed to be
resistent to ci-adrenoceptor blocking agents (see Pig. 4/p)» This
observation is in agreement with previous findings (Johnson et al.,
1969a; Stone, 1973a), and probably reflects the failure of o(—
adrenoceptor blocking agents to interact directly with £2—receptors
(Nickerson, 1967). Consequently, we were able to demonstrate that,
on the same cell, the antagonism of excitatory responses to phenyl¬
ephrine occurred when depressant responses were not affected (see
Pig. 4/v). Occasionally, a depressant response could be revealed
after the abolition of the excitatory response to IPNA, suggesting
an action of IPNA at both types of receptor and also the lower
affinity of the antagonist for inhibitory ^-receptors. The selective
blockade of excitatory c^-receptors may explain the observation that
a depressant response to IPNA could be revealed by phenoxybenzamine
on a cell which previously had not responded to IPNA; the failure of
IPNA to evoke a response in the absence of phenoxybenzamine could
have been due to a complete 'antagonistic agonism' resulting from
the activation of the functionally opposite — and (3—receptors
(see Appendix).
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The ^-adrenoceptor "blocking agents effectively abolished
depressant responses without affecting excitatory responses to
adrenergic agonists (see Pig. 6/v). These antatonists occasionally
unmasked excitatory responses after the abolition of depressant
responses to IFNA, or when IPNA alone was without any effect,
indicating the greater sensitivity of the inhibitory ^—receptors.
The ^-receptor blocking agents, however, were also capable of
antagonising excitatory responses. This finding is in agreement
with previous reports (Johnson et al., 1969a; Sevan et al., 1974a)»
This observation might seem to argue against our hypothesis that
the excitatory responses are mediated by -receptors. There is,
however, good experimental evidence in the periphery that the
conventional ^-receptor blocking agents can also block *1—receptors
at somewhat higher concentrations than are required for selective
—receptor blockade (Patil et al., 1968; Gulati et al., 19o9) • On
the basis of these observations, it might have been expected that
higher ejecting currents would be needed to apply the ^—adrenoceptor
blocking agents in order to antagonise excitatory responses than to
antagonise depressant responses. However, this was not apparent
in the present results, and it is unlikely that such a difference
could be detected using between-cell comparisons unless a considerably
larger number of cells is studied. The differential sensitivities
of inhibitory and excitatory receptors to ^-adrenoceptor blocking
agents may explain our previous observation that lower doses of
sotalol often potentiate excitatory neuronal responses to NA, whereas
higher doses have an antagonistic effect (Bevan et al., 1974a; 1974b).
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The potentiation may reflect the selective "blockade of masked
inhibitory ^-receptors, whereas the antagonism may reflect the
blockade of both the ^-receptors and the dominant excitatory
-receptors (see also Appendix).
Similarly to the situation in many peripheral tissues
(see Furchgott, 1972), - and ^-receptors mediate opposite^
effects on cortical neurones, the c^-receptors being excitatory
and the (3-receptors being inhibitory. Moreover, most neurones
studied provided evidence for the presence of both <si— and ^3 —
receptors (e.g. opposite effects of different agonists on the
same cell, see Fig. l/V; opposite effects of different doses of
IFNA on the same cell, see Fig. 2/V; reversal of the response by
an antagonist, see Fig. 3/Vb). Although the experimental evidence
presented here does not indicate where these receptors are localised,
the most parsimonious explanation seems to be that the two functionally
opposing populations of and ^3-receptors occur on the membrane of
the same cell (see also IV.4.1.).
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CHAPTER VI




Single neurones in the cerebral cortex can respond
both with excitation and depression to noradrenaline (NA)
applied by microelectrophoresis (see Chapters IV and V). The
experimental evidence presented in Chapter V suggests that these
responses are mediated by o(- and ^-adrenoceptors, the o(-
adrenoceptors being excitatory, and the ^-adrenoceptors being
inhibitory.
Cortical neurones are also sensitive to dopamine (Dl)
applied by microelectrophoresis, both excitatory and depressant
responses having been described (Bevan et al., 1975» Stone, 1976;
Bunney & Aghajanian, 1976). It is well documented in the periphery
that BA can stimulate both c-C— and (J-adrenoceptors, as well as
specific DA receptors (Goldberg, 1975)• If was of interest,
therefore, to determine whether the actions of DA on cortical
neurones are mediated by adrenoceptors, by DA receptors, or by
both. In the experiments described in this Chapter, we have
compared the actions of HA and DA on cortical neurones. We have
also examined whether phenoxybenzamine (an adrenoceptor
blocking agent; Nickerson, 1967) and neuroleptics (proposed
DA receptor blocking agents; Goldberg, 1975) can discriminate




All the experiments described in this Chapter were
conducted in rats anaesthetised with halothane. Our methods
for the surgical preparation of the animals are described in
IV.2.1. For the manufacture of six-barrelled raicropipettes
see II.2., for the methods of extracellular recording and
microelectrophoretic drug application see III.2.3. and III.2.4.
Six-barrelled micropipettes of tip dianrter 3-5 prn were
used. Tv/o barrels of each micropipette contained 4 M NaCl,
one for recording action potentials, the other for use in
current balancing. The remaining barrels contained drug
solutions. The following drug solutions were used: (-)—noradrenaline
bitartrate (O.Op M, pH 3.0-3.5)> dopamine hydrochloride
(O.Op M, pH 4.O-4.5); acetylcholine chloride (0.05 M, pH 3.5-4.0);
phenoxybenaamine hydrochloride (0.01 M, pH 3.0) ; haloperidol
(0.01 M, dissolved in 0.01 M tartaric acid, pH 4.0); c( —
flupenthixol dihydrochloride (0.01 M, pH 3.0); ^-flupenthixol
dihydro-phloride (0.01 M, pH 3.0).
Spontaneously active neurones were studied in two
areas of the cerebral cortex: a) prefrontal region (stereotaxic
co-ordinates, according to Konig & Klippel (1963): A 9*8-11.4»
L 0.5-2.4; b) parietal region: A 4.8-6.5, L 0.9-2.4). The area
of recording was prepared as described previously (Bradshax* &
Szabadi, 1972). The dura was either incised with a hypodermic
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needle, or was penetrated directly with the micropipette. All
the drugs were applied by microelectrophoresis. When a suitable
unit was encountered the agonists were applied in a regular
cycle. Between successive applications of agonists retaining
currents of —10 nA were passed. Retaining currents of —2p nA
were used for the antagonists. Intervals between successive
applications of the same agonist were kept constant in order
to standardise the effects of the retaining current upon drug
release during the ejection period (see II.3.3. and 111.3.2,).
The sizes of the neuronal responses to the agonists were
expressed as the total number of action potentials produced
in response to each drug application ('total spike number',
see III.2.5.).
The effects of the antagonists were evaluated in the
following way. When stable responses to the agonists had been
obtained, the antagonist was applied continuously, either by
removal of the retaining current (0 nA) thus allowing the
drug to diffuse out from the micropipette, or by the passage
of a weak ejecting current (5 to 10 nA), and the time-course
of the ejecting current was increased until antagonism was
observed. Then the application of the antagonist was terminated
and the time-course of recovery was followed.
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VI.2.2. MEASUPJSMSNT OF THE RELEASE OF HORADHBXALINE AND
DOPAMINE FROM MICROPIPETTES IN VITRO
Six—barrelled micropipettes were used in these
experiments. Three barrels of each pipette were filled with
0.05 M [carbinol- noradrenaline bit art rate; the remain¬
ing three contained [ethylamine-2-"^c] dopamine hydrochloride
(Radiochemical Centre, Amersham). The specific activities of
both solutions were 1.0 mCi/mmole.
Our methods for the collection of samples have been
described in II.2. Ten minute sample collection times were
used. Initially the rate of spontaneous release of radioactive
material was measured in the absence of any electrophoretic
current (4 samples). Then the rate of release of radioactive
material was measured in the presence of ejecting currents of
+25 nA (4 samples) and +50 nA (4 samples) passed through each
of the three barrels containing one of the catecholamines. Then,
after a further 4 samples of spontaneously released radioactivity
had been collected, the process was repeated for the three
barrels containing the other catecholamine. The mean dis¬
integrations per minute (dpm) obtained from the 8 samples of
spontaneously released material were subtracted from the dpm
obtained from each sample followed in the presence of an
ejecting current; the remaining dpm were used for calculating
the rate of electrophoretic release. The transport number (n)
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of each catecholamine was calculated from the following
formula:
n = RezF/3i
where is the rate of electrophoretic release (moles/sec),
z is the valency (z = 1 for both NA and HA), P is Faraday5s
constant, and i is the intensity of the ejecting current (amps)
passed through each of the three barrels containing the catechol¬
amine in question.
VI. 3. RESULTS
VI.3.1. COMPARISON OP THE AGOKISTIC EFFECTS OP NORADRENALINE
AHP DOPAMINE
a. Direction of responses to noradrenaline and dopamine
The directions of the responses (excitation or
depression) evoked by NA and DA were compared on 136 neurones
(prefrontal region 63 cells; parietal region 73 cells). Every
one of these cells responded in the same direction to the two
catecholamines, 103 being excited by both drugs, and 33 being
depressed by both drugs. This positive correlation between the
2
effects of NA and DA is statistically significant (r/. test, p<(0.000l).
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!><> Apparent potencies of noradrenaline and dopamine
The relative potencies of NA and M were assessed
either "by comparing the sizes of the responses evoked when the
two drugs were applied with identical ejecting currents or
in terms of the equipotent current ratio,, The equipotent
current ratio was defined as the ratio of the ejecting currents
(current for DA/current for NA) needed in order to evoke
responses of approximately equal magnitude (total spike numbers
not differing "by more than 20%) to the two catecholamines*. In
general, NA appeared to "be more potent than DA; this was true
both of excitatory and depressant responses® Of the 103 cells
excited by both drugs, 70 (68%) showed evidence for a greater
potency of NA (mean equipotent current ratio, 2.8), whereas on
the remaining 33 (32%) no difference in potency could be
observed. Of the 33 cells depressed by both drugs, 27 (82%)
shewed evidence for a grea,ter potency of NA than DA (mean
equipotent ratio, 3»2) whereas on the remaining 6 (l8%) no
difference in potency could be observed. Examples of these
observations are shown in Fig. l/VT. On none of the cells
studied was DA observed to be more potent than NA.
VI*3c2. EFFECTS OF ANTAGONISTS ON EXCITATORY RESPONSES TO
NORADRENALINE AND DOPAMINE
In these experiments we compared the effects of
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neuroleptic drugs, haloperidol, s4-flupenthixol and ^-flupenthixol
on excitatory responses to NA and DA. On every cell studied
acetylcholine (ACh.) was used as a control agonist.
The response to an agonist was regarded as antagonised
if its size ('total spike number') was reduced by ^Cffo or more
in the presence of the antagonist (see Bevan et al., 1974a-).
An antagonist was regarded as having discriminated (or partially
discriminated) between responses to two agonists if there was
a discrepancy of 2Cffc or more between the degree of antagonism
observed on successive responses to the two agonists.
The results obtained from all the antagonist studies
are summarised in Table l/VI. Studies conducted in the prefrontal
and in the parietal regions have been grouped together, since
there was no detectable difference between the patterns of
drug interaction observed in the two regions.
a. Phenoxybenzamine
The effects of phenoxybenzamine were examined on 16
cells. On all the cells tested phenoxybenzamine (10—10 nA)
reversibly antagonised the response to NA without affecting
the response to ACh. On 9 of the cells the response to HA
was also antagonised; however, on the remaining 7 cells phenoxy—
benzamine discriminated between the responses to NA and DA, the
response to DA being affected to a much smaller degree than
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the response to NA (see Fig. 2/vi). On two cells, depressant
responses to the catecholamines appeared when the excitatory-
responses were antagonised.
b. Halopsridol
The effects of haloperidol were tested on 12 cells.
On 11 cells haloperidol (5~20 nA) antagonised the response to
DA when the response to ACh was not affected. On 3 of these
cells the response to NA was antagonised equally to the response
to DAj however, on the remaining 7 cells, haloperidol discriminated
between the responses to the two catecholamines, the response
to NA being affected to a lesser degree than the response to DA
(see Fig. 3/Vl)0
Co oL —Flupenthixol
The effects of <*C~flupenthixol were studied on 8 cells.
In every case e4-flupenthixol (5-10 nA) antagonised the response
to DA when the response to ACh was unaffected. On 2 cells the
response to NA was affected equally to the response to DA5 however,
on the remaining 6 cells oC-flupenthixol partially discriminated
between the responses to the two catecholamines, the response to
RA being affected to a lesser degree than the response to DA
(see Fig. 4/Vl).
d» ^ -Flupenthixol
The effects of ^-flupenthixol were studied on 14 cells.


















































































specific effect, either failing to affect the responses to any
of the agonists, or (especially when higher ejecting currents
were used) reducing the responses to all three agonists and
suppressing the spike amplitude. However, on the remaining
5 cells the responses to the catecholamines were antagonised
when the response to ACh was unaffected: on 2 cells the responses
to NA and DA were equally affected, whereas on the other 3 cells
the response to DA was affected to a greater extent than was
the response to NA.
VI.3.3. H33LEASE OP NORADRENALINE AMD DOPAMINE FROM MICROPIPSTTBS
IN VITRO
The transport numbers of HA and DA were compared using
4 micropipettes; the results obtained are shown in Table 2/Vl.
In the case of each micropipette tested the transport number
of DA was higher than that of NA; this difference was statistically
significant in three of the four pipettes.
VI.4. DISCUS3I0H
In agreement with previous reports, the results
presented in this Chapter show that catecholamines can evoke
both excitatory and depressant responses on cortical neurones
(Johnson et al.t 1969; Sevan et al.t 1974a» 1975)- 14e






present results also indicate that HA and DA evoke qualitatively
similar actions when tested on the same neurones, in that the
direction of the responses evoked "by the two drugs were
invariably the same.
On most of the cells tested KA had a greater apparent
potency than DA, and in no case did we observe DA to have a greater
apparent potency than NA. In microelectrophoresis experiments
a difference between the apparent potencies of two compounds
may reflect physical rather than biological factors. For instance,
a lower transport number of one compound will be reflected in
a lower rate of release from the raicropipette when both compounds
are released with identical ejecting currents (see Curtis, 1964;
see also Chapters II and III). However, the greater apparent
potency of HA than DA seen in the present experiments probably
reflects a genuine biological potency difference, since when
the transport numbers of the two catecholamines were compared
within the same micropipette the transport number of DA tended
to be somewhat higher than that of HA.
On nearly half the cells tested, the c7—adrenoceptor
blocking agent, phenoxybenzamine could discriminate between
the excitatory responses to HA and DA; the responses to HA being
more sensitive to the antagonistic effect of phenoxybenzamine
than the responses to DA. The neuroleptics, haloperidol and
«(-flupenthixol, drugs that are believed to block DA receptors
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(Miller et al.t 1974; Goldberg, 1975; Kelly & Miller, 1975)t
could also discriminate between excitatory responses to the
two catecholamines; in this case, however, the responses to
DA appeared to be more sensitive to the antagonists than the
responses to NA. The partial selectivity of phenoxybenzamine
and of the neuroleptics suggests that the excitatory responses
to the catecholamines may be mediated by two populations of
receptors. One population may be more sensitive to NA than
to DA, and may be more readily blocked by phenoxybenzamine
than by the neuroleptics; this population probably consists
of oi-adrenoceptors. The other population of receptors may
be more sensitive to DA than to NA, and may be more readily
blocked by neuroleptics than by phenoxybenzamine; this
population may be tentatively defined as a separate population
of excitatory DA receptors.
On a substantial proportion of the cells tested,
however, the antagonists failed to discriminate between responses
to the two catecholamines. One possible explanation for this
lack of selectivity could be that only one population of
receptors was present on these cells, and that these receptors
were activated by both agonists. An alternative possibility
is that, although both kinds of receptor occurred on these
cells, the antagonist - in the dose range used - was not specific
for one receptor type.
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In our experiments -flupenthixol was a more effective
and more selective antagonist of DA-induced excitation than was
—flupenthixol. A similar difference in potency "between the
two isomers of fiupenthixol has been noted in other test systems,
for example the DA—stimulated cyclic AMP production in striatal
homogenates (Miller, et al., 1974) astL the rotational behaviour
induced by amphetamine and apomorphine in rats with unilateral
lesions of the substantia nigra (Kelly & Miller, 1975)* It
is noteworthy, however, that in the present experiments —
flupenthixol was observed to have a specific antagonistic effect
on excitatory responses to DA on some cells.
In Chapter V we provided evidence that both oL~ and
^—adrenoceptors can occur on cortical neurones, the c4—receptors
mediating excitation, and the ^-receptors mediating depression.
In the present experiments we observed that neurones which
were depressed by NA could also be depressed by DA; however we
did not study the effects of antagonists upon these depressant
responses to DA. It remains to be determined, therefore,
whether a separate population of inhibitory DA receptors exists
on cortical neurones, or whether the depressant effects of DA
are mediated, at least in part, by [i-adrenoceptors.
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CHAPTER VII
COMPARISON OP NORADRENALINE AND DOPA 021 CORTICAL NEURONES
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VII.1. INTRODUCTION
L-3, 4—4ihydroxyphenylalanine (DOPA) is x/idely used
in the treatment of Parkinson's disease. DOPA is the metabolic
precursor of dopamine (DA), and it is generally assumed that
DOPA exerts its therapeutic effect via the synthesis and
release of DA in the caudate nucleus (Hornykiewicz, 1974)*
However, DOPA is also a precursor of noradrenaline (NA), and
it has been suggested that in structures receiving a NA innervation,
exogenously administered DOPA may cause the release of NA from
presynaptic terminals and thus mimic the actions of NA on post¬
synaptic cells (And^n, Carlsson & Haggendal, 1969). In the
experiments reported here we compared the effects of microelectro-
phoretically applied DOPA and NA on single neurones in the
cerebral cortex, since this structure is known to be innervated
by NA-containing neurones (Puxe, 1965)*
VII.2. METHODS
The experiments were conducted on adult cats of either
sex (2—3.5 kg) and on male albino Wistar rats (250-300 g). The
animals were anaesthetized with halothane (0.5—1.2$). Our methods
for the surgical preparation of the animals, for the manufacture
of six—barrelled glass micropipettes, for extracellular recording
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and. for microelectrophoretic drug application, have been
described in previous Chapters (II.2.; III.2.; IV.2.).
Hicropipettes having tip diameters of 3-5 p
were used. The following drug solutions were used: L—3,
4-dihydroxyphenylalanine methylester HC1 (0.05 M, pH 5»0)>
(-)—noradrenaline bitartrate (0.05 M, pH 3.0—3.5)» acetyl¬
choline chloride (0.05 M, pH 3.5-4.0), phentolamine mesylate
(0.01 M, pH 4.5~5»5)> propranolol HC1 (0.01 M, pH 4-5—5»5)»
atropine sulphate (0.01 M, pH 5*5-6.0).
Only spontaneously active neurones were studied
in these experiments. All the drugs were applied by micro¬
electrophoresis. When a suitable unit was encountered, the
agonists were applied in a regular cycle. Between successive
drug applications retaining currents of -10 nA were passed.
Intervals between successive applications of the same agonist
were kept constant in order to standardise the effects of the
retaining current upon drug release during the ejection periods
(see II.3.3. and III.3.2.). The sizes of the neuronal responses
to the agonists were expressed as the total number of action
potentials produced in response to each drug application
(♦total spike number* see III.2.5*).
Our method for the evaluation of the effects of
antagonists is described in V.2. and VI.2.
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VII.3. RESULTS
VII.3.1* AGONISTIC EFFECT OF DOPA
a. Responses of cortical neurones to DOPA
Both excitatory and depressant responses to DOPA were
observed in these experiments. The effect of DOPA (25~'150 nAv
applied for 25-100 sec) was tested on 51 neurones in the rat;
44 were excited and 7 were depressed by DOPA. Eleven neurones
were studied in the cat; of these 10 'were excited and one
depressed by DOPA. The predominance of excitatory responses
in both species is statistically significant (binomial test,
p <C 0.01 in both cases).
b. Direction of responses to DOPA and noradrenaline
Forty cells were studied which yielded consistent
responses to both DOPA and NA (cat: 10 cells; rat: 30 cells).
Every one of these cells responded in the same direction to the
two drugs, cells excited by DOPA being also excited by NA and
cells depressed by DOPA being also depressed by NA (Fig. 1/VTl).
This positive correlation between the effects of the two drugs
2
is statistically significant (*X test ,p ^0.001).
c. Comparison of apparent potencies of DOPA and noradrenaline
In 34 of the 40 cells on which the effects of DOPA and


























(binomial test, p«< O.Ol). When DOPA and NA were applied to
the same cell with identical ejecting pulses the size of the
response (see Methods) evoked by NA was 1,8-3.4 times greater
(inter—quartile range) than the response evoked by DOPA, In
order to obtain approximately equivalent responses to the
two drugs, the current needed to apply DOPA was 2,0-3.0 times
greater (inter-quartile range) than that needed to apply NA,
The lower potency of DOPA than NA was apparent in the case of
both excitatory and depressant responses. Examples are shown
in Fig. 2/VII.
d» Comparison of latencies to onset of responses to DOPA and
noradrenaline
sOf
The latencies to onset* responses to DOPA and NA were
compared in 12 cells to which the two drugs we re applied with
identical ejecting currents. The latencies of responses to
both were 1,7-2.3 times greater (inter-quartile range), than
those of responses to NA.
VII.3.2. EFFECTS OF ANTAGONISTS ON RESPONSES TO DOPA
In these experiments the effects of the antagonists
on responses to DOPA were compared with their effects on
responses to NA and acetylcholine (ACh),














The effects of phentol amine were studied, on 12 colls
excited by DOPA (cat: 6 cells; rat: 6 cells). In all the
cells tested, phentolamine (0~40 nA, applied for 10-60 min)
reversibly antagonised excitatory responses to DOPA; excitatory
responses to HA were also antagonised. These effects of
phentolarnine occurred at times when responses to ACh were not
affected (see Fig. 3/Vll). However, more prolonged applications
of phentolamine were sometimes accompanied by loss of spike
amplitude and reduced sensitivity to ACh.
In two cells in the rat, phentolamine failed to
antagonise depressant responses to DOPA and NA.
b, Propranolol
The effects of propranolol on excitatory responses
to DOPA, NA and ACh were tested on 11 cells in the rat. In
8 of these cells propranolol (CKLO nA, applied for 10-40 minutes)
reversibly antagonised the responses to DOPA and NA without
affecting responses to ACh (see Fig. 4/VIl). In the remaining
3 cells, propranolol produced a reduction in spike amplitude
which precluded successful drug interaction studies.
c„ Atropine
The effects of atropine on excitatory responses to DOPA





























tested, atropine (0-10 nA, applied for 10—30 min) reversibly
antagonised the responses to ACh with little effect on responses
to DOPA. An example of a cell on which the effects of both
atropine and propranolol were studied is shown in Fig. 5/VII.
On one cell atropine reversibly abolished the excitatory effects
of ACh without affecting depressant responses to DOPA.
VII,4. DISCUSSION
The results reported here indicate that the effects
of DOPA on single cortical neurones are very similar to those
of NA. Firstly, it was found that cells invariably responded
in the same direction to the two drugs. This contrasts with
much lower correlations between the effects of NA and ACh, or
NA and 5—HT on cortical neurones (Johnson et, al», 1969a; Bradshaw
et al«, ].971 i Bevan et al., 1974a). The present finding of a
close correlation between the effects of DOPA and NA seems to
be in contrast with the observations of Krnjevii & Phillis (1963c)
who reported that DOPA had a weak excitatory action on cortical
neurones while NA was predominantly depressant. However, these
authors did not report within-cell comparisons of the effects
of the two drugs.
Secondly, the excitatory effects of both DOPA and NA
could be abolished by phentolamine and propranolol when responses
to ACh remained unaffected, while responses to DOPA were not
affected by atropine when responses to ACh were completely
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- 191 -
to NA and ACh in our experiments is in agreement with the
observations of Johnson et al., (1969a), and also with the
observations presented in Chapter V. The evidence presented
in Chapter V suggests that the excitatory responses to NA
are mediated via cC -adrenoceptors. The selective antagonism
of these responses by the (/—adrenoceptor blocking agent
phentolamine supports this hypothesis. The antagonism of
the excitatory responses to NA by propranolol, a (i-receptor
blocking agent, is probably due to the (/—adrenoceptor
blocking property of this compound (for discussion see V.4«)»
A possible explanation for the agonistic effects of
DOPA seen in our experiments is the release of NA from
noradrenergic nerve terminals. There is evidence that such
a mechanism underlies the facilitatory effects of DOPA on
spinal reflexes (Anden et al., 1969? Anden, Engel & Rubenson,
1972a) and the stimulant effects of DOPA on locomotor activity
(Corrodi, Fuxe, Ljongdahl & Ogren, 1970). Since these actions
of DOPA coincide with raised levels of NA in the CNS, and can
be blocked by drugs which inhibit the synthesis of NA from
DOPA, it is unlikely that DOPA exerts a direct action of its
own in these test systems. However, in the present experiments,
the possibility cannot be excluded that DOPA acted directly on
*
post-synaptic NA receptors. (The observation that the latency
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to onset of responses to DOPA was greater than that of responses
to HA. might he taken as evidence in favour of an indirect action
of DOPA, however the dependence of response latency upon physical
factors such as transport number, diffusion coefficient and
the parameters of the ejecting and retaining currents (see
Chapters II and III) makes such observations very difficult to
interpret.)
An alternative possibility is that agonistic actions
of DOPA were mediated by DA rather than HA. Recent evidence suggests
that there are DA-containing nerve terminals in the cerebral
cortex (Tierry, Hir3ch, Tassin, Blanc & Glowinski, 1974> Fuxe,
Hokfelt, Johansson, Jonsson, Lidbrink & Ljungdahl, 1974) and
that DA can be synthesised in these terminals from systemically
administered DOPA (Hokfelt, Ljungdahl, Fuxe & Johansson, 1974).
Moreover, DOPA may be decarboxylated in 5 HT—containing nerve
terminals, with the subsequent release of DA (Butcher, Engel
& Fuxe, 1970). If, in the present experiments, DOPA acted
either directly or indirectly on DA receptors, then the ant¬
agonistic effects of phentolamine and propranolol on responses
to DOPA and HA would indicate that DA receptors are highly
similar to HA receptors on cortical neurones (cf. Chapter VI).
Finally, some comment is needed about the apparently
lower potency of DOPA than HA seen in our experiments. Such
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a difference in potency might reflect physical factors, such
as difference between the transport numbers and diffusion
coefficients of• the two drugs (see III.4.). However, the
lower potency of DOPA might also be due to biological factors,
such as the extra-neuronal accumulation of DOPA (Butcher et al.
1970» And^n et al., 1972b), the retention of nex-fly synthesised
catecholamines in presynaptic stores after DOPA administration
(Butcher et al., 1970), or, if the primary action of DOPA
is post-synaptic, difference between the affinities and/or
intrinsic activities of the two drugs at NA receptors.
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CHAPTER VIII




It is generally believed that the tricyclic antidepressant
drugs exert their antidepressant effects by blocking the (re)uptake
of noradrenaline (HA) into NA-containing nerve terminals, and
thereby potentiating the pharmacological actions of NA on
post-synaptic receptor sites (Schildkraut, 1965; Davis, 1970)»
This hypothesis is based on observations made in the
peripheral nervous system and in different peripheral pharmacological
test systems. Tricyclic antidepressants (e.g. imipramine,
desipramine) block the uptake of HA into sympathetically innervated
tissues (Hertting et al., 1951; Iversen, 1965), and they are
also able to potentiate the responses of adrenergically innervated
tissues to exogenously applied HA (Sigg et al., 1963; Sturman,
1971J McCulloch & Story, 1972), and to sympathetic nerve stimul¬
ation (Sigg et al., 19o3). It has been suggested that the
potentiation of responses to HA is due to the blockade of
uptake into nerve terminals (Hertting et al., 1961; Iversen, 1965;
Schildkraut, 1965). As imipramine and desipramine block the
uptake of NA into brain tissues as well (Ross & Renyi, 1967),
it has been assumed that the tricyclic antidepressants should
potentiate the pharmacological effects of monoamines in the
brain (Schildkraut, 1965; Davis, 1970).
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In the experiments described in this Chapter, we
investigated how responses to NA can "be modified "by two tricyclic
antidepressant drugs, imipraraine and aesipramine. For the sake
of comparison, we have also examined the effects of desipramine
on neuronal responses to glutamate.
The cerebral cortex is a relevant structure to conduct
such an investigation. There is evidence that the neocortex
receives innervation from NA—containing neurones (Puxe, 1965 >
Descarries et al., 1977)» Moreover, cerebral cortical neurones
are sensitive to NA applied by microelectrophoresis: both
excitatory and depressant responses have been described (see
Chapters IV and V). It is possible, therefore, that these
responses are mediated by subsynaptic receptors, and that
presynaptic processes, such as uptake into NA—containing nerve
terminals, may influence the responses observed.
VIII.2. METHODS
All the experiments described in this Chapter were
conducted on cats. Our methods for the preparation of the
animals have been described in III.2.1. For the methods of
manufacturing five-barrelled glass micropipettes see II.2. and
III.2.2.; for the methods of recording action potentials and
applying drugs by microelectrophoresis see III.2.3. and III.2.4.
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The micropipettes were filled with the following drug
solutions: noradrenaline bitartrate (0.2 M, pH 3.0-3.5)t sodium
glutamate (0.2 M, pH adjusted to 8.5 by the addition of 0.1 NaOH),
imipramine hydrochloride (0.2 M, pH 4»4)» desmethyliraipramine
hydrochloride (0.15 M, pH 4»5)«
All the neurones studied were spontaneously active.
All the drugs were applied by microelectrophoresis. Repeated
responses to the monoamines (or glutamate) were compared before
and after a brief application of the antidepressant. Our
measure of the dose of the antidepressant was the electrophoretic
charge passed (intensity of electrophoretic current x time of
passage of current) (see VIII.4*)• The sizes of excitatory
responses to the agonists were expressed as the total number
of spikes generated in response to each application of an
agonist ('total spike number* ; see III.2.5.). In the case
of depressant responses, the total number of spikes generated
between the onset of the drug application and the recovery of
the baseline firing rate was subtracted from the number of spikes
emitted during an equivalent control period before the drug
had been applied, and the figure obtained was used as a
measure of the size of the depressant response. The intervals
between drug applications were kept constant as far as possible.
During these intervals a retaining current of 25 nA was passed.
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VIII.3. RESULTS
VIII.3.1. DIRECT EFFECTS OF IKIPRAN.INE AND BE5IPRAMIME ON
NEURONAL FIRING
The direct effect of imipramine on the firing rate
was studied on 144 cells; the effect of desipramine was
investigated on 154 cells. The dose of antidepressant
applied was 25—100 nA passed for 20—60 sec. The effects
observed are summarised in Table l/vill. It is apparent
that the vast majority of the cells (82,6 and 83.8%) were
not directly affected by the antidepressants. The excitation
or depression observed was always of a temporary nature, and
the original baseline firing rate recovered within a minute
after the application of the antidepressant had been
terminated, On occasions a reduction in spike amplitude
was observed; such cells were not used for drug—interaction
studies.
On 29 cells a longer, continuous application of
the antidepressants was also tested (5—50 r-^ Passed for up
to 20 min). This continuous application of the antidepressant
resulted in a cumulative effect on firing rate: first the
firing rate was gradually reduced, and later a decrease in
spike amplitude developed. This progressively developing
effect on spike amplitude could be observed even when very
low ejecting currents were passed for a longer period. Theref
a shorter application of the antidepressants was used for the
drug—interaction studies described below.
TABLEl/VTII.Effectsofimipramineanddesipramineos glcorticalurones Effect(numberofc lls) ExcitationDepressionReductionNeffectT tal
I—'
spikeamplitudevg
Imipramine148311944 (9.8/0)(5.6/)(2, o)( 2.6/)(1 0/) Desipramine91312954 (5.8/0)(8.4/0)(2. /)( 3.8/)(1 0
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VIII.3.2. EFFECTS OF IMIPRAMINE AND DB5IPRAMIHE ON NEURONAL
RESPONSES TO NORADRENALINE
a. Excitatory responses
Drug-interaction studies were successfully completed
on 70 neurones responding with a clear increase in firing rate
to NA. Cells were excluded if the variation in the size of
response exceeded — 1 Ofc. Imipramine was studied on 31 cells,
desipramine on 39 cells. Both potentiation and antagonism of
the response to NA. could be observed after a brief application
(25-100 nA for 20-60 sec) of either of the antidepressants.
Potentiation of the response was seen on 49 cells.
A response was regarded as potentiated if there was more than
20/a increase in the size of the average control response. The
degree of potentiation was 51^-138% (inter-quartile range).
The potentiated response had a characteristic time—course compared
to the control response: the peak of the response was usually
higher, and the recovery time longer. The latency of the
potentiated response could be either shorter or longer than
that of the control response. On a few cells only one response
showed potentiation, on the majority of the cells, however,
several responses were potentiated, and the control response
recovered only after a longer time (up to 90 min).
Antagonism of the response was seen on 45 cells.
Antagonism appeared as a reduction in the total spike number
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compared, to the control. This reduction in size varied between
20-10C$,
The occurrence of potentiation and antagonism followed
a well—defined pattern. The following patterns could be
observed:
'Sjarly* potentiation. In this case the first response after
the antidepressant showed the greatest degree of potentiation.
(The first application of NA after the antidepressant usually
followed less than one and half minutes after the application
of the antidepressant.) Subsequent responses became gradually
smaller until recovery of the control could be seen. Recovery
usually occurred 10-20 rnin after the antidepressant had been
applied. Early potentiation was seen on 18 neurones.
'bate' potentiation. In this case, potentiation developed
gradually, achieving a maximum 10—30 min after the application
of the antidepressant. Recovery occurred 30-60 rain after the
antidepressant had been applied. Late potentiation was seen
on 18 cells. Examples of late potentiation are shown in Figs.
l/VIII, 3/VIII and 4/VIII.
3. Antagonism followed by potentiation. In this case, the
first response after the antidepressant was reduced in size.
This initial antagonism was later followed by potentiation,
and finally by gradual recovery of the response. This pattern
of drug-interaction was observed on 31 cells. Antagonism
invariably preceded potentiation, the reverse v/as never seen.
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4* Antagonism only was seen on 14 cells. In this case an
initial antagonism of the response was followed "by recovery.
On some cells a number of studies were conducted and more than
one pattern of drug—interaction could be observed (see below).
There was no qualitative difference between the
effects of imiprarnine.and desipramine: both antidepressants
modified the response according to one of the four patterns.
In an attempt to identify whether the pattern of drug—
interaction was related to the dose of antidepressant applied,
we compared the effects of two or more doses of the same
antidepressant on responses to noradrenaline on the same cells.
The doses of antidepressant applied were within the range used
in all of the drug-interaction studies. Increasing doses of
imipramine were tested on 6 cellst and the effects of increasing
doses of desipramine were studied 011 12 cells. We have found
that 1, a higher dose was required to cause late potentiation
than early potentiation; 2. a higher dose was required to cause
antagonism than potentiation only. An example of the effects
of the two different doses of desipramine on the size of






















FIGUHS 4/VIII. Effects of two Moses' of desipramine on neuronal
responses to noradrenaline.
Ordinate: total spike number (%; the size of the control
responses is taken as IGCffo) ; abscissa: running time (min). Each
dot represents one individual response; closed circles; responses
from study I in Fig 3/VTII; open circles : responses from study II
in Fig. 3/VIII.
The smaller dose of dssipramine (pO nA for 30 sec) caused
•late potentiation', whereas the bigger dose of desipramine (50 nA




The effects of the two antidepressants were studied
oxi 11 cells depressed by noradrenaline. Imipramine was studied
on 6 cells, and desipramine was tested on 8 cells. Both
potentiation and antagonism of the depressant responses after
a brief application of the antidepressants could be observed
(Fig. 5/VTII and 6/viIl). Potentiation was seen on 12 cells,
antagonism was observed on 3 cells. The same patterns of
drug—interaction were seen as with excitatory responses:
1. early potentiation (3 cells); 2. late potentiation (7 cells);
3. antagonism folloi-xed by potentiation (2 cells); 4# antagonism
only (l cell). There was no qualitative difference between
the effects of imipramine and desipramine.
On 1 cell imipramine reversed the depressant response
into an excitation (Pig. 7/viIl).
VIII. 3.3. EFFECT OP DSSIPRAMIME ON NEURONAL RESPONSES TO C-LUTAMATE
The effect of desipramine on excitatory responses to
glutamate was studied on 9 cells. On most of these cells several
different doses of desipramine were tested. The dose of
desipramine varied between 10-100 nA applied for 20-300 sec.
The effects of glutamate on the firing rate were tested for
10-20 min following the application of the antidepressant. On
none of the cells could any change be observed in the size of
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VIII.4. DISCUSSION
Imipraraine and. desipramine, when applied for a hrief
period of time, did not have any effect on the firing rates
of the vast majority of cortical neurones (see Table l/VIIl).
On a small number of cells, however, a response to imipramine
or desipramine could be observed. A possible explanation for
this effect of the antidepressants themselves could be that
it reflects the interaction between endogenously released HA
and the antidepressants. As responses to 5—HT (Bradshaw et al.t
1974) and ACh (Bevan et al., 1975a) are also affected by
imipramine and desipramine, an interaction with 5—HT and ACh,
released by serotonergic and cholinergic terminals, respectively,
should also be considered. On a few cells, a reduction in
spike amplitude could be observed in response to either of the
antidepressants. This probably reflects the local anaesthetic
action of these drugs (Domenjoz & Theobald, 1959)*
We have found that imipramine and desipramine have
a dual effect on responses of cerebral cortical neurones to
HA: both potentiation and antagonism of the responses can
be observed after a brief application of either of the anti¬
depressants. Similarly, Avanzino et al. (1971) have reported
that imipramine can both potentiate and antagonise neuronal
responses to NA in the brain stem. On the other hand, only
potentiation of responses to HA by desipramine has been described
on cerebellar Purkinje cells (Hoffer et al., 1971b)•
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The dual effects of the antidepressants occurred according
to a dose-dependent pattern in our experiments: when different
doses of the same antidepressant were compared on the same cells,
smaller doses potentiated, and bigger doses antagonised the
neuronal responses to NA (see Pigs. 3/VIII and 4/viIl). This
dual effect can be interpreted in terms of two independent
mechanisms: a more sensitive potentiating mechanism, and a
less sensitive antagonising mechanism. The pattern of occurrence
of both potentiation and antagonism in our experiments may be
explicable in terms of hypothetical concentration changes
following a brief application of the antidepressant (Pig.
8/viIl). After the brief ejecting pulse the concentration of
the antidepressant probably rises quickly to a peak, and then
gradually declines (Castillo & Katz, 1955)• When a relatively
small dose of antidepressant is applied, (curve 1 in Fig. 8/viIl)
the concentration rises fast above the hypothetical threshold
for the potentiating mechanism (P), but it does not reach the
higher threshold for the antagonising mechanism (A). Thus
potentiation of the response to NA is observed. The first response
after the antidepressant, which coincides with the highest
antidepressant concentration, will show the greatest degree
of potentiation ('early potentiation'). 'When a slightly bigger
dose of antidepressant is applied (curve 2 in Pig. 8/VTIl), the
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FIGURE 8/VTII. Hypothetical concentration changes following a
"brief application of an antidepressant.
Horizontal lines show the threshold for the potentiating
(P) and the antagonising (A) mechanisms (see text). Curve 1, 2,
3: concentration curves following small, intermediated and large
doses of the antidepressant.
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concentration may rise slightly above the antagonism threshold
(A). Therefore, at the peak of the concentration curve the
size of the response to NA will reflect the relationship
between the activation of the two mechanisms. Thus a smaller
degree of potentiation may be followed by a greater degree of
potentiation as the concentration falls below the antagonism
threshold ('late potentiation*). If a still bigger dose is
applied (curve 3 in Fig. 8/VlIl), the concentration of the
antidepressant rises high above the antagonism threshold.
Thus the response to NA may be first reduced in size, and
potentiation develops later, as the concentration of the
antidepressant falls (antagonism followed by potentiation).
The occurrence of antagonism followed by recovery (but by no
potentiation), does not fit readily into this model. A possible
explanation is that the study was not continued for long
enough after the appearance of recovery, since this recovery
occurred very often after a longer delay (up to 90—100 min).
Another possibility is that in these cases the existence of a
relatively higher concentration of the antidepressant for a
longer time results in a persistent binding of the antidepres¬
sant to the receptors, thus interfering with the appearance
of potentiation when the concentration of the antidepressant
falls below the antagonism threshold.
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The dual effect of the antidepressants on responses
to NA may reflect the separate presynaptic and post-synaptic
actions of these drugs. Potentiation of neuronal responses
to NA hy imipramine and desipramine may reflect the "blockade
of uptake of NA into pre—synaptic terminals. It has "been
demonstrated that there is a powerful uptake mechanism for
NA in the "brain, and that this mechanism can he blocked by
imipramine and desipramine (Glowinski & Axelrod, 1964;
Ross & Renyi, 1967). Furthermore, it has been reported that,
after pre-treatment with 6-hydroxydopamine, desipramine fails
to potentiate responses of cerebellar Purkinje cells to NA
(Hoffer et al.t 19?lh). As 6-hydroxydopamine destroys the
NA—containing neurones in the brain (Bloom et al., 1969),
this observation could indicate the importance of NA-containing
terminals for the potentiation of neuronal responses to exogenously
applied NA. Antagonism of neuronal responses to NA, on the
other hand, may be due to the blockade of post-synaptic NA—
receptors by the tricyclic antidepressants. The antagonism
of excitatory responses to NA, which are mediated by cL-
adrenoceptors (see Chapter V), probably reflects the well—
documented ol —adrenoceptor blocking properties of imipramine
and desipramine (Callingham, 1966; Sturman, 1971 ; McCuiloch
& Story, 1972). The antagonism of depressant responses to
NA, which are mediated by ^-adrenoceptors, would suggest that
imipramine and desipramine may be able to block ^-adrenoceptors
as well. Indeed, recent evidence indicates that the number
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of p-receptors in the "brain decreases after chronic pre—
treatment with desiprarr.ine (Banerjee et al♦, 1977); this observ¬
ation could indicate an irreversible (*-adrenoceptor blocking
action of the antidepressant (see Furchgott, 1972; Triggle &
Triggle, 1976). Furthermore, there is evidence in the periphery
which suggests that imipramine and desipramine may have p —
adrenoceptor blocking properties (e.g. Govier, 1967; Tamayo
et al., 1973 ; Scriabine, 1969).
On one cell, imipramine reversed the depressant response
into an excitation (Fig. 7/viIl). This observation would suggest
that the inhibitory ([?)) receptors are more sensitive to the
antidepressants than the excitatory (<A) receptors: the selective
blockade of the dominant inhibitory ^—adrenoceptors may have
resulted in the unmasking of the excitatory effect mediated
by the {^-adrenoceptors.
The tricyclic antidepressants imipramine and desipramine
can modify not only neuronal responses to NA, but also neuronal
responses to 5~^T and ACh: both potentiation and antagonism
of these responses has been described (Bradshaw et al.t 1974;
Bevan et al., 1975a-). The antidepressants are specific, however,
in that responses to glutamate are not affected (VIII.3.3.).
This would suggest that imipramine and desipramine do not interfere
with the basic machinery of spike initiation.
- 217 -
CHAPTER IX
EFFECT OF IPRINDOLE ON NEURONAL RESPONSES TO NORADRENALINE
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IX,1. INTRODUCTION
According to the monoamine theory of affective disorders,
the tricyclic antidepressant drugs exert their antidepressant
effects by potentiating the pharmacological actions of NA at
post-synaptic receptor sites in the brain (Schildkraut, 1965?
Davis, 1970). It is generally believed that the NA—potentiating
effect of the tricyclic antidepressants is due to their ability
to block the uptake of NA into NA-containing nerve terminals
(iversen, 1974)* Previous reports on imipraraine and desipramine
seem to confirm this hypothesis. It has been shown that
these antidepressants block the uptake of noradrenaline (NA)
into brain tissue (Ross & Renyi, 1967), and that they also
potentiate neuronal responses to NA (see Chapter Till), There
are, however, reports suggesting that the 'uptake blockade
hypothesis' of potentiation may not apply to another antidepressant,
iprixidole.
Iprindole is a tricylic antidepressant drug with a
similar structure and clinical antidepressant efficacy to
imipramine (imlah et al.t 1968; Rickels et al.t 1973). Similarly
to imipramine, 'iprindole potentiates the peripheral effects
of NA (Gluckman & Baum , 1969). However, in contrast to
imipramine and other tricyclic antidepressant, compounds,
iprindole does not block the uptake of NA into sympathetically
innervated tissues (Gluckman & Baum,1969; Lahti & Maickel, 197l)»
- 219 -
It has also been reported that, in contrast to imipramine
and desiprarnine, iprindole is ineffective in blocking the
uptake of NA (Ross, Renyi & Ogren, 1971 j Rosloff & Davis, 1974)
into brain tissue. Therefore, it was of interest to examine
how pharmacological responses to NA are affected by iprindole
in the brain.
IX.2. METHODS
All the experiments described in this Chapter
were conducted in rats. Our methods for the preparation
of the animals have been described in IV.2. For the methods
of manufacturing six-barrelled glass micropipettes see II.2.
and III.2.2.; for the methods of recording action potentials
and applying drugs by microelectrophoresis see III.2.3. and
III.2.4.
The micropipettes irere filled with the following
drug solutions: noradrenaline bitartrate (0.1 M, pH 3.0—3.5)»
dopamine hydrochloride (0.1 M, pH 4.0—4*5)» 5-4ydroxytryptamine
bimaleate (0.1 H, pH 3.5)j acetylcholine chloride (0.1 K,
pH 3.6), sodium glutamate (0.05 M, pH adjusted to 8.5 by the
addition of 0.1 M NaOH), and iprindole hydrochloride (0.1 M,
pH 4.6).
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All the neurones studied were spontaneously active.
All the drugs were applied by microelectrophoresis. Repeated
responses to an agonist were compared before and after a
brief application of iprindole. In order to ensure that
standard ejecting current pulses gave rise to standard pulses
of drug ejection, the intervals between drug applications
were kept constant using a sequential timing device (see
II.3.3. and III.3.2.). A retaining current of 25 nA was
passed between drug ejections. Cells were excluded from
drug interaction studies if the variation in the size of
responses to an agonist exceeded - lOfo.
The magnitude of a response was measured by calculat¬
ing the difference between the number of spikes generated
during the response and the number of spikes generated
during an equivalent period when no drug was applied ('total
spike number'; see III.2.5.).
IX.3. results
IX.3.1. DIRECT EFFECT OF IPRIKBOLE Oh neuronal FIRING
The effect of iprindole on the firing rate was
studied on 68 cells. The dose of iprindole applied was
30-100 nA passed for 30-60 seconds. Four cells (5«97" of
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the total population of 68) responded with a clear increase
in firing rate to the application of iprindole, whereas 18
cells (26.5<fo) were depressed (for examples see Fig. l/ix).
There was no significant correlation between the dose of
iprindole applied and the effect on neuronal firing. The
excitation or depression was always of a temporary nature,
and the original baseline firing rate recovered within 1-3
minutes after the application of iprindole had been terminated.
On occasions a reduction in spike amplitude was observed;
such cells were not used for drag interaction studies.
IX.3.2. EFFECT OF IPRINDOLE ON NEURONAL RESPONSES TO NORAPHEETALIKE
a. Excitatory responses
Both potentiation and antagonism of excitatory
responses to NA could be observed after a brief application
(30—IOC nA for 30—60 seconds) of iprindole.
Potentiation was seen on 6 cells. A response was
regarded as potentiated if there was more than 2C$- increase
over the size of the mean control response (see VIII.3.2.).
An example of potentiation is shown in Fig. 2/lX. On one
cell, the response was first reduced in size following the
application of iprindole; this antagonism was followed later
by potentiation, and finally by recovery of the control
IPR100
s—§1 CiZZZTIr.-J. !PR100
FIGUREl/lX.Examplesofres onsesfcorticalneuronestiprindole Ratemeterrecordingsofthfiri grat fwocorticaln uronesthat.Or inate firingate(sp kes/sec);abscissae:runningtim(mi ).Horizontalbarsind c temicro lectro- phoreticdrugapplications;numbersref rtintensitiesfjectingcurr nt( A). Left:depressantsponsetoi rindole;right:excitatoryresponstip indol .
SPIKES/S
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response. (A response was regarded as antagonised if there
was more than 20j£ decrease in the size of the response compared
to the mean of the control responses.)
h. Depressant responses
Both potentiation and antagonism of depressant
responses to NA could he observed after a brief application
of iprindole. Potentiation was seen on 10 cells, antagonism
was seen on 3 cells. On 2 cells both antagonism and
potentiation could be observed; in both cases antagonism
preceded potentiation, A.n example of the potentiation of
the depressant response to NA by iprindole is shown in
Pig. 3/lX.
IX. 3.3c EFPBCT OP IPRINDOLE ON NEURONAL RESPONSES TO GLUTAMTB
The effect of iprindole on excitatory responses to
glutamate was studied on 10 cells. The effects of glutamate
on the firing rate were studied for 20-30 minutes following
the application of iprindole. On none of the cells could any
significant change be observed in the size of the response to
glutamate after the application of iprindole.
IX.4. DISCUSSION
A brief application of iprindole did not affect
















































On a third cf the cells (32.4/2), however, a response to
iprindole was observed. A possible explanation for this
effect of iprindole itself could be that it reflects the
interaction between endogenously released neurotransmitters
and the antidepressant. Similarly to iprindole, imipramine
and desipramine can also evoke both excitatory and depressant
responses on spontaneously firing cortical neurones (see
VIII.3*1*)• On a few cells, a reduction in spike amplitude
was observed in response to iprindole. This probably
reflects a local anaesthetic action of the drug. A similar
local anaesthetic action has been observed "with other
tricyclic antidepressants (see VIII.3.1. and Domenjoz &
Theobald, 1959).
We have found that iprindole, similarly to
imipramine and desipramine (see Chapter VIII) can cause both
antagonism and potentiation of responses of cortical neurones
to NA. When both antagonism and potentiation of the response
occurred after a single application of iprindole, antagonism
preceded the development of potentiation. After a brief
ejecting pulse, the concentration of iprindole probably
rises quickly to a peak, and then gradually declines, so that
antagonism of the response to NA is likely to reflect a higher,
and potentiation a lower concentration of the antidepressant
(see VIII.4.).
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The most plausible explanation for antagonism is
the blockade of NA-receptors on the post-s.ynaptic neurone.
This would indicate that iprindole probably shares the
adrenoceptor blocking actions of other tricyclic antidepressants
(see Chapter VIIl). Indeed, recent evidence suggests that
iprindole, similarly to desipramine, can interact 'with
^-adrenoceptors in the brain (Banerjee et al., 1977; see
also ¥111.4.).
It is more difficult to interpret the potentiation
of neuronal responses to NA by iprindole. As iprindole
is ineffective in blocking the uptake of NA into brain
tissue (Ross et al.t 1971)» uptake blockade cannot be an
explanation for the potentiation observed in our experiments.
Therefore, it is necessary to consider whether potentiation
could be explained by a post-synaptic mechanism.
One possibility is that not only antagonism, but
also potentiation of excitatory responses to NA by iprindole
is due to post—synaptic receptor blockade. If we assume
that inhibitory G—adrenoceptors are more sensitive to the
antidepressants that the excitatory d-adrenoceptors, a lower
concentration of the antidepressant might block the masked
inhibitory receptors, 'without affecting the dominant excitatory
receptors, thus causing potentiation of the response. Indeed,
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sotalol, a ^-adrenoceptor blocking agent c.an potentiate
excitatory responses to NA (Bevan et al., 1974b). The
selective blockade of the inhibitory receptors may explain
the reversal of the depressant response into an excitatory
one by imipramine (Fig. 7/VIIl), and the antagonism of the
small initial depressant phase of a biphasic response as
potentiation of the excitatory phase develops after the
application of imipramine (Fig. l/vill). It would be
difficult, however, to interpret the potentiation of depressant
responses by the blockade of masked receptors, since in this
case it would be necessary to assume a greater sensitivity
of the excitatory oi—adrenoceptors to the antidepressants.
Another possible 'post-synaptic' explanation for
potentiation could be that it is due to the inhibition of the
enzyme phosphodiesterase in the post-synaptic neurone. There
is experimental evidence that the tricyclic antidepressants
imipramine, desipramine and iprindole reduce the activity
of this enzyme (Muschek & McNeill, 1971 j Daly, 1975)*
Furthermore, it has been reported that both oi- and j^-
adrenoceptor stimulation in the mammalian brain can result
in the activation of adenylate cyclase (see Daly, 1976). If
the adenylate cyclase system plays a role in the mediation of
both excitatory and depressant neuronal responses to NA, it
would be expected that the inhibition of phosphodiesterase,
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the enzyme responsible for the destruction of cyclic-AMP, would
cause potentiation of the responses to NA. Indeed, it has
been reported that the phosphodiesterase inhibitors aminophylline
and papaverine (Lake et al., 1972), and ICI-63, 197 (Stone &
Taylor, 1977) can potentiate depressant responses to NA on
cortical neurones. (Note, however, that there are doubts
concerning the specificity of this effect; Lake et al., 1972).
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CHAPTER X
EFFECT OF D3SIPRAMINE ON NEURONAL RESPONSES TO MESCALINE
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X.l. INTRODUCTION
It is well known that the tricyclic antidepressant
drugs imipramine and desipramine hlock the uptake of noradren¬
aline (NA) into nerve terminals (Horn et al.t 1971)» These
drugs also potentiate pharmacological responses to NA in the
periphery (Sigg. et al.t 19&3) and in the central nervous
system (see Chapter VIII). Although it is widely "believed
that there is a causal relationship "between uptake "blockade
and potentiation (iversen, 1974)» recent evidence indicates
that potentiation of responses to NA can occur in situations
where uptake blockade is unlikely to operate. For instance,
desipramine can potentiate neuronal responses to NA and
dopamine in the caudate nucleus (Sevan et al., 1975c)t although
it does not block the uptake of catecholamines in this
structure (Horn et al., 197l)» Furthermore, iprindole, a
tricyclic antidepressant with little uptake-blocking activity
(Ross et al., 1971) is effective in potentiating the responses
of single cortical neurones to NA (see Chapter IX). In this
Chapter further evidence is presented suggesting that uptake
blockade is not a necessary condition for potentiation of
neuronal responses to NA.
The hallucinogenic monoamine mescaline (3» 4> 5-"tTi¬
met hoxyphenylethyl amine) can evoke responses on cortical neurones
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which are similar to those evoked by noradrenaline (Bevan
et al., 1974a; see also Pig. l/lV). It is known that
mescaline has an extremely low affinity for uptake mechanisms
in the periphery (iversen, 1967). Moreover, it has recently
been reported that although there is a weak active uptake
process accumulating mescaline into cortical synaptosomes,
this process is not affected by desipramine (Bevan et al., 1977)*
In the present study we examined whether neuronal responses to
mescaline can be potentiated by desipramine.
X.2. METHODS
Spontaneously active single neurones -were studied in
the cerebral cortices of cats and rats anaesthetised with
halothane. All the drugs were applied by microelectrophoresis.
Our techniques for the surgical preparation of the animals,
for the extracellular recording of action potentials, and the
microelectrophoretic application of drugs from six-barrelled
micropipettes have been described in previous Chapters (see
II.2., III.2., and IV.2.).
The micropipettes contained the following drug
solutions: mescaline hydrochloride (0.05 K, pH 4«0) ;
(-)noradrenaline bitartrate (C.05 M, pH 3.5) » sodium glutamate
(0.05 M, pH adjusted to 8.5 with MaOH); desipramine hydrochloride
(0.15 M, pH 4.5).
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Repeated responses to mescaline were compared before
and after a brief application of desipramine (25—100 nA
applied for 20—60 seconds). Cells were excluded if the variation
between control responded exceeded — 10% (see Chapter VTIl).
Only excitatory responses to mescaline were selected for
study in these experiments. Total spike number was used
as a measure of the response (see III.2.5.). Cells were
excluded if the variation between control responses exceeded
— 10% (see Chapter VIII). Repeated responses to mescaline were
compared before and after a brief application of desipramine
(25—100 nA; 20—60 sec). A response was regarded as potentiated
if there was an increase of 20% or more over the size of the
mean control response; a response was regarded as antagonised
if there was a decrease of 20% or more in the size of the
response compared with the mean of the control responses
(see Chapter VIII).
X.3« RESULTS
X.3.1. EXPERIMENTS WITH CATS
The effect of desipramine was studied in the cat on
11 cortical neurones which responded with a clear and consistent
excitation to mescaline. On 5 of these cells the response to
mescaline was potentiated following an application of
desipramine. On 6 cells desipramine antagonised the response
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to mescaline» On 2 cells "both antagonism and potentiation
could be observed following a brief application of desipramine:
the antagonism preceded the potentiation. An example of a
study in which both potentiation and antagonism could be
observed on the same cell is shown in Pig. l/X.
Xc 3.2. EXPERIMENTS WITH RATS
Seventeen cortical neurones were studied in the rat.
In these studies, glutamate was used as a control agonist.
Desipramine potentiated the response to mescaline on 10 cells;
on 5 of these cells the potentiation was preceded by antagonism
of the response. Responses to glutamate wcre not affected by
desipramine,
X.4. DISCUSSION
The effects of desipramine on responses to mescaline
are similar to its effects on responses to NA (see Chapter VIII).
Both antagonism and potentiation of neuronal responses to
mescaline could be observed. The antagonism may reflect the
^-adrenolytic action of desipramine (Callingham, 1967), since
mescaline and NA probably activate similar receptors on cortical
neurones (Bevan et al.t 1974a).
RESPONSETAGONI T totalspikenumber(percent)
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The potentiation of responses to mescaline is more
difficult to explain: uptake mechanisms are unlikely to he
involved, since desipramine does not block the uptake of
mescaline into cortical synaptosomes (Bevan et al., 1977) • Ail
alternative possibility is that the potentiation has a post¬
synaptic origin: desipramine may block 'masked* inhibitory
receptors on the post-synaptic neurone and thus increase the
size" of the observed excitatory response to mescaline, or it
may inhibit the enzyme phosphodiesterase in the post-synaptic
cell and thus cause potentiation of the cyclic AMP—mediated




COMPARISON OF THE EFFECTS OP DSSIPRAMINS ON NEURONAL RESPONSES
TO TYRAKINE AND NORADRENALINE
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XI.1. INTRODUCTION
Tyramine is an indirectly acting sympathomimetic
amine: it is generally believed that it exerts its pharmacologic
actions by the release of NA from pre—synaptic stores (Burn &
Rand, 1958? Trendelenburg, 1972). It has been reported
that the tricyclic antidepressant drug desipramine blocks the
uptake of tyramine into sympathetically innervated tissues
(Brodie et al.t 1970)» an|i thus antagonises pharmacological
responses to tyramine (Gessa et al., 1966; Pozard & Mwaluko,
1978). Desipramine, however, can also block the uptake of
NA (Hertting et al., 1961; Iversen, 1965)» 'which may result in
potentiation of the responses to NA (3igg et al., 1983;
Sturman, 1970). Thus desipramine, and other uptake-blocking
tricyclic antidepressants (e.g. nortriptyline) can discriminate
between pharmacological responses to NA and tyramine: while
responses to NA are potentiated, responses to tyramine are
antagonised by the same concentration of the antidepressant
(Barnett et al., 1968; Pozard & Mwaluko, 1978; Doggrell
& Woodruff, 1977).
The results in Chapter '/III show that desipramine
can potentiate neuronal responses to NA in the brain. The
experiments described in this Chapter were performed in
order to 1. compare the agonistic activities of tyramine and
NA on cortical neurones, and 2. examine whether desipramine





Male albino Wistar rats (250—350g) were used in
these experiments. The animals were anaesthetised with
halothane (0.8—1.0/fe), Our methods for the surgical prepara¬
tion of the animals, for the manufacture of six—barrelled
micropipettes, for the extracellular recording of action
potentials, and for the microelectrophoretic application
of drugs have been described in previous Chapters (II.2.,
III.2. and IV.2.).
Six-barrelled micropipettes of tip diameter
3.0—5.0 jjm were used. Two barrels of each micropipette
contained 4 M NaCl, one for recording action potentials,
the other for use in current balancing. The remaining
barrels contained drug solutions. The following drug
solutions were used; tyramine hydrochloride (0.05 M, pH 5*0)5
(-)noradrenaline bitartrate (O.Op M, pH 3.0-3.5)? DL-homocysteic
acid (0.05 M, pH adjusted to 8.0 with NaCH); desipramine
hydrochloride (0.005 M, pH 4»5)«
Spontaneously active neurones were studied in
the cerebral cortex (stereotaxic co-ordinates, according
to Konig & Klippel (1963):A 4.8-6.5, L 0.9-2.4). The
area of recording was prepared as described previously
(see III.2.1.). The dura was either incised with a hypo—
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dermic needle, or was penetrated directly with, the micropipette.
All the drugs were applied by microelectrophoresis. When
a suitable unit was encountered, the agonists were applied
in a regular cycle. Between successive applications of
agonists retaining currents of -10 nA were passed. Retaining
currents of —25 nA were used for desipramine. Intervals
between successive applications of the same agonist were
kept constant in order to standardise the effects of the
retaining current upon drug release during the ejection
period (see II.3.3., III.3.2.).
Two measures of the overall size of the neuronal
response were used in these experiments (see III.2.5*)*
Total spike number was used when changes in the size of
the response to a particular agonist were assessed. Total
spike number is the total number of action potentials
produced in response to each drug application; this
measure is proportional to the area enclosed by the response
curve. Maximum change in firing rate was used when
responses to different agonists were compared, e.g. when
assessing the relative potencies of tyramine and MA.
The effect of desipramine was evaluated in the
following way. When stable responses to the agonists had
been obtained, desipramine was applied continuously, either
by removal of the retaining current (i.e. 0 nA) thus allowing
the drug to diffuse out from the micropipette, or by the
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passage of a weak ejecting current (5 to 10 nA), and. the
time-course of the developing antagonism or potentiation
was followed. If necessary, the intensity of the ejecting
current was increased until antagonism or potentiation
was observed. Then the application of desipramine was
terminated, and the time—course of recovery of the
responses to the agonist(s) was followed.
XI. 2.2. MEASUREMENT 0? THE RSLSASB OP TYRAHINE Aim
NORADRENALINE FROM KICROPIPETTBS IN VITRO
Six-barrelled micropipettes were used in
these experiments. Three barrels of each micropipette
v;ere filled with O.Op M ^ sidechain-2-^^C j tyramine;
hydrochloride; the remaining three barrels contained
0.05 M [carbinol-^cl noradrenaline bitartrate (Radiochemical
Centre, Amersham). The specific activities of both
solutions were 1.0 mCi/mmole. Our methods for the
collection of samples, and for the calculation of
transport numbers have been described in II.2. and VI.2.2,
XI.3. RESULTS
XI.3.1. COMPARISON OF AGONISTIC EFFECTS OF TYRAMINS AND NORADRENALINE
a. Responses of cortical neurones to tyramine
Both excitatory and depressant responses to tyramine
were observed in these experiments. Out of l6p cells
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responding to tyramine, 111 cells (67.3/0 were excited,
and 54 cells (32.7?0 were depressed by the drug. The
predominance of excitatory responses is statistically
significant (binomial test; p<,0.0l).
b. Comparison of directions of responses to tyramine and NA
Each of the l6p cells responding to tyramine
(see above), responded also to NA. The correlation
between the directions of the responses (excitation or
depression) is summarized in Table l/xi. It is apparent
from the table that the great majority of the cells
responded in the same direction to the two drugs, cells
excited by tyramine being also excited by NA, and cells
depressed by tyramine being also depressed by NA. This
positive correlation between the effects of tyramine and
NA is statistically significant (^ test; p<7 0.00l).
Examples of the cells responding in the same directions
to the two drugs are shown in Pig. l/xi.
c. Comparison of apparent potencies of tyramine and NA
The relative potencies of tyramine and NA were
assessed in terms of the equipotent current ratio. The
equipotent current ratio was defined as the ratio of
ejecting currents (current for tyramine/current for NA)
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X test; p < 0-001
+ : excitatory responses; - : depressant responses.
Numbers: number of cells responding to both tyramine and noradrenaline.
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FIGURE l/xi. Correlation "between the effects of tyramine and
noradrenaline.
Ratemeter recordings of the firing rates of two cortical
neurones in the rat (A and 3). Ordinates: firing rate (spikes/sec);
abscissae: running time (min). Horizontal bars indicate microelectro-
phoretic drug applications; numbers refer to intensities of ejecting
current (nA).
A: A cell which was excited by both tyramine (TYR) and
noradrenaline (NA).
B: A cell which was depressed by both tyramine and noradren-
aline.
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needed, in order to evoke responses of approximately equal
magnitude (maximum changes in firing rate not differing
by more than 20^) to the two amines.
The relative potencies of the two drugs were
compared on 67 cells (44 cells excited by both drugs,
23 cells depressed by both drugs). On each cell, in
the case of both excitatory and depressant responses,
tyramine appeared to be less potent than NA: the mean
/ \ "4"
equipotent current ratio (— s.e.m.j was 3.02 - 0.22 for
excitatory responses, and 2.52 — 0.32 for depressant
responses. In the case of both excitatory and depressant
responses, the .potency difference between the two amines
was statistically significant (t test; p<C0.00l).
Examples of the potency comparisons are shown in Fig. 2/XI.
d. Comparison of the time-course of responses to tyramine and HA
Two time-course parameters were measured: latency
to onset and recovery time. Latency to onset is the time
elapsed between the beginning of the ejecting pulse and
the onset of the neuronal response; recovery time is the
time elapsed between the termination of the ejecting pulse
and the offset of the neuronal response (see III.2.5.).
These parameters tjere measured on 67 cells giving approximately












FIGUHS 2/XI. Comparison of apparent potencies of tyramine and
noradrenaline.
Ratemeter recordings of the firing rates of two cortical
neurones in the rat (one neurone was excited, the other neurone was
depressed by tyramine and noradrenaline). Ordinates: firing rate
(spikes/sec); abscissae: running time (min). Horizontal bars indicate
microelectrophoretic drug applications; numbers refer to intensities
of ejecting current (nA).
Excitatory responses: In order to evoke approximately
equivalent responses, a higher current was needed to apply tyramine
(TYR) than noradrenaline (NA).
Depressant responses:
A: Tyramine evoked a smaller response than noradrenaline
when both drugs were applied with identical ejecting currents.
B: In order to evoke approximately equivalent responses, a
higher current was needed to apply tyramine than noradrenaline.
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firing rate; see above) to the two amines. Of the 67 cells,
44 cells were excited, and 23 cells were depressed by both
drugs. The mean ratios of the time-course
parameters are shown in Table 2/XI. These ratios were
obtained by dividing the value of the parameter in the
case of the response to tyramine by the value of the
parameter in the case of the response to NA. It is apparent
from the table that the values of these ratios were greater
than one indicating that tyramine evoked 'slower' responses
than NA. Examples of this finding are shown in Pig. 3/xi.
XI.3.2, EFFECTS OP DESIPRAKIKE ON NEURONAL RESPONSES TO
TYRAMINE ANN NORADKBNALINE
Desipramine, applied continuously from a dilute
solution (0.005 H) with a low ejecting current (0-10 nA),
usually did not have any effect on the firing of the neurone.
On some cells, however, a decrease in firing rate occurred,
or the spike amplitude was reduced. Such cells were not
used for drug-interact ion studies.
a. Excitatory responses
Drug—interaction studies were successfully completed
on 47 cortical neurones excited by both tyramine and NA.
DL—homocysteic acid was used as a control agonist. On
41 cells, desipramine could discriminate between responses
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Table 2/xi. Ratios of the parameters of the time-courses of
neuronal responses to tyramine and, noradrenaline
ratio op' time—course parameters













t_ test: * p^O.Ol; ** p <C 0.001
EXCITATORYRESPONSES DEPRESSANTRESPONSES
- 250 -
i:o tyramine and. NA: on all these cells the response to
tyramine was abolished, while the response to NA was
either potentiated (ll cells) or unaffected (30 cells).
On the remaining 6 neurones, the excitatory responses to
tyramine and NA were equally antagonised. Responses to
DL—hornocysteic acid, were not affected by desipramine.
Recovery of responses to tyramine and NA from the effects
of desipramine usually was very slow, taking on occasions
as long as two hours to develop. On a few cells full
recovery of the responses could not be observed even
after several hours. Examples of the effects of desipramine
on excitatory responses to tyramine and NA are shown in
Pigs. 4/XI and 5/XI.
b. Depressant responses
The effects of desipramine were examined on 10
cells depressed by both tyrarnine and NA. On 8 of these
cells, the response to tyramine was antagonised., while
the response to NA was either potentiated (5 cells) or
unaffected (3 cells). On the remaining 2 cells, responses
to both amines were equally antagonised.
XI.3.3. COMPARISON OP THE TRANSPORT NUMBERS OP TYRAMINE
AND NORADRENALINE
The transport numbers of tyramine and NA were
































shown in Table 3/kI. There was no significant difference between
the transport numbers of tyramine and NA (paired t test; p = 0.115).
XI.4. DISCUSSION
There have been only a few studies of the pharmacological
actions of tyramine in the brain. Hoffer et al. (1971) reported
that tyramine, similarly to NA, could evoke depressant responses on
cerebellar Purkinje cells. These authors suggested that tyramine
might have primarily a direct post-synaptic effect in the bradn,
since responses to tyramine could be evoked after pretreatment with
6—hydroxy-dopamine, an agent which destroys NA-containing nerve term¬
inals (Bloom et al., 1969). On the other hand, there is evidence
that the machinery exists in the brain for an indirect action of
tyramine: 1. tyramine is accumulated by an active uptake process
into brain tissue (Ross & Renyi, 1966); 2. this uptake process is
inhibited by desipramine (Steinberg & Smith, 1970); and 3. tyramine
can displace NA from brain synaptosomes (Colburn & Kopin, 1972).
The experiments presented in this Chapter seem to support the
hypothesis that tyramine may have an indirect action in the brain.
XI.4,1. THE AGONISTIC EFFECT 0? THIAMINE ON CORTICAL NEUR0IT5S
Tyramine, when applied by microelectrophoresis to
spontaneously active cortical neurones, could evoke both excitatory
and depressant responses. There were similarities between the
agonistic effects of tyramine and NA: 1. every tyramine—sensitive
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TABLE 3/XI. Transport numbers of noradrenaline and tyramine obtained
from eiffht six-barrelled, micropipettes
Transport number
(mean —--s.e.m. of 8 observations)
Noradrenaline Tyramine
1 4.0 0.292 - 0.013 0.391 - 0.025
2 3.5 0.229 i 0.046 0.460 ~ 0.049
3 5.0 0.257 ± 0.015 0.248 - 0.013
4 4.0 0.409 - 0.012 0.432 ~ 0.014
5 4.0 0.250 - 0.016 0.279 - 0.009
6 4.0 0.197 - 0.009 0.253 - 0.011
7 4.0 0.255 1 0.003 0.265 - 0.006
8 5.0 0.377 1 0.008 0.367 - 0.014
Pipette Tip diameter
(11m)
Paired t-test; p = 0,115
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cell was also sensitive to NA; 2. the vast majority of the neurones
responded in the same directions to the two amines: neurones excited
hy tyramine being also excited by NA, and neurones depressed by
tyramine being also depressed by NA.
When compared on the same neurones, tyramine appeared to
have a lower potency than NA. Since there was no significant
difference between the transport numbers of tyramins and NA, it
can be assumed that identical ejecting currents resulted in similar
rates of release of the two amines from the micropipettes (see
Chapter II). It is probable, therefore, that the observed difference
in potency reflects a genuine biological difference between the two
drugs. The lower potency of tyramine may reflect an indirect action
of the amine, since it has been reported that tyramine does not
displace NA stoichimometrically from adrenergic terminals (Axelrod,
et al., 1962).
The responses to tyramine had a slower time-course (longer
latency and longer recovery time) than responses to NA. Such a
difference between the time—courses could reflect a difference
between the physical mobilities of tyramine and NA molecules (sea
Szabadi & Bradshaw, 1974)» This is, however, not likely to have been
the case in the present experiments, since the transport numbers of
the two drugs were very similar, indicating similar mobilities for
the tyramine and NA molecules. The slower time-course of the response
to tyramine may reflect the time which is required for the tyramine
molecules released from the micropipette to reach the NA—containing
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nerve terminals, to "be taken up "by the terminals, to displace and
release KA, and for the released NA molecules to reach the post¬
synaptic receptors.
XI. 4» 2. THE EFFECT OF DE3IPRAHIKE ON NEURONAL RESPONSES TO TYRAMIKS
Desipramine, applied continuously from one "barrel of the
micropipette, could discriminate "between neuronal responses to
tyramine and NA: while responses to tyramine were antagonised, responses
to KA 'were potentiated. A similar discrimination by desipramine between
pharmacological responses to tyramine and KA has been reported in the
periphery (Barnett et al., 1968; Fozard & Mwaluko, 1976). The most
plausible explanation for this observation is the blockade of the KA-
uptake mechanism by desipramine: uptake blockade would prevent
tyramine from reaching the presynaptic KA stores, and thus would
prevent the pharmacological response; on the other hand, uptake
blockade would result in potentiation of the response to KA by
interfering with the major process of removal of KA from the post¬
synaptic receptor sites (see Iversen, 1974)• Indeed, there is
evidence that desipramine blocks the uptake of both KA (Ross & Renyi,
1967) and tyramine ( Ross & Renyi, 1967 ) into brain tissue.
Although potentiation of the response to KA could sometimes
be observed when the response to tyramine was antagonised (see Pig.
5/xi), on many occasions no potentiation of the response to KA could
be seen (see Pig, 4/Xl). This observation may reflect a separate
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postsynaptic action of desipramine. It is well documented that
desipramine has postsynaptic adrenoceptor blocking properties in
the periphery (Callingham, 1966; Sturman, 1971? McCulloch & Story,
1972). Furthermore, the experimental evidence presented in Chapter
VIII shows that desipraraine can antagonise responses of cortical
neurones to NA. It is possible, therefore, that, in some experi¬
ments, the blockade of post—synaptic receptors by desipramine
prevented the development of the potentiation of responses to NA
which would have resulted from the pre-synaptic uptake blockade.
The present results are compatible with the hypothesis
that there is a close relationship between uptake blockade and
potentiation of neuronal responses to NA. There is evidence,
however, that desipramine can potentiate neuronal responses to KA,
and to other monoamines, in situations where uptake blockade is
unlikely to operate. Thus responses to KA and dopamine are
potentiated in the caudate nucleus (Sevan et al., 1975^) where
desipramine is ineffective in blocking the uptake of catecholamines
(Horn et al., 197l). Iprinaole, a tricyclic antidepressant which
is ineffective in blocking the uptake of NA into brain tissue
(Ross et al., 1971)? can potentiate neuronal responses to NA (see
Chapter IX). Finally, neuronal responses to mescaline are also
potentiated by desipramine (see Chapter X), although the uptake
of mescaline into brain synaptosomes is not affected by desipramine
(Sevan et al., 1977)• These observations suggest that, although
blockade may result in potentiation, its presence is not a pre¬
requisite for potentiation, and that there may be some postsynaptic
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mechanisms which contribute to the potentiation of neuronal responses
to IIA by desipraraine (see IX.4»).
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APPENDIX
ANTAGONISTIC AGONISM: A THEORETICAL MODEL
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A.l. PRSFAGS
The experiments described, in this thesis (see
Chapters IV, V, VI, VII) show that noradrenaline (NA)
applied by microelectrophoresis can have both excitatory
and depressant effects on single cortical neurones, suggesting
the presence of both excitatory and inhibitory receptors for
NA. Furthermore, there is evidence indicating that both
excitatory and inhibitory receptors for NA can co-exist on
the same cells (see Chapters IV and V).
The review of the literature suggests that the
co-existence of two functionally opposite receptor populations
for the same agonist in the same pharmacological test system
is a common phenomenon. The theoretical model presented in
this Appendix examines the quantitative pharmacology of these
•opposite receptors'.
A.2, INTRODUCTION
A pharmacological agonist can have either of two
effects on a muscular or a neuronal test system: it can
cause either an increase (i.e. excitation) or a decrease
(i.e. inhibition) in the activity of the system. Pharmacological
receptors mediating these effects can therefore be classified
on a functional basis as excitatory or inhibitory receptors.
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A special case of drug action is when the same agonist can
activate both excitatory and inhibitory receptors in the
same effector tissue. As the two kinds of receptor are in
a functionally antagonistic relationship, the term antagonistic
agonisrn could be used to describe this type of drug action.
Dale reported in 1906 (Dale, 1906) that adrenaline can act
at both excitatory and inhibitory receptors in the vascular
bed, and Furchgott suggested in 1955 (Furchgott, 1955) that
these receptors may occur on the same smooth muscle cell.
It has emerged, however, only during the last decade that
many physiologically important drugs may activate two opposing
receptor populations both on smooth muscle cells and on
neurones.
A,2.1. FUNCTIONALLY OPPOSITE RECEPTORS ON SMOOTH MUSCL2 CSLLS
A review of the literature reveals that most of the
sympathomimetic amines can activate 'opposite receptors' in
smooth muscle preparations. Adrenaline and noradrenaline
act at both excitatory and inhibitory receptors in the vascular
smooth muscle (Furchgott, 1955j Guimaraes & Osswald, 1969) >
in the heart (Govier, Mosal et al., 1966; Benfey & Varma, 1967),
in the gut (Guimaraes, 1969; Haffner et al., 1969; Belisle
& Gagnon, 1971; Haffner, 1971; Tamayo et al., 1974). in the
guinea pig trachea and lung (Sveritt & Cairncross, 1969?
Persson & Johnson, 1970) t in the mouse spleen (ignarrc &.
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Titus, 1968), in the cat nictitating membrane (Smith, 1963),
and in the rat uterus (Diamond & Erody, 1966). Isoprenaline
activates both kinds of receptor in the vascular smooth
muscle (Purchgott, 1955; Guimaraes & Osswald, 1969? DiSalvo
& Pell, 1974)» in the gut (Guimaraes, 1969), in the mouse
spleen (ignarro & Titus, 1968), in the cat nictitating
membrane (Trendelenburg et al., 1971? Trendelenburg, 1974)»
in the guinea pig vas deferens and seminal vesicle (Large,
1965; Spedding & Weetman, 1972), and in the human urinary
bladder (Awad et al., 1974) • Pher.ylephrine acts at
opposite receptors in the heart (Eenfey & Varma, 1967),
in the gut (Guimaraes, 1969; Haffner, 1971? Gagnon, 1972),
and in the human urinary bladder (Awad et al., 1974)• Both
metaraminol and methoxamine activate both types of receptor
in the gut (Gagnon, 1972). Dopamine acts at both excitatory
and inhibitory receptors in the vascular smooth muscle
(Goldberg, 1975)• In general, the excitatory receptors
are of the cL type, whereas the inhibitory receptors are of
the p type (Ahlquist, 1948).
Similarly to the catecholamines, histamine can also
activate both excitatory and inhibitory receptors in some
tissues, such as rabbit blood vessels (Glover et al., 1973;
Parsons & Owen, 1973), pulmonary vessels in the guinea pig
(Okpako, 1972; Goadby & Phillips, 1973), and sheep bronchi
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(Eyre, 1973). In all these tissues the excitatory receptors
are of the type, whereas the inhibitory receptors are of
the type (Black et al., 1972).
A.2.2. FUNCTIONALLY OPPOSITE RECEPTORS OK NERVE CELLS
a. Invertebrates
The existence of opposite receptors to acetylcholine
has been described on abdominal ganglion cells in Aplysia
(Wachtel & Kandel, 1967)f on buccal ganglion cells in
Aplysia (Gardner & Kandel, 1972), on pleural ganglion cells
in Aplysia (Kehoe, 1972a; 1972b), and on the buccal ganglion
cells of the mollusc Kavanax (Levitan & Tauc, 1972; 1975)•
The excitatory receptor mediates an increase in sodium
permeability, and can be blocked by both curare and
hexamethonium (Kehoe, 1972a; 1972b; Kehoe & Harder, 1976).
It has been possible to separate two inhibitory receptors
which differ from each other in ionic selectivity and
pharmacological specificity. One kind of inhibitory receptor
mediates an increase in chloride permeability, and can be
blocked by curare, but not by hexamethonium. The other kind
of inhibitory receptor mediates an increase in potassium
permeability, and can be selectively blocked by tetraethyl—
ammonium (TEA), but not by curare (Kehoe, 1972a; Kehoe & Harder,
1976). The sodium-dependent excitatory receptor can co—exist
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with the chloride-dependent inhibitory receptor (Gardner &
Kandel, 1972; Kehce, 1972b; Levitan & Tauc, 1972; Levitan
& Tauc, 1975)» with the potassium—dependent inhibitory
receptor (Kehoe, unpublished; see Kehoe, 1972b), or
indeed with both types of inhibitory receptor (Kehoe,
1972b). The stimulation of the presynaptic neurons can
evoke a biphasic synaptic potential consisting of an
excitatory post-synaptic potential (EBSP) and an inhibitory
post-synaptic potential (IPS?) (Gardner & Kandel, 1972;
Levitan & Tauc, 1975)» or an EPSP at low frequency of
stimulation, which is reversed into an IP3P as the stimula¬
tion frequency is increased (Wachtel & Kandel, 1967), or
a monophasic EPSP which is converted into an IPSP by
hexamethonium, the specific blocker of the excitatory
receptors (Kehoe, 1972b).
Dopamine can also activate both excitatory and
inhibitory receptors on the same neurones in the pleural
ganglion of Aplysia (Ascher, 1972; Ascher, 1973)» and in
the pleural ganglion of Planorbis (Serry & Cottrell, 1973;
1975) • Tbe excitatory receptor probably mediates an increase
in sodium permeability (Ascher, 1973), and can be blocked
by curare and strychnine, but not by hexamethonium (Ascher,
1972; Ascher, 1973; Berry & Cottrell, 1975)• The inhibitory
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receptor mediates an increase in potassium permeability
(Ascher, 1972), and can be blocked by ergometrine (Ascher,
1972; Ascher, 1973J Berry & Cottrell, 1975)- The stimulation
of the presynaptic neurone can evoke a biphasic post-synaptic
potential consisting of an EPSP followed by an IPSP (Berry
& Cottrell, 1972; 1975).
Opposite receptors to glutamate have been described
on neurones in the suboesophageal ganglion of the snail
(Helix aspersa): the excitatory receptor is stimulated by
kainic acid and quisqualic acid, whereas the inhibitory
receptor is stimulated by quisqualic acid, but not by
kainic acid (Walker, 1976). The cells containing both
receptors respond in a biphasic fashion to glutamate: an
initial inhibitory phase is followed by an excitation
(Walker, 1976).
b. Vertebrates
Both excitatory and inhibitory receptors to
5-hydroxyt ryot am ine ("Be Groat & Lalley, 1973) and to histamine
(Brimble & Wallis, 1973) have been described on sympathetic
ganglion cells.
Both excitatory and inhibitory receptors to acetylcholine
have been described on single neurones in the mammalian CHS
(see Krnjevii, 1974? 1975)- There are two kinds of excitatory
a
receptor: mucarinic receptor whose activation results in a
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reduction in potassium perraeability, and a nicotinic receptor
mediating an excitatory response via an increase in "both
sodium and potassium permeabilities (Krnjevi6, 1975)* The
inhibitory acetylcholine receptor is muscarinic, and its
activation results either in an increase in potassium
permeability, or a reduction in sodium permeability (Krnjevic,
1975)• There is experimental evidence indicating that both
excitatory and inhibitory acetylcholine receptors can co¬
exist on the same neurone. It has been reported that acetyl—
jS -methylcholine, a muscarinic agonist, depresses neurones in
the supraoptic nuclei of cats, whereas the same neurones are
excited by nictotine; the depressant responses are antagonised
by atropine, whereas the excitatory responses are antagonised
by dihydro- (3-erythroidine (Barker et al., 197l)» A- similar
observation was made in the brain stem (Bradley & Bray, 1976):
the same neurone could be excited by acetylcholine, but
depressed by muscarine; nicotine was always excitatory.
The monoamines noradrenaline, dopamine and 5~hydroxy-
tryptamine applied by microelectrophoresis can evoke both
excitatory and depressant responses on neurones in the mammalian
brain (see Curtis & Crawford, 1969; Krnjevic, 1974)- 4
neurone can respond in a biphasic fashion to a monoamine:
an initial depressant phase is followed by an excitatory
phase suggesting that both inhibitory and excitatory receptors
may co-exist on the same cell (see Chapter IV). The
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experimental evidence presented in Chapter V suggests that
noradrenaline can stimulate both ot— and ^—adrenoceptors on
cortical neurones, and that the -receptors mediate excitatory,
and the (^-receptors mediate depressant responses. There is also
evidence suggesting that the functionally antagonistic oi— and
receptors can co-exist on the same cell: the same cell can be
depressed by a low dose of isoprenaline and salbutamol
(stimulants of ^—receptors), and excited by methoxamine and
phenylephrine (stimulants of od-receptors); a lower dose of
isoprenaline evokes depressant responses (by stimulating ^ —
receptors), whereas a higher dose causes excitation on the same
cell (probably by stimulating cL —receptors as well); the antagonism
of excitatory responses to adrenergic agonists by od—adrenoceptor
blocking agents can unmask an underlying depression, and antagonism
of depressant responses by -adrenoceptor blocking agents can
reveal an excitatory response.
A.3. TH3 M0D3L
Ariens et al. (1964b) used the term 'double agonism*
in order to describe the phenomenon when: *a compound induces an
effect by interaction with two different specific receptors but
by means of a common effector*.
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Antagonistic agonism can "be defined as the special
-
, x
case of double agonism when the two receptors activated
by the agonist mediate opposite effects. If it is assumed
that the two kinds of receptor are functionally independent,
the model described for "functional antagonism" can be applied
(see Ariens et al., 1964b). According to this model the
total effect is obtained as the algebraic sum of the
individual effects produced by the activation of each kind
of receptor. This antagonistic agonism can be described by
the following scheme:
, 7
In deriving equations for drug-receptor interaction
at each of the receptors the same general postulates are
used as described by van Rossum (1966). A further simplifying
assumption which is made in the ensuing discussion is that
no 'spare receptors' (Stephenson, 1956) are present in the
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system. (When a receptor reserve exists for either of the
two kinds of receptor, it has been argued that 'biological
stimuli' rather than effects should be summated in order
to derive the total effect j^see van den Brink 1971 j 1973^} )•
The following notation is used in this Chapter:
A stands for the agonist;R^+^ and R^ ^ are the opposite
receptors; ®(+) anc^ ®( ) are effects produced by the
interaction between drug A and ) respectively;
E^ is the total effect observed. (N.B. The subscripts (+)
and (-) are used here to indicate the opposing nature of
the two receptor populations; (+) does not necessarily mean
'excitatory', nor does (—) necessarily mean 'inhibitory'.)
A.3.1. RELATIONSHIP BETWEEN AGONIST CONCENTRATION AIJD EFFECT
The interaction between agonist A and the opposite
receptors ^ can be broken down into the
following two steps:
1. Relationship between agonist concentration and











where an^ ^( ) are intrinsic activities of A on
and ^ respectively; ^A(h) ant^ ^A(-) arS ^^ssoc^a^^-on
constants for the drug-receptor complexes an^- AR^ )
respectively; M is the concentration of the agonist.
2. Summation of the effects:
Bt-E(+)-E(-)' <2>
where E. is the total effect,
t
As a concentration—effect curve is defined by the
'A®values of &{ and Kft? the concent rat ion~E, curve can be
obtained if the relative values of U. ^ ( ^ and ^, and of
^A(+) an^ KA( ) are known. ikis basis, it is possible to
distinguish between five different cases of agonist action.
These five cases are illustrated in Fig. 1/Appendix» This
figure shows for each of the five cases the relationship
between agonist concentration [a] and effects and
(broken lines), and also the resulting concentration—total
effect curve obtained by the summation of the two individual
curves (solid line). In calculating these curves, it was
assumed, for the sake of simplicity, that the baseline activity
of the test system is half-way between maximum inhibition
and maximum excitation, i.e. the range of effect (r) is the
same in both directions: ~ r( )• For"the calculations
of the curves, the agonist-.concent rat ion was expressed as














££52-1= c£(+) = ^(_) i Ka(+) - Ka(_}
In this case, the two concentration-effect curves are mirror
images of each other, and for any value of [A], = E^,
and E = 0. Thus the functional antagonism is complete, andX
no response can be observed.
£s£-2= ^(+) - *(_) ; Ki(+) <ka(_)
In this case, the relationship between concentration and
is described by a monophasic bell-shaped curve. As [A]
increases, E^ first increases up to a peak, and then declines
asymptotically towards zero. The value of A which corresponds
to E (the peak value of E, ) may be called the 'reversal
XlTlclX X
concentration' c Wxt) for thejconcentration—effect curve.
Since at all values of [a} E^ the activation
of R, x overrides the effect of the activation of R \. Thus
(+) -)
R^^ can be called the dominant, and R^ ^ the masked receptors
(see IV.4.1.).
Cas8 3: ^ (+) > ^(-)5 KA(+) - KA(-)
In this case, the relationship between concentration and E^
is described by a monophasic saturation curve, in which
^tmax r(+) *
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case 4: °^(+) > ^(-); ka(+)<ka(~)
In this case, E first rises to a peak (Ej_ ), and then*t bmax
declines asymptotically to a plateau level.
sasaa: (+) > «T(_) t ka(+)> ka(-)
In this case, a biphasic curve describes the relationship
between agonist concentration and E^. The first phase
has a trough which is attained at M- Wr. The curve
intersects the line representing the baseline activity of
the system at a well-defined point. The agonist concentration
value corresponding to this point can be called the *iso—response'
concentration ( [a] ) since if [a] = e^_ = 0. If
M <W±» E(_ ^•^,E^+^, and E^ is in the negative direction,
indicating the dominance of • -f IaI z7 E(„)*
and E is in the positive direction, indicating the dominance
of Thus at [a] = [A], a switch in receptor dominance
occurs.
The five cases of agonist action described above
exhaust all the possibilities, since (+) and (-) are formally
identical (either can stand for excitatory, or either
for inhibitory). Thus the case where ^ and
EA(+) ^A(-) "t° Case 4»
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A.3,2, THS ACTION OF ANTAGONISTS
Let us consider how a drug B acting at and/or
**(-) change the interaction Between drug A and
and/or R^ ^ respectively, and how this is reflected in the
concentration-effect curves shown in Fig. i/Appendix. For
the sake of simplicity, let us assume that Ji= 0 (where |3 is
the intrinsic activity of B), and thus B acts as a competitive
antagonist of A (Ariens et al., 1964a). Thus the equation












KA(-) + M + kA(-) —
KB(-)
t »
where E and E ^ ^ are the effects in the presence of
B; is the dissociation constant for the antagonist-
receptor complex BR^ is the dissociation constant
for BR^_\, and[sjis the concentration of antagonist B.
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The total effect in the presence of antagonist B
(E ) will he:"t
E't =eV) ""eV) (5)
Equation (5) was used in order to calculate how
the concentration-effect curves shown in Pige 1 change in
the presence of given concentrations of B (see Pig. 2/Appendix)«
Three types of competitive interaction are discussed.
Type A interaction: ^g(>N = ,?0 ^ (see Column A in Pig.
In this type of interaction, the concentration-effect curve
resulting from the interaction Between A and R^ ^ will he
displaced to the right in a parallel fashion, whereas the
concentration-effect curve resulting from the interaction
between A and
^ will not change. The shift in the concentration-
E/ \ curve will result in an increase in E, for all values(-) t
of [A] (i.e. E .j."p>E_j_), The observed pharmacological effect
Will depend on the algebraic sign of E,• If E, = 0, drug B
"G u
will unmask a positive effect (l in Column A); if E_|_ 0,
drug B will potentiate a positive effect (2, 3, 4 and 5 in
Column A); if E^ < 0, drug B will antagonise or reverse a
negative effect (5 in Column A).
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Type B interaction: ) (see Column B in Fig. 2).
In this type of interaction, the concent ration-E^^ and the
concentration-3^_^ curves will he displaced to the right to
the same extent "by a given value of [b(\ , and this will
result in a parallel shift of the concent rat ion-E^ curve
to the right. In Case 1, where E^ = 0, drug B will not "be
able to unmask either a positive or a negative effect. In
Case 3t the simple saturation curve will be displaced to the
right, and thus E <( E at all values of Fa] , i.e. the
"Co
pharmacological effect of B will be antagonism of the positive
effect. In Cases 2, 4•> and 5. where the concent rat ion-E.,
U
curves have ascending and descending limbs, a displacement
of the curve to the right will result in an intersection
t
between the concentration-E, and the concentration-E,t x
curves. The point of intersection can be defined as the
value of £a| ([A3^a» or • isc-antagonism' concentration)
at which e = e . If [a] [a] . , e a e, , i.e. drug b"Co t ^ 13, X X
antagonises the effect; if [a! E i«e»
drug B potentiates the effect (2, 4 and 5 in Column 3).
An increase in £3] will cause an increase in the value of
Mia (2. 4 and 5 in Column B) , and also in the value of [a] ^
(5 in Column B),
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Type C interaction: = °<><^^s(+) (see Column C in Pig.
In this type of interaction, S for all values of U1 •
The observed, pharmacological effect will depend on the
t
algebraic signs of and E : 1. if E^ = 0, the effect of
B will he unmasking of a latent negative response (l in Column C);
t
2, if E ■> 0, and E + > 0, the effect of B will he antagonism13 X T
of a positive response (2, 3, 4 a^d 5 in Column C); 3. if
t
0, and E ^ 0, the effect of B will he reversal of a
positive response (2, 3, 4 and 5 in Column C); A. if ^ 0T
the effect of B will he potentiation of a negative response
(5 in Column C). Increasing concentrations of B may produce
qualitatively different effects: 1. a lower concentration
of B may cause antagonism of a positive response; 2. a
higher concentration may cause reversal of a positive response;
3. a still higher concentration may potentiate the reversed
response (2, 3 and 4 in Column C).
Competitive interactions of Types A, B and C are
extreme examples, hut they can he used for deriving intermediate
types. If X_g^, hut , the effect of drug
B on the concentration-effect curves will he a combination
of Types A and B. Thus a lower concentration of drug B
may potentiate, whereas a higher concentration may .antagonise
the response to a given concentration of drug A. Similarly,
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if Kg/+^< but "the effect of drug B on
the concentration-effect curves will be a combination of Types
B and C. Thus a lower concentration of drug B may antagonise,
a higher concentration may reverse the response, whereas
a still higher concentration may antagonise the reversed
response.
A.4. APPLICATIONS OF THB MODEL
In this section the different cases of agonist
and antagonist action described by the model are illustrated
by experimental examples taken from the literature. Although
alternative explanations might be found for some of the
experimental findings referred to, the model has the
advantage of offering a comprehensive framework for the
interpretation of a wide range of agonist and antagonist effect.
A.A.I. UMASKING OF LATENT RESPONSES
In Case 1 of antagonistic agonism no response to
the agonist is obtained although the agonist activates both
excitatory and inhibitory receptors (see Fig. l/Appendix).
The existence of receptor activation can be revealed by an
antagonist which selectively blocks one kind of receptor
(e.g. inhibitory), and thus unmasks a latent response resulting
from the activation of the opposite type of receptor
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(e.g. excitatory).
Thus the unmasking of latent excitatory adrenergic
responses hy ^-adrenoceptor blocking agents, and of latent
inhibitory responses by od—adrenoceptor blocking agents has
been described (Govier et al.t 1966; Everitt & Cairncross,
1969; Persson & Johnson, 1970)»
A.4.2. BELL-SHAPED DOSE-RESPONSE CURVES
Bell-shaped dose-response curves characterize
Case 2 of antagonistic agonism. The role of the opposite
receptors in these curves can be revealed either by the
use of selective blockers of one receptor kind, or by the
use of agonists acting only at one kind of receptor.
In the rat stomach fundus, the bell-shaped
excitatory dose-response curve to adrenaline can be
converted either into an excitatory saturation curve by
propranolol, a blocker of inhibitory ^—receptors, or
into an inhibitory saturation curve by tolazoline, a
blocker of excitatory oA—receptors (Tamayo et al, 1974) •
In the guinea pig vas deferens and in the human urinary
bladder, the bell—shaped inhibitory dose-response curve
to isoprenaline can be converted into an inhibitory satura¬
tion curve by phenoxybenzamine, a blocker of masked
excitatory cA-receptors (Large, 1965; Awad et al., 1974)»
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In the guinea pig pulmonary artery, the hell-shaped dose
effect curve to histamine can "be converted into an inhibitory
curve by mepyramine, a blocker of the dominant receptors
(Okpako, 1972). On neurones in the supraoptic nucleus,
acetylcholine, acting at both excitatory nicotinic, and
inhibitory muscarinic receptors, evokes an excitatory
bell-shaped dose-response curve; the dose-response curve
to nicotine is a simple excitatory saturation curve (Sakai
et al., 1974).
Bell—shaped dose—response curves in themselves,
however, do not necessarily indicate an action at opposite
receptors: such curves can also result from auto—inhibition
(Ariens et al., 1964b) or desensitization (Bown et al»,
1973? Frankhuijzen, 1975)*
A.4*3. BIPHASIC DOSE-HESPONSB CURVES
A biphasic dose-response curve (cf. Case 5 of
agonist action) to isoprenaline has been obtained in the
guinea pig seminal vesicle and vas deferens (Spedding &
Weetman, 1972); in the mouse spleen (ignarro & Titus, 1968);
and in the cat nictitating membrane (Trendelenburg, 1974)*
Similarly, biphasic dose-response curves to noradrenaline
and adrenaline have been described in the rabbit heart
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(Benfey & Varma, 1967)- In..all these cases, the first phase
of the curve reflects the activation of (J~, and the second
phase reflects the activation of 06"receptors, indicating
that isoprenaline, noradrenaline and adrenaline have a
greater affinity for than for U-receptors, and also
that these agonists have a greater intrinsic activity at
0L- than at ^-receptors.
A.4*4. POTENTIATION BY ANTAGONISTS
The model predicts that the selective blockade
of masked receptors will result in the potentiation of the
response (see Column A in Pig. 2/Appendix).
In the case of opposite adrenoceptors, the potentiation
of excitatory ( c£- ) actions by ^-adrenoceptor blocking agents
and of inhibitory (^) actions by ^-adrenoceptor blocking
agents is well documented (Large, 19&5i Ignarro & Titus, 1968;
Guimaraes, 1969; Haffner et al, 1969; Persson & Johnson, 1970;
DiSalvo & Pell, 1974; Trendelenburg, 1974)* In "the case
of opposite histamine receptors, the potentiation of both
excitatory and inhibitory actions of histamine by
and receptor blocking agents, respectively, has also
been described (Eyre, 1973; Glover et al., 1973; Goadby &
Phillips, 1973; Parsons & Owen, 1973).
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A.4. 5» REVERSAL BY ANTAGONISTS
According to the model, the selective blockade of the
dominant receptors may result in the reversal of the response
(see Column C in Fig. 2/Appendix).
In the case of opposite adrenoceptors, the reversal
of excitatory (<=£) actions by tL —adrenoceptors blocking agents,
and of inhibitory ( (J ) actions by adrenoceptors blocking
agents is well documented (Large, 1985; Diamond & Brody, 1966;
Ignarro & Titus, 1968; Everitt & Cairncross, 1969? Guimaraes
& Osswald, 1969; Haffner et al, 1969? Persson & Johnson, 1970?
Belisle & Gagnon, 197l). I** the case of opposite histamine
receptors, the reversal of both excitatory H-^ and inhibitory
actions of histamine by and receptor blocking agents,
respectively, has also been described (Okpako, 1972; Eyre,
1973; Goadby & Phillips, 1973).
A.4.6. TILS DUAL ACTION OF ANTAGONISTS
An antagonist may have affinity for both the excitatory
and inhibitory receptors (see Column B, Fig. 2/Appendix), but
the affinity for one kind of receptor may be greater than
for the other one. Such an antagonist may be called a
• dual antagonist'.
It is well documented that traditional [i —adrenoceptor
blocking agents block not only but also o(.-adrenoceptors,
and that od-receptor blockade occurs at somewhat higher
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concentrations than is required for the blocade of (3 —
receptors (Patil et al.t 1968; Gulati et al., 1969)•
In systems which contain both ^ — and <4-receptors it
has been demonstrated that low concentrations of |3>-
adrenoceptor blocking agents can potentiate excitatory
responses to adrenergic agonists, whereas higher concentrations
of the same antagonists antagonise the responses (Burks &
Cooper, 1967).
A.5. POSSIBLE FUNCTIONAL SIGNIFICANCE OF OPPOSITE RECEPTORS
ON NEURONES
'Antagonistic agonism', resulting from the action of a
neurotransmitter at both excitatory and inhibitory receptors on
the same post-synaptic membrane, is a paradoxical phenomenon:
it is difficult to see the immediate biological purpose of such
a mechanism. Although there are indications that this phenomenon
may exist in the mammalian central nervous system, it seems to
be more prevalent in invertebrates, suggesting that we are dealing
with a phylogenetically old arrangement. It is of interest that
a similar organisation of receptors is common on smooth muscle
cells where functionally antagonistic and ^-adrenoceptors
have been known to exist since Dale's classical experiments with
ergot (Dale, 1906;for review see A.2.).
- 285 -
A.5.1. THE TIME—COURSE 0? NEURONAL RESPONSES
The action of a neurotransmitter at functionally masked
receptors may influence the time-course of the response determined
by the activation of the dominant receptors: the latency of the
response will be elongated and the recovery phase will be shortened.
Furthermore, the activation of masked receptors may create a
contrast effect: if, for example, the dominant receptors are
excitatory, the excitatory responses may be preceded and followed
by inhibitory phases, resulting from the selective activation of
the inhibitory receptors at low concentrations of the agonist.
A.5,2. SWITCH BETWEEN EXCITATION AND INHIBITION
The existence of both excitatory and inhibitory receptors
to the same neurotransmitter substance on the same membrane creates
a degree of plasticity for synaptic transmission: the net effect of
the same transmitter may be excitatory or inhibitory in the same
synapse depending on the relationship between the two kinds of
receptor. Therefore, it is important to understand all those
factors which may influence this relationship.
If the neurotransmitter evokes a biphasic dose response
curve (see Case 5 of antagonistic agonism), the direction of the
effect will depend on the dose applied: a low dose may be, for
example, inhibitory, and a higher dose may be excitatory. This
suggests that the amount of transmitter released from the pre¬
synaptic neurone may play a crucial role in determining xhe polarity
of the post-synaptic potential.
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The pre-synaptic neurone, however, can also modulate
the relationship "between the two opposite receptors in a different
way: if the post—synaptic membrane is exposed to a higher concentration
of the transmitter for a longer period, as may occur at higher
firing frequencies of the pre-synaptic neurone, one kind of
receptor may be selectively desensitised thus creating the
possibility for the reversal of the response (Wachtel & Kandel,
1967)• Thus, the same synapse may be excitatory at low levels
of synaptic activity, and inhibitory at higher levels of activity
(Wachtel & Kandel, 1967).
The relative contribution of each kind of receptor to the
net effect may also depend on the level of activity of the post¬
synaptic cell. It has been reported that the sizes of the
excitatory and inhibitory phases of biphasic responses to dopamine
in ganglion cells in Planorbis depend on the membrane potential:
as the cell is hyperpolarised, the excitatory phase increases and
the inhibitory phase decreases (Berry & Cottrell, 1975)• Similarly,
the effects of exogenously applied monoamines on cerebral cortical
neurones seem to be influenced by the baseline level of activity
of the post-synaptic neurone: excitatory responses being more common
at lower, and depressant responses being more frequent at higher
firing rates (see IV,3,2.), These observations suggest the
importance of other inputs to the post—synaptic cell in influencing
the relationship between the two opposite receptors.
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